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Abstract 
Abstract 
The interaction of metal complexes with DNA is the subject of tremendous interest 
because of its relevance in the development of new agents for biotechnology and 
medicine. Since DNA is the primary cellular receptor, many metal complexes exert their 
antitumour effects through binding to DNA, thereby interfere in the complicated 
mechanism of uncontrolled proliferation and contribute to the elimination of neoplastic 
cells by inhibiting replication, by inducing differentiation or by triggering apoptotic 
processes. 
Transition metal complexes can interact with DNA covalently or non-covalently by 
intercalation, groove binding or external electrostatic binding. Among the various factors 
governing the binding modes, the most significant is the 'molecular shape' of the 
interacting metal complex. Studies reveal that the ligand modifications in geometry, size, 
hydrophobicity, planarity, charge and hydrogen-bonding of the complexes, lead to subtle 
or to spectacular changes in the binding modes, location, affinity, and to a different 
cleavage effect. The introduction of more hydroxy! residues is likely to change the nature 
and strengthen coordination and hydrogen-bond interaction of the complex with DNA. 
Changes in the hydrophilicity or lipophilicity also affect the cellular uptake of the 
compounds. In this regard, the rapidly expanding field of glycobiology has had a positive 
impact on medicinal inorganic chemistry. Appending a carbohydrate to a metal-binding 
ligand has the ability to reduce toxicity, improve solubility and molecular targeting to a 
wide variety of metal-based drugs. Carbohydrate ligands with chelating functions for 
metal ions viz. N-glycosides, amino sugars, Schiff bases of sugars etc have been 
developed to generate a well-defined binding environment as well as increase the stability 
of the resultant metal complexes. A potential benefit of carbohydrate appended metal 
complex lies in their facile transport at the molecular level. 
To rationalize these findings, we have synthesized and characterized a variety of novel 
series of carbohydrate complexes with first row transition metal ions and organotin 
chlorides. The interaction studies of these complexes with calf thymus DNA has been 
studied by UV/vis, fluorescence, circular dichroism spectroscopy, cyclic voltammetry 
and viscosity measurements. 
A new series of chiral complexes [Cu(D-GlcC en*)2 (H20)2]Cl2, [Ni(D-GlcC en*)2]Cl2, 
[Cu(D-GlcC ea*) (H20)2]Cl2 and [Ni(D-GlcC ea*) (H20)2]C1: bearing carbohydrate 
moieties were synthesized by the condensation reactions of D-gluconic acid with 
[M(en)2]Cl2 /[M(ea)2]Cl2 where M = Cu(II), Ni(ll), en = ethane-1,2-diamine ea = 
2-hydroxy ethylamine. The complexes are subsequently characterized by elemental 
analysis, various spectroscopies techniques, conductance measurements and polarimetry. 
Molar conductance measurements show that the complexes are ionic and the spectral data 
are indicative of octahedral geometry of the complexes [Cu(D-G!cC en*)2 (H20)2]Cl2 , 
[Cu(D-GlcC ea*) (H20)2]Cl2, [Ni(D-GlcC ea*) (H20)2]Cl2 and the square planar 
geometry of complex [Ni(D-GlcC en*)2]Cl2. Polarimetric data along with CD spectra 
establish the chiral nature of complexes. Solution stabilities of these complexes were 
evaluated by cyclic voltammetric techniques as a function of pH. Electrochemical 
behaviour of the complexes was studied in aqueous solution and showed an irreversible 
Cu'VCu' couple. Kinetic studies of complex [Cu(D-GlcC en*)2 (H20)2]Cl2 and [Cu(D-
GlcC ea*) (H20)2]Cl2 with calf thymus DNA have been investigated 
spectrophotometrically under pseudo-first order conditions, and kobs values have been 
evaluated. Circular dichroism, cyclic voltammetry determinations along with viscosity 
measurements have also been carried out to authenticate the binding of DNA with metal 
complexes. The experimental results suggest that complexes [Cu(D-GlcC en*)2 
(H20)2]Cl2 and [Cu(D-GlcC ea*) (H20)2]Cl2 bind to DNA by covalent bond formation. 
The novel macrocyclic complexes 2-amino-2-deoxy-A^-[2-(l,3,5,8,lI-
pentaazacyclotridecan-3-yl)ethyl]-p-D-glucopyranosylaminecopper(Il)/nickel(II) 
[MacCu/Ni (D-GlcN-en)*]Cl2 dichloride were prepared and thoroughly characterized by 
various techniques. Molar conductance measurements showed that complexes are ionic in 
nature. On the basis of spectroscopic data, both complexes were assigned a square-planar 
geometry and are found to be highly stable and hydrolytically robust in H2O over a wide 
range of pH, as confirmed by conductance measurements and cyclic voltammetry. The 
complex [MacCu (D-GlcN-en)*]Cl2 was found to bind to CT DNA, with a binding 
constant Kb of 2.4 x 10^  M~', as derived by UV/vis titration and confirmed by CV, 
circular dichroism and viscosity measurements. DNA binding seems to occur mostly via 
H-bonding. In an in vitro antitumour MTT assay, complex [MacCu (D-GlcN-en)*]Cl2 
III 
exhibited significant anticancer activity against the SY5Y and PC-12 cell lines, with an 
estimated IC50 value in the micromolar range, similar to the standard drug 5-fluorouracil. 
Organotin (!V) compounds have brond spectrum of biological activities especially 
anticancer activity. The presence of organic ligands viz. carbohydrates and their 
derivatives modifies their biological properties significantly. Organotin (iV) compounds 
have been widely used in synthetic carbohydrate chemistry, the reason being the 
regioselective directing power of the organometal cation towards reactivity of the sugar 
substrate. They provide reliable high yielding methods for obtaining mono substituted 
derivatives of diols or polyols with high selectivity. 
The novel Sn(lV) saccharide complexes l-{(2-ethoxy) imino}-2-amino-l, 2-dideoxy-D-
glucose tin (IV) dichloride (GATDC) and l-{(2-ethoxy) amino}-2-amino-l, 2-dideoxy-
D-glucose Iriphenyl tin (IV) (GATPT) were synthesized and characterized by 
spectroscopic (IR, 'H , '^C, 2D cosy and "^Sn NMR, EPR, UV-vis, FAB mass) and 
analytical methods. In both the complexes Sn(IV) metal ion is present in four coordinated 
environment as confirmed by "^Sn NMR spectroscopy. The interaction of complexes 
GATDC and GATPT with calf thymus DNA were studied by electronic absorption 
titration, luminescence titration, circular dichroism and viscometric measurements. Upon 
addition of CT DNA the absorption spectrum of GATPT exhibited hypochromism with a 
red shift of 3 nm while GATDC showed hyperchromism with no shift. Additionally 
there was a reverse effect on the specific relative viscosity of CT DNA bound to GATDC 
and GATPT. These results are suggestive of strong interaction of GATPT with CT DNA 
IV 
than GATDC. To evaluate the induction of apoptosis by GATPT MTT assay, DNA 
fragmentation and Hoechst 33342 DNA staining experiments were performed. 
Furthermore to investigate the gene mediated pathway of GATPT induced apoptosis 
western blot analysis of whole cell lysates and mitochondrial fractions were carried out 
with Bcl-2 and p-53 family proteins on a PC-12 cell line. Caspase-3 colorimetry assay 
were also carried out to ascertain the involvement of caspase-3 in GATPT triggered 
apoptosis. 
Compartmental ligands containing two adjacent but dissimilar coordination sites are of 
particular interest as for the recent recognition of the asymmetric nature of a number of 
bimetallic biosites. The ability of individual metal ions to play possibly different 
functions in dinuclear sites in metalloenzymes led to the design of a large number of 
asymmetric ligands where two compartments would provide a different coordination 
surrounding for the two metal ions. In view of this, diazine linkages have been utilized in 
a series of heterotrimetallic complexes in bringing two copper (11) centers into close 
proximity. The SchilTbase compartmental ligand Lib IC32II32N6O2J was .synthesized by 
employing a three step synthetic method which was metallated with copper(II), 
manganese(II), cobalt(ll), nickel(II) ions [LM"2Cl2] and was further metallated with 
tintetrachloride to yield heterotrimetallic complexes [LCu"/Ni"2Sn'^Cl6]. All the 
complexes were characterized by elemental analysis and various spectroscopic 
techniques. The homodinuclear complexes possess two different environments (N2 and 
N2O2 donor sets) for holding the metal ions. The metal ion in N2 set exhibits square 
planar geometry with two chloride ions in the inner sphere but rhombic structure is found 
in tetradentate N2O2 Schiff base cavity while in heterotrinuclear complexes Sn(lV) atom 
is in the octahedral environment. The interaction of complexes LCu 2CI2 and 
LCu"2Sn'^ 'Cl6 with calf thymus DNA was carried out by absorption spectroscopy and 
cyclic voltammetry. The intrinsic binding constants (Kb) of complex LCu 2CI2 and 
LCu'^ Sn'^ '^Clf, were determined as 3.2 x 10^  M'' and 9.6 x 10^  M"', respectively 
suggesting that complex LCu"2Sn'^ Cl6 binds more strongly to CT DNA than complex 
LCu"2Cl2. Fluorescence studies along with viscosity measurements were also carried out 
to authenticate the binding of metal complexes with DNA. 
In another set of experiments, carboxamide dinuclear complexes Bis [aqua 1,8-(1,2-
dicarboxamido benzene) 3,6-diazaoctane copper (II)/nickel (II)] tetrachloride 
[lVIacCu2/Ni2(BC)]Cl4 were synthesized by a two component one-pot metal template 
condensation between phthalic anhydride and i,8-diamino-3,6-diazaoctane. Elemental 
analysis, molar conductance measurements, electronic absorption, infra-red, electron 
paramagnetic resonance, nuclear magnetic resonance, atomic absorption and electron 
spray mass spectral studies have been performed to probe the nature and structure of the 
complexes. The interaction of the complex [MacCu2(BC)]Cl4 with calf thymus has been 
studied by using absorption, emission and circular dichoric- spectral methods, viscometry 
and cyclic voltammetry. A strong hyperchromism along with a red shift in UV bands and 
hypochromism in the ligand field band of the complex [MacCu2(BC)]Cl4 on interaction 
with CT DNA imply a covalent mode of DNA binding. This is supported by studying the 
VI 
reactivity of complex [MacCu2(BC)]Cl4 by CD and viscometry. The variation in relative 
emission intensity of DNA bound ethidium bromide observed upon treatment with the 
complex [MacCu2(BC)]Cl4 was consistent with the trend of DNA binding studies. Cyclic 
voltammetry studies revealed that the complex [MacCu2(BC)]Cl4 preferred to bind to 
DNA in Cu(ll) rather than Cu(I) oxidation state. 
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Abstract 
Abstract 
The interaction of metal complexes with DNA is the subject of tremendous interest 
because of its relevance in the development of new agents for biotechnology and 
medicine. Since DNA is the primary cellular receptor, many metal complexes exert their 
antitumour effects through binding to DNA, thereby interfere in the complicated 
mechanism of uncontrolled proliferation and contribute to the elimination of neoplastic 
cells by inhibiting replication, by inducing differentiation or by triggering apoptotic 
processes. 
Transition metal complexes can interact with DNA covalently or non-covalently by 
intercalation, groove binding or external electrostatic binding. Among the various factors 
governing the binding modes, the most significant is the 'molecular shape' of the 
interacting metal complex. Studies reveal that the ligand modifications in geometry, size, 
hydrophobicity, planarity, charge and hydrogen-bonding of the complexes, lead to subtle 
or to spectacular changes in the binding modes, location, affinity, and to a different 
cleavage effect. The introduction of more hydroxyl residues is likely to change the nature 
and strengthen coordination and hydrogen-bond interaction of the complex with DNA. 
Changes in the hydrophilicity or lipophilicity also affect the cellular uptake of the 
compounds. In this regard, the rapidly expanding field of glycobiology has had a positive 
impact on medicinal inorganic chemistry. Appending a carbohydrate to a metal-binding 
ligand has the ability to reduce toxicity, improve solubility and molecular targeting to a 
wide variety of metal-based drugs. Carbohydrate ligands with chelating functions for 
metal ions vi/.. N-glycosidcs, amino sugars, Schiff bases of sugars etc have been 
developed to generate a well-defined binding environment as well as increase the stability 
of the resultant metal complexes. A potential benefit of carbohydrate appended metal 
complex lies in their facile transport at the molecular level. 
To rationalize these findings, we have synthesized and characterized a variety of novel 
series of carbohydrate complexes with first row transition metal ions and organotin 
chlorides. The interaction studies of these complexes with calf thymus DNA has been 
studied by UV/vis, fluorescence, circular dichroism spectroscopy, cyclic voltammetry 
and viscosity measurements. 
A new series of chiral complexes [Cu(D-GlcC en*): (H20)2]Cl2, [Ni(D-GlcC en*)2]Cl2, 
[Cu(D-GlcC ea*) (H20)2]Cl2 and [Ni(D-GlcC ea*) (H20)2]Cl2 bearing carbohydrate 
moieties were synthesized by the condensation reactions of D-gluconic acid with 
[M(en)2]Cl2 /[M(ea)2]Cl2 where M = Cu(II), Ni(II), en = ethane-1,2-diamine ea = 
2-hydroxy ethylamine. The complexes are subsequently characterized by elemental 
analysis, various spectroscopies techniques, conductance measurements and polarimetry. 
Molar conductance measurements show that the complexes are ionic and the spectral data 
are indicative of octahedral geometry of the complexes [Cu(D-GlcC en*)2 (H20)2]Cl2 , 
[Cu(D-GlcC ea*) (H20)2]Cl2, [Ni(D-GlcC ea*) (H20)2]Cl2 and the square planar 
geometry of complex [Ni(D-GlcC en*)2]Cl2. Polarimetric data along with CD spectra 
establish the chiral nature of complexes. Solution stabilities of these complexes were 
evaluated by cyclic voltammetric techniques as a function of pH. Electrochemical 
behaviour of the complexes was studied in aqueous solution and showed an irreversible 
Cu'VCu' couple. Kinetic studies of complex [Cu(D-GlcC en*). (H20)2]Cl2 and [Cu(D-
GlcC ea*) (H20)2]Ci2 with calf thymus DNA have been investigated 
spectrophotometrically under pseudo-first order conditions, and kobs values have been 
evaluated. Circular dichroism, cyclic voltammetry determinations along with viscosity 
measurements have also been carried out to authenticate the binding of DNA with metal 
complexes. The experimental results suggest that complexes [Cu(D-GlcC en*)2 
(H20)2]Cl2 and [Cu(D-GlcC ea*) (H20)2]Cl2 bind to DNA by covalent bond formation. 
The novel macrocyclic complexes 2-amino-2-deoxy-A^-[2-(l,3,5,8,l 1-
pentaazacyclotridecan-3-yl)ethyl]-p-D-glucopyranosylaminecopper(II)/nickel(Il) 
[MacCu/Ni (D-GlcN-en)*]Cl2 dichloride were prepared and thoroughly characterized by 
various techniques. Molar conductance measurements showed that complexes are ionic in 
nature. On the basis of spectroscopic data, both complexes were assigned a square-planar 
geometry and are found to be highly stable and hydrolytically robust in H2O over a wide 
range of pH, as confirmed by conductance measurements and cyclic voltammetry. The 
complex [MacCu (D-GlcN-en)*]Cl2 was found to bind to CT DNA, with a binding 
constant Kb of 2.4 x 10^  M"', as derived by UV/vis titration and confirmed by CV, 
circular dichroism and viscosity measurements. DNA binding seems to occur mostly via 
H-bonding. In an in vitro antitumour MTT assay, complex [MacCu (D-GlcN-en)*]Cl2 
ni 
exhibited significant anticancer activity against the SY5Y and PC-12 cell lines, with an 
estimated IC50 value in the micromolar range, similar to the standard drug 5-fluorouracil. 
Organotin (IV) compounds have broad spectrum of biological activities especially 
anticancer activity. The presence of organic ligands viz. carbohydrates and their 
derivatives modifies their biological properties significantly. Organotin (IV) compounds 
have been widely used in synthetic carbohydrate chemistry, the reason being the 
regioselective directing power of the organometal cation towards reactivity of the sugar 
substrate. They provide reliable high yielding methods for obtaining mono substituted 
derivatives of diols or polyols with high selectivity. 
The novel Sn(IV) saccharide complexes l-{(2-ethoxy) imino}-2-amino-l, 2-dideoxy-D-
glucose tin (IV) dichloride (GATDC) and l-{(2-ethoxy) amino}-2-amino-l, 2-dideoxy-
D-glucose triphenyl tin (IV) (GATPT) were synthesized and characterized by 
spectroscopic (IR, 'H , '^C, 2D cosy and "^Sn NMR, EPR, UV-vis, FAB mass) and 
analytical methods. In both the complexes Sn(IV) metal ion is present in four coordinated 
environment as confirmed by "^Sn NMR spectroscopy. The interaction of complexes 
GATDC and GATPT with calf thymus DNA were studied by electronic absorption 
titration, luminescence titration, circular dichroism and viscometric measurements. Upon 
addition of CT DNA the absorption spectrum of GATPT exhibited hypochromism with a 
red shift of 3 nm while GATDC showed hyperchromism with no shift. Additionally 
there was a reverse effect on the specific relative viscosity of CT DNA bound to GATDC 
and GATPT. These results are suggestive of strong interaction of GATPT with CT DNA 
IV 
than GATDC. To evaluate the induction of apoptosis by GATPT MTT assay, DNA 
fragmentation and Hoechst 33342 DNA staining experiments were performed. 
Furthermore to investigate the gene mediated pathway of GATPT induced apoptosis 
western blot analysis of whole cell lysates and mitochondrial fractions were carried out 
with Bcl-2 and p-53 family proteins on a PC-12 cell line. Caspase-3 colorimetry assay 
were also carried out to ascertain the involvement of caspase-3 in GATPT triggered 
apoptosis. 
Compartmental ligands containing two adjacent but dissimilar coordination sites are of 
particular interest as for the recent recognition of the asymmetric nature of a number of 
bimetallic biosites. The ability of individual metal ions to play possibly different 
functions in dinuclear sites in metalloenzymes led to the design of a large number of 
asymmetric ligands where two compartments would provide a different coordination 
surrounding for the two metal ions. In view of this, diazine linkages have been utilized in 
a series of heterotrimetallic complexes in bringing two copper (II) centers into close 
proximity. The Schiff base compartmental ligand LH2 [C32H32N6O2] was synthesized by 
employing a three step synthetic method which was metallated with copper(ll), 
manganese(II), cobalt(II), nick:el(II) ions [LM"2Cl2] and was further metallated with 
tintetrachloride to yield heterotrimetallic complexes [LCu"/Ni"2Sn'^Cl6]. All the 
complexes were characterized by elemental analysis and various spectroscopic 
techniques. The homodinuclear complexes possess two different environments (N2 and 
N2O2 donor sets) for holding the metal ions. The metal ion in NT set exhibits square 
planar geometry with two chloride ions in tho inner sphere but rhombic structure is found 
in tetradentate N2O2 Schiff base cavity while in heterotrinuclear complexes Sn(IV) atom 
is in the octahedral environment. The interaction of complexes LCu"2Cl2 and 
LCu"2Sn'^ Cl6 with calf thymus DNA was carried out by absorption spectroscopy and 
cyclic voltammetry. The intrinsic binding constants (Kb) of complex LCu"2Cl2 and 
LCu"2Sn'^ Cl6 were determined as 3.2 x 10^  M'' and 9.6 x 10^  M'', respectively 
suggesting that complex LCu"2Sn'^ Cl6 binds more strongly to CT DNA than complex 
LCu"2Cl2. Fluorescence studies along with viscosity measurements were also carried out 
to authenticate the binding of metal complexes with DNA. 
In another set of experiments, carboxamide dinuclear complexes Bis [aqua 1,8-(1,2-
dicarboxamido benzene) 3,6-diazaoctane copper (II)/nick;eI (II)] tetrachloride 
[MacCu2/Ni2(BC)]Cl4 were synthesized by a two component one-pot metal template 
condensation between phthalic anhydride and l,8-diamino-3,6-diazaoctane. Elemental 
analysis, molar conductance measurements, electronic absorption, infra-red, electron 
paramagnetic resonance, nuclear magnetic resonance, atomic absorption and electron 
spray mass spectral studies have been performed to probe the nature and structure of the 
complexes. The interaction of the complex [MacCu2(BC)]Cl4 with calf thymus has been 
studied by using absorption, emission and circular dichoric spectral methods, viscometry 
and cyclic voltammetry. A strong hyperchromism along with a red shift in UV bands and 
hypochromism in the ligand field band of the complex [MacCu2(BC)]Cl4 on interaction 
with CT DNA imply a covalent mode of DNA binding. This is supported by studying the 
VI 
reactivity of complex [MacCu2(BC)]Ci4 by CD and viscometry. The variation in relative 
emission intensity of DNA bound ethidium bromide observed upon treatment with the 
complex [MacCu2(BC)]Cl4 was consistent with the trend of DNA binding studies. Cyclic 
voltammetry studies revealed that the complex [MacCu2(BC)]Cl4 preferred to bind to 
DNA in Cu(II) rather than Cu(I) oxidation state. 
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Abbreviations 
BCA 
CD 
CTDNA 
CV 
cytoc 
DAPI 
D-GlcC 
D-GlcN 
D-GlcN-ea 
D-GlcN-en 
(D-GlcN-en)* 
DMEM 
DMF 
DMSO 
ea 
ea* 
ECL 
EDTA 
en 
en* 
EthBr 
EtOH 
FBS 
FHS 
5-Fu 
bicinchoninic acid 
circular dichroism 
calf-thymus DNA 
cyclic voltammetry 
cytochrome c 
4', 6-diamidino-2-phenylindole 
condensation product of D-gluconic acid 
2-amino-2-deoxy-D-glucose 
l-{(2-hydroxyethyl) amino}-2-amino-l,2-dideoxy-D-glucose 
l-{(2-aminoethyl) amino}-2-amino-l,2-dideoxy-D-glucose 
l-{(2-iminoethyl) amino}-2-amino-l,2-dideoxy-D-glucose 
Dulbecco's modified Eagle medium 
dimethylformamide 
dimethylsulfoxide 
2-hydroxy ethylamine 
deprotonated/condensed 2-hydroxy ethylamine 
enhanced chemiluminescence 
ethylenediaminetetraacetic acid 
ethane-1,2-d iam i ne 
deprotonated/condensed ethane-1,2-diamine 
ethidium bromide 
ethanol 
fetal bovine serum 
fetal horse serum 
5-fluorouracil 
GATDC 
GATPT 
IL 
LMCT 
LNT 
[MacCu D-GlcN-en*]Cl2 
[MacNi D-GIcN-en*]Cl2 
[MacCu2(BC)]Cl4 
[MacNi2(BC)]Cl4 
MDM2 
MeOH 
MTT 
N2A 
Oh 
PI 
pNA 
PBS 
PC-12 
PMSF 
i-PrOH 
PVDF 
l-{(2-ethoxy) imino}-2-amino-l,2-dideoxy-D-glucose tin 
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Introduction 
Introduction 
Bioinorganic chemistry, at the interface between biology and inorganic chemistry is a 
discipline of growing significance in both therapeutic and diagnostic medicine. Metal 
ions and metal coordination compounds are known to affect cellular processes in a 
dramatic way. This metal effect influences not only natural processes, such as cell 
division and gene expression, but also non-natural processes, such as toxicity 
carcinogenicity and antitumoiir chemistry []]. Therapeutic applications of metal 
complexes are varied, encompassing anticancer agents, antibacterials, antivirals, 
antiparasitics and antiarthritics [2-5]. The design and synthesis of small metal complexes 
that bind and react at specific sequences of DNA become important as bioinorganic 
chemists begin to define, on a molecular level, how genetic information is expressed. 
Understanding DNA targeting with specificity is therefore, potentially useful in 
developing design principles to guide the synthesis of improved chemotherapeutic agents, 
sensitive chemical probes of DNA structures in solution and tools for the molecular 
biologist to dissect genetic systems [6-14]. 
The development of cisplatin as a successful antitumour drug is the prototypical success 
story [15]. The large number of patients who have been cured after cisplatin treatment of 
cancer is impressive (Figure 1). However, elusive mechanism of action, severe side 
effects (e.g. nausea, ear damage, vomiting, nephrotoxicity) and the problem of 
developing drug resistance during the treatment remain to be crucial challenges. 
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Figure 1. Platinum (II) complexes in worldwide clinical use, cisplatin (left), carboplatin 
(middle), oxaliplatin (right) 
Increasing demand for effective new anticancer drug able to circumvent these problems 
has stimulated investigations in metal DNA binding properties of non-platinum metal 
complexes and organotin compounds. A novel DNA binding metal compound with 
anticancer activity and clinical efficacy must fulfill the following key requirements [16]., 
(i) good intrinsic properties, including saline solubility and enough stability to 
arrive intact at the cellular target 
(ii) efficient transport properties in blood and through membranes 
(iii) efficient DNA binding properties 
(iv) the ability to differentiate between cancerous and normal cells 
(v) activity against tumours that are, or have become resistant to cisplatin and 
derivatives. 
Cancers spread when affected cells proliferate, forming tumours of varying degrees. The 
cancers are derived from numerous tissues with multiple etiologies and endless 
combination of genetic and/or epigenetic alterations, thus the therapies for cancers must 
be as diverse as the disease itself [17]. Chemotherapy is widely used for treating cancers. 
In chemotherapy, the key issue is killing the tumour cells, without causing too much 
harm to healthy cells i.e. apoptosis. Apoptosis is a highly controlled process in which cell 
death is executed through the activation of specific signaling pathways [18]. Within cells 
there are positive and negative regulatory pathways of apoptosis and it is the balance 
between these pathways that determine cell fate. Morphologically, apoptotic cells are 
characterized by cell shrinking, chromatin aggregation, nuclear condensation, DNA 
degradation and budding of plasma membrane into compact membrane enclosed 
structures called 'apoptotic bodies' which contain cytosol, the condensed chromatin and 
organelles (Figure 2). The apoptotic bodies are engulfed by macrophages and thus are 
removed from the tissue without causing an inflammatory response [19]. Although the 
biochemical and molecular factors regulating apoptosis are complex, important 
regulatory mechanisms include death receptors, caspases, mitochondria, Bcl-2 and p-53 
tumour-suppressor genes (Figure 3) [20]. Apoptotic processes are of widespread 
biological significance involving development, differentiation, proliferation/homeostasis, 
regulation and function of the immune system and removal of defect and harmful cells. 
Defects in apoptosis can result in cancer, autoimmune disease and spreading of viral 
infections [21]. 
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Figure 2. Hallmarks of the apoptotic cell death process 
Figure 3. Diagrammatic representation of some major apoptotic signaling pathways 
Transition metal complexes stand out as exceptional candidates for artificial nucleases of 
DNA due to their ability to recognize and react selectively with individual target sites 
[22-32]. Stable, inert, water soluble, versatile structures, spectroscopically and 
electrochemically active metal centers are the unique signatures of transition metal 
complexes, which makes them sensitive diagnostic agents [33]. Additionally transition 
metal complexes exhibit significant modulation effects, which can tune the mode of 
binding and their reactivity towards biomolecules. A vast number of ligands can be 
readily 'plugged' in and out of a wide variety of metal centers. This unique attribute of 
metal complexes provides system that utilizes strength of both synthetic organic 
chemistry and transition metal complexes. 
Any metal ion or complex is subject to the potential limitations in the Bertrand diagram, 
(Figure 4) which is usually used in discussing the essentiality of elements [34]. 
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Figure 4. Bertrand diagram indicating the relationship betiveen benefit/detriment from 
an element and its concentration. Great variations are found in each region depending 
on the nature of the element 
The area of optimum physiological response will vary greatly according to the element, 
its speciation and oxidation state and the biochemistry of the specific compound in which 
it is found. Therefore, the areas of deficiency, toxicity and optimum physiological 
response can be dramatically varied by considering a combination of these variables, as 
well as design features of the potential ligand which may be altered to tune the delivery 
of that metal ion into the biological system [35]. Thus the refinement of biological 
properties of metal complexes by well tailored, multifunctional ligands offer exciting 
possibilities and can play an integral role in muting the potential toxicity of the 
metallodrug to have a positive impact in areas of diagnosis and therapy [36]. 
Ligands can modify the reactivity, lipophilicity, oral/systematic bioavailability of metal 
ions, stabilization of oxidation state, substitutional inertness depending on the 
requirements for chemotherapy [37-38]. In this regard, carbohydrates are potentially 
attractive molecules for drug designing because they either (1) may be taken up 
selectively into tumours due to the high metabolic rate of tumour cells vs. normal cells or 
[39-40] (2) their nucleosides may be intracellularly converted to the corresponding 
nucleotides through phosphorylation by appropriate enzymes, or (3) they may potentially 
be incorporated into tumour DNA, thereby enhancing the cytotoxicity of the compounds 
[41]. 
Carbohydrates have a wide spread occurrence in nature and are indispensable compounds 
for living organisms [42]. They are involved in various processes, such as storage, 
transport and transmission of genetic information, enzymatic reactions [43] and 
regulation of the metabolism [44]. Carbohydrates and their derivatives are qualified as 
potential ligands not only due to their extensive presence in the biological systems but 
also due to their hydroxyl rich periphery, coordinating ability, homochirality, stereo 
specificity, weak immunogenicity, hydro solubility and low toxicity [45]. 
Studies pertaining to the interaction of metal ions with carbohydrates (and their 
derivatives) are of paramount importance owing to their co-existence in biological 
systems [46-47]. Although complexation of carbohydrates with metals confers manifold 
applications in agriculture, industry and pharmaceuticals [48-49] yet bioinorganic 
chemistry with sugars however, is largely unexplored in comparison with that of amino 
acids and nucleic acids, mainly due to their multifunctionality, hygroscopic nature and 
complicated stereo chemistry [50]. Investigations have shown that there are novel classes 
of metal chelates of sugar derivatives that are active against different bacteria, viruses and 
cancers [51-54]. Hence metal saccharide interactions are important from pharmacological 
viewpoint, as saccharides are unique chiral polyfunctional bioligands [55]. 
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Figure 5. (a) Peroxo-bridged dinuclear Cobalt (III) complexes containing N-glycoside 
ligands from Tris(2-aminoethyl)amine and D-glucose (b) Molecular structure of Copper 
(II) complex containing N-glycoside derived from D-glucose and Tris(2-
aminoethyl) am ine 
Metal complexes of N-glycosides derived from reactions of various carbohydrates and 
their derivatives with different amines is the most extensively studied class of compounds 
by S. Yano et al [56-59]. Their approach was to attach a chelating ligand to a 
carbohydrate, which subsequently binds to the metal center. This tactic offers advantage 
by providing a number of stable and easily characterized complexes. The complexes were 
exhaustively characterized by various spectroscopic techniques and the results suggested 
that the stereo structures of these sugar complexes (Figure 5) could be modified by 
varying the polyamines and the metal ion used [60-66]. 
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Figure 6. Structures of Nickel (II) complexes containing N-glycoside derived from 
ethylenediamine and (a) D-glucosamine, (b) D-galactosamine 
Amino sugars such as, D-glucosamine is an attractive carbohydrate scaffold, as the 
primary amine acts as a site for functionalization (Figure 6). Furthermore, D-glucosamine 
and its analogous amino sugars have several donor atoms capable of binding with metal 
ions [67-68]. Evidence in the literature reveals the importance of N-functionalized 
glucosamine in active transport and accumulation in tumours in vivo [69]. Besides this, 
metal complexes containing N-glycosides derived from polyamine and D-glucosamine 
have shown effective antitumour and antifungal activities [70]. These findings provide 
clue that metal complexes of N-glycosides especially amino sugars are promising 
candidates for chemotherapy. 
Schiff bases are considered as 'privileged ligands' as they bind with different metal ions 
in various oxidation states [71]. Formation of Schiff s base by condensing the amino 
sugar with aromatic aldehydes has also been known since 1922, [72] but surprisingly the 
inorganic chemists have not much explored the potential of the saccharide-based Schiff 
bases. This may be attributed to the problem of the rearrangement of the glycosylamines 
in solution via the formation of imonium ion intermediates, resulting in mutarotation, 
R = Ac, R' = Me, X = H 
R = Ac, R' = Me, X = COjH 
M = Cu(II), Zn(II), Co(n), VO(II) 
Figure 7. Schiff bases of acetylated D-glucosamine and carbonyl derivatives (left), its 
dinuclear bridged copper (II) complex (middle), bis chelates of transition metal ions 
(right) 
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hydrolysis, transglycosylation or Amadori rearrangements [73]. However, the pioneering 
work of Adam and Hall [74] related to Schiff bases of acetylated D-glucosamine and a 
carbonyl derivatives, which gave normal bis chelates and dinuclcar bridge complexes arc 
worth mentioning (Figure 7). Recently a few structurally characterized metal complexes 
of saccharide-derived Schiff s base ligand (Figure 8) have been reported and formation of 
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Figure 8. Various saccharide-derived Schiffs base ligands and their copper (II) 
complexes 
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multinuclear complexes was observed in all the cases [75-77]. Additionally, a 
mononuclear Ni(Il) complex with Schiff base derived from amino sugar (Figure 9) have 
also been reported by B. Matsuhiro et al [78]. Schiff base ligands derived from 
carbohydrates will provide an efficient route for constructing chiral multinuclear 
complexes, which can be exploited as significant catalysts and auxiliaries for obtaining 
diastereometrically pure pharmaceuticals. 
OHCH, 
Figure 9. Structure of bis-N-[2-deoxy-D-glucopyranosyl-2-(2-hydroxybenzaldiminate)] 
Ni(II) complex 
Another well documented interaction between carbohydrates and metal ion occurs in the 
treatment of iron overload or iron deficiency [79-80]. The Fe(lll) ion is known to form 
strong complexes with oxygen-based ligands like the highly water soluble and weakly 
immunogenic carbohydrates. C.P. Rao et al [81] have synthesized a number of Fe(lll) 
complexes of saccharides, their derivatives and characterized by a variety of analytical, 
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spectral (FTIR, UV/vis, EPR, Mossbauer and EXAFS) magnetic and electrochemical 
techniques. In vitro absorption of Fe(IIl)-glucose complex has also been studied using 
everted sacs of rat intestines and the results have been compared with that of simple ferric 
chloride. Fe(III)-saccharide complexes have shown regular protein synthesis even in 
hemin deficient rabbit reticulocyte lysate indicating that these complexes play a role that 
is equivalent to that played by hemin in order to restore the normal synthesis of protein. 
Thus, the iron-saccharide complexes, having high water solubility, good hydrolytic 
stability, controlled release of iron, efficient transport through membranes and 
complimentary to the hemin deficiency in lysate can act as therapeutic, being a good 
nutrient. 
As new designer strategies, C. Policar et al have tailored sugar scaffold by appending 
them with desired Lewis bases at selected positions around sugar cycles [82]. These 
sugar-functionalized ligands were then used as a host for cationic transition metals. 
Cobalt (II) complexes of these ligands (Figure 10) were tested for superoxide dismutase-
like (SOD-like) activity through a modified McCord-Fridovich assay, as such an activity 
is of pharmaceutical interest for protection against oxidative stress and related 
neurodegenerative disorder like Alzheimer's disease [83]. These complexes were found 
to inhibit the reduction of ferricytochrome c by superoxide (Figure 11) with IC50 (with 
[cyto Fe '"]) = 22nM of ca. 2iiM. Such low molecular weight complexes displaying 
SOD-like activity have a potential use as pharmaceuticals as they lack the major enzyme 
drawbacks [84-85]. Structurally these compounds are quite attractive to be utilized with 
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Figure 10. Ball and stick drawing of the Co (II) complex of 3,4,6-tri-0-(2-picolyl)-1,2-0-
rthylidene-a-D-galactopyranose (on the left) and 3,4,6-tn-0-(2-picolyl)-D-galactal 
ligands (on the right) 
macrocyclic precursors or can be easily further functionalized in order to modulate 
properties such as hydro/lipophilicity, which are important pharmacological parameters 
regarding the delivery to cells. 
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Figure 11. McCord-Fridovich assay performed on Co(II) complex. The reduction of 
ferricytochrome c was followed at 550 nm. SI corresponds to the slope of the kinetic trace 
for cytcFe(III) reduction before introduction of the complex and S2 to the slope recorded 
after addition of the putative SOD-mimic. (SI - S2) S2 is equal to 1 at the IC50 value 
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The scavenging effect on superoxide free radicals of Schiff base saccharide ligands and 
their Cu(ll), Zn(Il), Fe(ll), Co(ll) and Ni(ll) complexes (Figure 12) were also 
demonstrated by H. Shen et a! [86]. 
H. OH 
L ,N=CH 
HO 
Figure 12. Proposed chemical structures of the complexes. R= 3-Me, 4-Me; M=Cu(II), 
Zn(II), Ni(II), L= none; M= Fe(II), Co(II). L=H20 
Dirk Steinborn et al [87-89] has taken the advantage of carbohydrate ligands in 
improving the solubility, molecular targeting and lowering the toxicity of platinum 
complexes. One of the first examples of this approach was a carbohydrate-linked 
cisplatin analogue (Figure 13a) for chemotherapy [90]. More recently, a series of 
platinum terpyridine complexes containing a glycosylated acetylide unit (Figure 13b) 
were reported [91]. One of their derivatives was found to be significantly more cytotoxic 
than cisplatin (up to -100 times higher in potency) and it was concluded that the 
glycosylated arlyacetylide unit not only enhanced complex solubility but was a key 
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Figure 13 (a) A carbohydrate cisplatin analogue (b) and a platinum terpyridine complex 
containing a glycosylated acetylide unit 
structural motif in governing the observed cytotoxicity. Another example [92] of metal-
based glycol-conjugate medicinal agent utilizing the advantage of carbohydrate 
appendage include asymmetric tricarbonyl rhenium (VI) dipicolylamine complex, as 
tumour targeting metallodrug (Figure 14). 
Figure 14. Model of (2-(bis(2-pyridinylmethyl)amino)ethyl-[i-D-glucoypyranosyl)-
tricarhonylrhenuim chloride 
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Organotin compounds display significant antitumour activity against various tumour cells 
[93-98]. The binding ability of organotin compounds towards DNA depends on the 
coordination number and nature of groups bonded to the central tin atom. The phosphate 
group of DNA sugar backbone usually act as an anchoring site [99-101] and nitrogen of 
DNA base binding is extremely effective, this often result in the stabilization of the tin 
center as an octahedral stable species. The presence of organic ligands viz. carbohydrates 
modifies the biological properties such as transport across the membrane, solubility in 
non toxic solvent such as water and stereochemistry of organotin complexes [102-104]. 
Figure 15. Proposed solid-state structure for (a) R2SnGalA (R = Me, n-Bu) and (b) 
PhiSnGalA 
Several report have been cited in the literature pertaining to the strong sugar organotin 
(IV) cation complexation. In a research article by N. Bertazzi et al, the synthesis of 
diorganotin (IV) complexes of D-Galacturonic acid was described [105]. The complexes 
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were characterized by IR, Mossbauer, 'H , '^C and "^Sn NMR spectroscopy. The FTIR 
data suggest that D-galacturonic acid (H2GalA), in the dialkyltin derivatives, behaves as a 
dianionic ligand, coordinating the tin (IV) atom through an ester-type carboxylate and 
deprotonated alcoholic hydroxo groups, whereas a bridging carboxylate occurred in the 
diphenyltin (IV) complex (Figure 15). 
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Figure 16. Rotational equilibrium ofa.fi-RySnGalfA (R2 = Me, n-Bu, Ph) in solution 
In D2O solution, R2Sn (IV) moieties seem to be mainly coordinated by the GalA '^ in the 
P-furanosidic (P-GalfA^") form, involving the p-furanosidic ring in rotational equilibrium 
(Figure 16). However, the a-furanosidic (a-GalfA "^)> a-pyranosidic (a-GalpA'") and the P 
pyranosidic (P- GalpA ") isomers were involved in the coordination upon the tin atom to 
a minor extent (Figure 17). 
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Figure 17. Equilibrium in D2O solution ofa./i-MeySnGalpA 
Tumour screening studies have shown that organotin (IV) compounds are very important 
in cancer chemotherapy because of their apoptosis inducing character [106-109]. A novel 
antitumour agent triphenyl tin benzimidazolethiol (TPT) (Figure 18a) has been developed 
by our group [110], which was far more potent than cisplatin in inducing apoptosis in 
Hela cells (Figure 18b). 
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Figure 18. (a) Structure of triphenyl tin benzimidazolethiol (TPT) (b) The dose 
dependent response of Hela cells towards different molar concentration of TPT or 
cisplatin after 24 hours of treatment was measurement by MTT assay 
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Several experiments were carried out for diagnosing tlie signaling pathway, which 
suggested that the apoptotic effects of TPT on tumour ceils were mediated through p-53 
pathway. The up regulation of Bak at the transcriptional level resulted in the release of 
cytochrome c from mitochondria to cytosol and subsequently the activation of 
procaspases 9, 3 suggested that TPT induced apoptosis signaling proceeds by an intrinsic 
mitochondrial pathway. 
In another report, cytotoxic activity of bis (4-acyl-5-pyrazoionato) dihalotin (IV) 
compounds were analyzed on five (JR8, SK-MEL-5, MEL 501, 2/21 and 2/60) melanoma 
cell lines [111]. The results obtained could have clinical relevance for treatment of 
refractory tumours (Figure 19). 
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Figure 19. (a) Structure of bis (4-acyl-5-pyrazoionato) dihalotin (IV) (b) Dose-response 
survival curves ofJR8 (0), SK-MEL (o), Mel 501(L), 2/2 If), 2/60 (A) cells exposed to 
bis (4-acyl-5-pyrazoionato) dihalotin (IV) 
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The metal complexes containing macrocyclic ligands have received a great deal of 
attention because of their potential medicinal applications such as diagnosis and 
treatment of tumours, antimicrobial, antifertility, anti-inflammatory and analgesic agents 
[112-118]. Recognizing the importance of macrocyclic complexes in supramolecular 
science, bioinorganic chemistry and biomedical application particular care needs to be 
taken to design synthetic routes for these compounds. Among many synthetic strategies 
to macrocyclic ligands involve the use of the metal ion template to orient the reacting 
groups of substrates in the desired conformation for the ring to close [119-122]. The 
favourable enthalpy for the formation of metal-ligand bonds overcomes the unfavourable 
entropy of the ordering of the multidentate ligand around the metal ion and hence it 
promotes the cyclization reaction [123-125]. The effective method for the synthesis of 
Schiff base macrocyclic complexes, involves the condensation reaction between suitable 
dicarbonyl compounds and primary diamines carried out in the presence of appropriate 
metal ions, which serve as templates in directing the steric course of the reaction. In the 
metal template effects, the metal ion through coordination organizes the linear substrate 
to facilitate the condensation process which may lead either [1 + 1] or [2+2] macrocyclic 
products (Figure 20). In this regard, azamacrocyclic framework offer excellent binding 
environments for the Cu(II) ion, combining high thermodynamic stability and aqueous 
solubility [126]. Whether the cyclization proceeds through an intramolecular 
condensation to give a [1 + 1] macrocycle or through the biomolecular steps leading to a 
[2+2] macrocycle depends on the relative proportions of linear substrates, the nature of 
22 
the cation and reactants (chain length, number and location of potential donor atoms), the 
ratio of the template, ionic radius to the cavity size, conformation of acyclic intermediates 
and coordination properties of counter ions [127-131]. 
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Figure 20. Metal templated synthesis of [1 + 1] and [2+2] Schijf base macrocyclic 
complexes 
Assembling macrocyclic architecture bearing a pendant arm constitutes a de novo 
synthetic strategy as it increases the stability of metal complexes, and tunes the selectivity 
between various metal ions. Pendant groups are also used to covalently attach substrates, 
to enforce specific oxidation states and coordination geometries and to influence the 
strength of the ligand field [132-133]. Thus the macrocyclic complexes with these 
peculiar characteristics are found to be powerful tools for medicinal inorganic chemistry. 
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J. Kang et al [134] have reported the template synthesis of hexaazamacrocyclic 
copper(II) complex, (Cu(II)L) where, L = 1, 8-Dihydroxyethyl-l, 3, 6, 8, 10, 13-
hexaazacyclotetradecane copper(II) perchlorate monohydrate) (Figure 21) and its 
interaction with calf thymus DNA by various techniques viz. absorption, emission, 
viscosity measurements, electrochemical studies and DNA cleavage. 
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Figure 21. The structure of 1,8-Dihydroxyethyl-l,3,6,8,10,IS-hexaazacyclotetradecane 
copper (II) perchlorate monohydrate (Cii(II)L) 
In another report, E.L. Chang et al [135] have developed a kinetically inert Co(III)-cylen 
based complex (Co(IIl)-cycmmb). The complex was very potent in inhibiting the 
translocation of RNA into protein (Figure 22). The inhibition appeared to proceed 
through two pathways. The first pathway involved the kinetic or substitutional inertness 
of Co(lll) for the RNA template at short contact times. This interaction was mediated 
through the kinetic inertness of Co(lll) for the phosphate groups of the nucleotides, as 
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well as coordination of Co(lII) to the nitrogenous bases. The second pathway occurred at 
longer contact times and was mediated by the hydrolysis of the phosphodiester backbone. 
This was first report that demonstrated use of a metal-chelate complex to achieve the 
inhibition of the translation of RNA into proteins. 
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Figure 22. Structure of the Co(III)-cycmmb complex 
Macrocyclic complex [Ni(CR)](Ci04)2 where CR-[2,12-dimethyl-3,7,ll,17-
tetraazabicyclo-[] 1.3.l]heptadeca-l(17),2,11,13,15-petaenato] was prepared by the 
template condensation reaction using 2,5 diacetyl pyridine and bis-(3-aminopropylamine) 
while complex [Ni(cylam)](C104)2 (where cyclam=l,4,8,l 1 tetraazacyclotetradecane) 
was obtained by the reaction between Ni(C104)2.H20 and cylam at ratio of 1:1 in aqueous 
EtOH solution (Figure 23). Interaction of these complexes with nucleotides GMP, AMP 
and ApG in aqueous solution has been monitored by 'H , '^ N NMR and UV spectroscopy. 
The complex NiCR oxidized GMP gradually but do not affect AMP significantly. On the 
other hand Ni(cyclam) do not oxidize GMP or AMP at the 1: 1 concentration of oxidant 
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used. This is due to tiie lower redox potential of Ni(cylam). ApG binds less efficiently to 
the nickel complexes but is easily oxidized than the mononucleotides [136]. 
ri. 
.NH 
' 1 ^ 
k/J 
Figure 23. Structure of CR (CR=[2,12-dimethyl-3,7,ll,17-tetraazabicyclo-
[11.3.1]heptadeca-l(17),2,llJ3,15-petaenato]) and cyclam (cyclam=I,4,8,ll 
tetraazacyclotetradecane) 
The carboxamide [-C(0)NH-] group, ubiquitous throughout nature in the primary 
structure of proteins, is an important iigand construction unit for coordination chemists. 
P.K. Mascharak et al [137-141] have synthesized a huge number of pyridine 
carboxamides. This exciting recent development in amide moieties stems from their close 
relationship to molecules of biological significance such as haemocyanin, tyrosinase etc. 
In particular, various anticancer agents possessing amide groups like, [hexamethylene-
bis-acetamide], [142] aminoptexin, D-penicillamine, phenylalanine mustard and 6-
mercaptopurine showed an increased anticancer activity when administered as metal 
complexes [143]. Recently, it was reported that metal chelates of carboxamide linkages 
containing heterocyclic ligands such as pyridine, thiazole and quinoline (Figure 24) were 
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found to possess potent anticancer activities [144-146]. It is this activity, which 
underlines the prominence of amide-based complexes in chemotherapy. 
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Figure 24. Structures of carboxamide linkages containing heterocyclic ligands 
Deoxyribonucleic acid (DNA) is the primary cellular target molecule for most anticancer 
therapies according to cell biology. Binding studies of small molecules with DNA are 
very important in the development of new therapeutic reagents and DNA molecular 
probes [147]. Nucleic acids under physiological conditions are polyanions composed of 
heterocyclic bases linked to a sugar-phosphate backbone. Thus they are quite amenable to 
probe with positively charged transition metal ions. DNA is a flexible, dynamic and 
polymorphic in structure that can assume a variety of interconverting forms [148]. Each 
form has its own biological role in the regulation of the life of cell. Selective stabilization 
of one of these forms can help to discover and better understand their biological roles. 
Genetic information is provided by the DNA in at least two different ways. First, the 
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sequence of its nucleotides determines the primary structure of the protein. Second, DNA 
can regulate gene expression through its shape [149]. 
Structurally DNA is characterized in A, B and Z forms [150]. Ihc Watson and Crick 
structure refers to the B form, with hydrogen bonding interactions between the two 
antiparallel strands of nucleic acids. There are two well defined right handed grooves, 
termed as the major and minor grooves and each has characteristic width and depth which 
together result into the distinctive shape associated with helical form [151]. The major 
groove is a shallow, almost convex surface and the minor groove is a narrow crevice, 
zigzagging in a left handed fashion along the side of the major groove (Figure 25). 
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Figure 25. Space filling models for dijferent double stranded DNA helical conformations 
A-(left), B-(center), and Z- (right) DNA. The sugar phosphate backbone is shown in dark 
and the base pairs in light form 
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Coordination compounds offer many binding modes to polynucleotides, including outer 
sphere non-covalent binding, metal coordination to nucleobases and phosphate backbone 
sites, as well as strand cleavage induced by oxidation using redox-active metal centers 
(Figure 26). In covalent binding the labile ligand of the complexes is replaced by a 
nitrogenous base of DNA such as guanine N7. On the other hand, the non-covalent DNA 
interactions include intercalation, electrostatic interaction, hydrogen bonding and groove 
(surface) binding of cationic metal complexes along outside of DNA helix, along major 
or minor groove. Intercalation involves the partial insertion of aromatic heterocyclic rings 
of ligands between the DNA base pairs. 
Figure 26. External binding (left), intercalation (middle), groove (right) binding 
The numerous side effects of cisplatin as a chemotherapeutic agent leave room for the 
selection of other metals for the synthesis of bioactive molecules. Among these, Cu(II) 
ion is especially attractive due to its occurrence in biological systems and participation as 
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an integral part of the active site-of different types of metalloproteins, wliich recognize its 
coordination witii tlie human body functions. The exploration of copper complexes as 
chemical nucleases is well documented [152-158] because they possess biological 
accessible redox potential and relatively high nucleobases affinity [159-160]. 
Recent report on copper (II) complexes of three linear unsymmetrical tridentate ligands 
[161] viz. N-methyl-N'-(pyrid-2-ylmethyl) ethylenediamine (LI), N,N-dimethyl-N'-
(pyrid-2-yl methyl)ethylenediamine (L2) and N,N-dimethyl-N'-((6-methyl)pyrid-2-
ylmethyl) ethylenediamine (L3) (Figure 27) have shown promising DNA binding 
properties. The DNA binding behaviour of these complexes has been investigated by 
number of techniques, which helped to explore the relationship between structure-
nuclease activity of these complexes. 
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Figure 27. Structures of ligands 
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The observed hypochromism and hyperchromism in the ligand field bands of 
[Cu(Ll)Cl2], [Cu(L2)Cl2] and [Cu(L3)Cl2], respectively in presence of CT DNA 
suggested that the copper complexes are coordinated to the DNA base such as guanine N7 
of DNA double helix. These spectral changes commensurate with the CuN4 coordination 
geometries of the DNA-bound [Cu(L2)Cl2] and [Cu(L3)Cl2] complexes are more 
distorted than that of the DNA-bound [Cu(Ll)Cl2] complex obviously due to the 
sterically hindering -NMe2 group of the [Cu(L2)Cl2] and [Cu(L3)Cl2] complexes and the 
6-Me group of the [Cu(L3)Cl2] complex. 
In order to gain support for the formation of CUN4 chromophore involving possibly 
guanine N7 coordination the interaction studies of all the three complexes with water-
soluble DNA components like adenosine-5'-monophosphate (AMP), guanosine-5'-
monophosphate (GMP), and cytidine (cytd) as well as N-methylimidazole (N-meim) 
have also been carried out using electronic absorption spectroscopy (Figure 28). 
800 
Wavelength (Bm) 
Figure 28. (a) Absorption spectra of [Cu(U)Cl2] (b) on interaction with methylimidazole 
(c) guanosine monophosphate (d) adenosine monophosphate (e) cytidine and (f) CT DNA 
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Competitive ethidium bromide binding study was also employed to understand the mode 
of DNA interaction of copper complexes. The complex [Cu(Ll)Cl2l was found to quench 
the emission intensity of ethidium bromide bound DNA more effectively than complex 
[Cu(L2)Cl2] and [Cu(L3)Cl2]. The experimental results reveal that the intrastrand 
crosslinking by [Cu(L2)Cl2] and [Cu(L3)Cl2] complexes causes the formation of kinks on 
the DNA duplex restricting the release of bound EthBr leading to the observation of 
similar extend of EthBr quenching (Figure 29). 
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Figure 29. (a) Emission spectra of ethidium bromide (b) EthBr in presence of CT DNA 
(c) DNA+fCu(Ll)ChJ (d) DNA+[[Cu(L2)Cl2] and (e) DNA+f fCufLSjChJ 
To understand the DNA binding modes, viscosity measurements on the three copper 
complexes bound to DNA were undertaken. The viscosity of DNA enhanced significantly 
due to complete or partial intercalation of drugs into the DNA base stacking but it was 
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slightly reduced by electrostatic or covalent binding of molecules [162]. When all the 
three complexes were treated with CT DNA (160^M) and the copper complex 
concentration increased from 1/R = 0 to 0.5 (=[Cu]/[DNA]), the relative viscosity of CT 
DNA decreased slightly and then remained constant for [Cu(Ll)Cl2] and [Cu(L2)Cl2] 
complexes, however, for the [Cu(L3)Cl2] complex the viscosity decreased much more 
and then remained constant (Figure 30), indicating the shortening of DNA length by 
forming bends and kinks on the DNA double helix. 
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Figure 30. The effect of (a) [CufLljChJ (b) [Cu(L2)Cl2] and (c) [Cu(L3)Ch] on the 
viscosity ofCTDNA 
The use of electrochemical techniques for the determination of compounds of 
pharmaceutical interest is continually gaining importance. The inherent sensitivity and 
high selectivity of the techniques allow determination of electrode oxidation mechanisms 
both in newly synthesized samples and in body fluids [163]. These techniques rely on the 
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effect of the macromolecules (e.g. DNA) on the diffusion current of the metal complexes 
[164]. Several workers have shown that binding constants for redox active species can be 
obtained from straightforward voltammetric experiments in which DNA is titrated against 
the redox active molecule [165]. In this regard, cyclic voltammetry is the most effective 
and versatile electroanalytical technique available for the mechanistic study of redox 
systems. The results obtained from the redox properties of drugs and biomolecules have 
profound effects in understanding their in vivo redox behaviour and pharmaceutical 
activity [166-167]. 
I2CX)0| 
-929 
Figure 31. Cyclic voltammogram o/(a) [Cu(L2)Cl2j 0.5 x 10'^ M in the absence CT 
DNA (b) and presence of 2.5 x 10'^ MCTDNA 
The formal potentials of Cu(II)/Cu(I) couple. E° obtained from DPV followed the trend, 
Cu(Ll)<Cu(L2)<Cu(L3). This is because the inductive effect of the terminal NMe groups 
would be expected to render the Cu-NMe2 bond stronger leading to more negative 
Cu(II)/Cu(I) redox potential. So the bulky N-methyl substitutents on the terminal amine 
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group of the L2 and L3 ligands tends to destabilize the Cu(II) state much less than that of 
6-methyl group on the pyridine ring of L3 ligand, thereby rendering the redox potentials 
of their complexes more positive [168]. While in presence of DNA (R = [DNA]/[Cu]=5) 
the reduction peak current decreases (Figure 31) revealing that the complexes are bound 
to DNA. 
The circular dichroism is an extremely appropriate technique to monitor the DNA 
structure and its modification upon interaction with metal complexes in solution. M. 
Palaiandavar et al [169] have demonstrated the effect of binding of mixed ligand copper 
(II) complexes of iminodiacetic acid (imda), 1,10-phenanthroline (phen), 5,6-dimethyl-
1,10-phenanthroline (5,6-dmp) and dipyrido-[3,2-J:2',3'-/l-quinoxaline (dpq) with calf 
thymus DNA by circular dichroism. The CD spectrum of CT DNA consists of a positive 
band at 275 nm (UV, Xmax 258 nm) due to base stacking and a negative band at 245 nm 
due to helicity, which are characteristic of DNA in right-handed B form [170]. When the 
copper complexes are incubated with CT DNA, the CD spectrum of DNA undergoes 
changes in both positive and negative bands (Figure 32) consistent with the partial 
intercalation of [Cu(imda)(phen)(H20)] and [Cu(imda)(dpq)] complexes. However, the 
large decrease in intensity of the DNA helicity band with a high value of red shift 
observed for [Cu(imda)(5,6-dmp)] complex indicate that this complex exhibits a different 
binding mode than [Cu(imda) (phen)(H20)] and [Cu(imda)(dpq)] complexes. It is 
possible that upon interaction with complex [Cu(imda) (5,6-dmp)] the B-DNA transforms 
into an A- like conformation. 
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Figure 32.(A) CD spectra of CT DMA in (he absence (a) and presence (b) of 
[Cu(mda)(phen)(H20)] (B) CD spectra ofCTDNA in the absence (a) and presence (b) 
of[Cu(imda)(5,6-dinp)] (C) CD spectra ofCTDNA in the absence (a) and presence (b) 
of[Cu (imda)(dpq)] 
Macrocyclic copper (II) complexes have been found to react with DNA by different 
binding modes and exhibit effective nuclease activity. Besides this, it is well established 
that the geometry of the complex binding to DNA is a very important factor in the study 
of the interactions of metal complexes with the nucleic acid. Thus, modifications in the 
macrocyclic complexes either by changing the substituents or by capping them with 
different ligands can create interesting differences in the space configurations and 
electronic structures of these complexes. Such modulations in macrocyclic complexes 
provide an opportunity to obtain structural insight into the binding event. 
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L. Ji et al [171] have reported three hexaazamacrocyclic complexes possessing different 
side chains at the 3,10 positions (Figure 33) and the effect of ligand modification on 
DNA binding behaviour of complexes. 
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Figure 33. Chemical structures of the macrocyclic copper (II) complexes 
On addition of calf thymus DNA complexes [CUL']^"^ and [CuL^]'^ exhibited 
hypochromism as well as a red shift in LMCT absorption bands while complex [CuL^ ]^ "^  
showed hyperchromism with no shift (Figure 34). These observations suggest that 
complex [CUL']^"^ binds to DNA through partial intercalation by providing an aromatic 
moiety of the extending side chains to overlap with the stacking base pairs of DNA helix. 
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On the other hand complex [CiiL"]"^ and [CuL^]"^ lacks any fused aromatic ring to 
facilitate intercalation rather they possess -NH and -OH groups which form hydrogen 
bonding with the base pairs of DNA. 
(a) , (b) 
200 220 240 260 200 300 320 340 
Wavelength (nm) 
200 220 240 260 280 300 320 340 
Wavstongth (nnrt) 
(c) 
220 240 260 2S0 300 320 340 
Wavelength {nm) 
Figure 34. Absorption spectra of (a) [Cul'f^ (b) [CuL^f (c) [CiiL^f^ in the absence 
(...) and presence (—) of increasing amounts of DNA 
Furthermore, binding constant (Kb) have also been determined for complexes [CUL']^'*', 
[CuL ]^^ ^ and [CuL^]'^ as 2.1 x 10^  M"', 4.0 x lO^M-' and 7.8 x 10' M"', respectively. The 
differences in binding constants of the three copper (II) complexes to DNA further 
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support that the functional groups on the side chain of macrocycle play a key role in 
deciding the mode and extent of binding of complexes to DNA. 
Metal complexes that have ability to bind DNA effectively under physiological 
conditions are suitable candidates to be investigated both in vitro and in vivo against 
cancer cells. Investigations involving in vitro and in vivo experiments against cancer cells 
have revealed that metal complexes can inhibit DNA much efficiently thereby, controls 
proliferation of cancerous cells - a prerequisite for an anticancer agent. 
Considering the remarkable activity of copper (II) complex containing tripodal NjO 
ligand towards DNA, A.H. Jr et al [172] have performed the cytotoxic and 
antiproliferative assays on human myeloid leukemia cells line (THP-1). In order to 
evaluate the mechanism of cell death, THP-1 cells treated with different concentration of 
complex [Cu(HPClNOL)(Cl)]Cl . MeOH, where HPCINOL = [l-(bis-pyridin-2-
ylmethyl-amino)-3-chloropropan-2-ol] stained with acridine orange (which is only 
permeable to apoptotic cells) were observed under fluorescence microscope (Figure 35 a, 
b). The picture presented the typical apoptotic cell with fragmented nuclei. Further, the 
analysis of the DNA isolated from the cells has also revealed that DNA fragmentation 
was involved in cell death (Figure 35 c) confirming the apoptotic mechanism induced by 
the new copper complex. 
Potential effect of new designer bimetallic compound tri-phenyl tin benzimadazolethiol 
copper chloride (TPT-CuCli) on the regulation of apoptosis in Hela cells, MCF-7 cells 
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Figure 35. (a) Photomicrography of apoptotic cells treated with 200 /uM of copper 
complex during 24 h. Arrow indicates the typical apoptotic cell with fragmented nucleus. 
Arrowhead shows an initial apoptosis phase, a cell with picnotic nucleus, (b) Control 
cells, (c) Agarose gel electrophoresis of DNA from cells treated with copper complex 
after 24 h: Lane 1, 200 fxM of copper complex; Lane 2, 100 ^M copper complex; Lane 3, 
50 juM of copper complex; Lane 4, control cells 
Treated Control 
Figure 36. Suppression of C6 glioblastoma tumour growth in vivo by intraperitoneal 
injection ofTPT-CuCh 
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and in vivo Wistar rat model have been studied [173]. Apoptotic induction by TPT-CuCb 
was shown to mediate in a p-53 dependent manner. Moreover, TPT-CuCb induced 
apoptosis was through an intrinsic mitochondrial pathway. In vivo studies using C(, 
glioblastoma xenograft rat model revealed that TPT-CuCb exhibits significant 
antiproliferative activity against tumour development with minimal cytotoxicity towards 
normal physiological function of the experimental rats (Figure 36). These findings imply 
the attractiveness of TPT-CuCb as a drug candidate for further development. 
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Present Work 
The present work stems from our continuous interest in defining and evaluating the key 
of nucleic acid binding metal complexes and also from our current efforts to explore the 
relationship between structure and nuclease activity of transition metal and organotin 
complexes. The rationale behind the design of these complexes is to develop such 
metallodrug, which can overcome the problems like, toxicity, resistance, solubility and 
target selectivity while delivering the therapeutic effects. 
In this context, carbohydrates are the preferred molecules due to their hydroxy rich 
periphery, good coordinating ability, inherent chirality, stereospecificity, weak 
immunogenecity, hydro solubility and low toxicity. Metal complexes of derivatized 
carbohydrates such as D-Gluconic acid and D-Glucosamine may help in elucidating the 
mechanistic pathway of metal containing pharmaceuticals at the molecular level, as 
carbohydrates are indispensable building blocks and energy source to living organisms. 
Additionally, N-glycosides formed by the reaction of carbohydrates and amines have 
proven to be excellent ligands, especially for the preparation and isolation of discrete, 
well assignable sugar-metal complexes of transition metal ions. Considering the 
coordinating ability and biocompatibility of carbohydrates, we have synthesized the three 
series of carbohydrate metal complexes containing D-Gluconic acid and N-glycosides of 
D-Glucosamine. 
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The extensive application of Schiff bases as ligands in medicinal inorganic chemistry and 
versatile nature of carboxamide linkages in biological systems sparked our interest to 
synthesize two series of metal chelates bearing these functionalities. 
In order to develop novel DNA probes with bioessential metal ion and new ligand 
architectures we have investigated the DNA binding capabilities of these metal 
complexes by employing several spectroscopic (UV/vis absorption, Circular dichroism 
and Fluorescence spectroscopy), electrochemical (Cyclic voltammetry) and physical 
(Viscosity measurements) techniques. 
Favourable physiological responses of efficient DNA binding metal complex need to be 
demonstrated by in vitro and in vivo investigation with targeted biomolecules and tissues. 
A mechanistic understanding of how metal complexes achieve their activities is crucial to 
their clinical success, as well as to the rational design of new compounds with improved 
potency. So in vitro antitumour activity of complex 2-Amino-2-deoxy-N-[2-(l,3,5,8,l 1-
pentaazacyclotridecan-3-yl)ethyl]-P-D-glucopyranosylamine copper(ll) dichloride on 
SH-SY5Y, PC-12 cell lines and l-{(2-ethoxy) amino}-2-amino-l, 2-dideoxy-D-glucose 
triphenyl tin (IV) complex on SH-SY5Y, PC-12 and N2A cancer cell lines have been 
checked. To analyze the gene mediated pathway through which newly synthesized 
complexes exert its therapeutic effect MTT assay, Hoechst 33342 DNA staining, cell 
cycle analysis, DNA fragmentation. Western blot analysis of whole cell lysates and 
mitochondrial fraction with Bcl-2 and p-53 family protein and caspase-3 colorimetric 
assay have been performed. 
CHAPTER II 
Experimental 
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CHAPTER II 
EXPERIMENTAL METHODS 
The following techniques were employed 
1. Characterization techniques 
1.1 Infrared spectroscopy 
1.2 Ultra-violet and visible spectroscopy 
1.3 Nuclear magnetic resonance spectroscopy 
1.4 Electron paramagnetic resonance spectroscopy 
1.5 Mass spectroscopy 
1.6 Molar conductance measurements 
1.7 Magnetic moment 
1.8 Polarimetry 
2. DNA binding studies 
2.1 Cyclic voltammetry 
2.2 Absorption spectral studies 
2.3 Fluorescence spectral studies 
2.4 Circular dichroism spectral studies 
2.5 Viscometry studies 
3. In vitro antitumour studies 
3.1 Cell counting 
3.2 MTT assay for cell viability 
3.3 Hoechst DNA staining 
3.4 DNA laddering experiments 
3.5 Flow cytometry 
3.6 Western blot analysis 
3.7 Caspase-3 colorimetric assay 
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1. Characterization techniques 
1.1 Infrared spectroscopy 
The infrared spectroscopy is a useful technique to characterize a compound. It results 
from transition between vibrational and rotational energy levels. IR region of the 
electromagnetic spectrum covers a wide range of wavelength from 200 to 4000 cm" . It 
has been found that in IR absorption, some of the vibrational frequencies are associated 
with specific groups of atoms and remain same irrespective of the molecules in which the 
group is present. These arc called characteristic frequencies [174] and their constancy 
results from the constancy of bond force constants from molecule to molecule. The 
important observation that the IR spectrum of a complex molecule consists of 
characteristic group frequencies makes IR spectroscopy, unique and powerful tool in 
structural analysis. 
1.2 Ultraviolet and visible spectroscopy 
When a molecule absorbs radiation, its energy is increased. This increased energy is 
equal to the energy of the incident photon expressed by the relation 
E - h v 
E =hc/X 
where h is Planck's constant, v is the frequency, X is the wavelength of the radiation and 
c is the velocity of light. Most of the compounds absorb light in the spectral region 
between 200 and 800 nm resulting in the excitation of electrons of the molecules from 
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ground state to higher electronic states. In transition metals, all the five'd' orbitals viz. 
dxy, dyz, dxz, di and dx^ -y^  are degenerate. However, in coordination compounds due to the 
presence of ligands, this degeneracy is destroyed and d orbitals split into two groups tjg 
(dxy, dyz and dxz) and Cg (dz^  and dx^ .y^ ) in an octahedral complex and t and e in a 
tetrahedral cohiplex. The set of tag orbitals goes below the original level of degenerate 
orbitals in octahedral complexes and the case is reversed in tetrahedral complexes (Figure 
37 a, b). At energy higher than the ligand field absorption bands. 
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Figure 37 (a). Splitting of the d energy levels in an octahedral complex 
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Figure 37 (b). Ligand field splitting of a tetrahedral complex, 'g' subscript is omitted in 
Td symmetry 
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we commonly observe one or more very intense bands that go off scale unless log e is 
plotted. These are the charge transfer bands, corresponding to electron transfer 
processes that might be either ligand -^ metal (L —• M) or metal —»• ligand (M -^ L). M 
—>^ L transitions occur for metal ion complexes that have filled, or nearly filled, tag 
orbitals with ligands that have low lying empty orbitals. These empty orbitals are ligand 
7t* orbitals in complexes such as those of pyridine, bipyridine, 1,10-phenanthroline, CN~, 
CO and NO. Figure 38 shows overlap of a t2g metal orbital and n* of CO. 
Ni — C = 0 : Ni=C = 0 '^>^Ni3<:c=0 
Valence bond representation 
(o) (b) 
C = 0 
Molecular orbital 
representation 
(c) 
Figure 38. Metal carbon double bonding 
The L —+ M charge-transfer (C-T) spectra have been studied more thoroughly. The 
intense bands are for Laporte-allowed transitions commonly of the p (ligand) —> (/(metal) 
type. The ionization energy for the ligand (or its ease of oxidation) as well as the 
oxidation state and electron configuration of the metal (or its ease of reduction) 
determines the energy of the transition. No net oxidation-reduction usually occurs, 
because of the short lifetime of the excited state [175]. 
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1.3 Nuclear magnetic resonance spectroscopy 
The nuclei of certain isotopes possess a mechanical spin or angular momentum. The 
NMR spectroscopy is concerned with nuclei having nuclear spin quantum number 1 = 
1/2, example of which include 'H , '^C, ^ 'P , "^Sn and '^F. 
For a nucleus with I = 1/2, there are two values for the nuclear spin angular momentum 
quantum number mi = ±1/2 which are degenerate in the absence of a magnetic field. 
However, in the presence of the magnetic field, this degeneracy is destroyed such that the 
positive value of mj corresponds to the lower energy state and negative value to higher 
energy state separated by AE. 
In an NMR experiment, one applies strong homogeneous magnetic field causing the 
nuclei to precess. Radiation of energy comparable to AE is then imposed with radio 
frequency transmitter equal to precision or Larmor frequency and the two are said to be 
in resonance. The energy can be transferred from the source to the sample. The NMR 
signal is obtained when a nucleus is excited from low energy to high energy state. 
1.4 Electron paramagnetic resonance spectroscopy 
EPR spectroscopy [176] is the branch of absorption spectroscopy in which radiation 
having frequency in the microwave region is absorbed by energy levels of electrons with 
unpaired spins. The magnetic energy splitting is done by applying a static magnetic field. 
For an electron of spin S = 1/2, the spin angular momentum quantum number will have 
values of ms = ±1/2. In absence of magnetic field, the two values of ms i.e. +1/2 and -1/2 
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will give rise to a doubly degenerate spin energy state. If a magnetic field is applied, this 
degeneracy is lifted and leads to the non-degenerate energy levels. The low energy level 
will have the spin magnetic moment aligned with the field and correspond to the quantum 
number ms = -1/2. On the other hand, the high energy state will have the spin magnetic 
moment opposed to the field and correspond to the quantum number ms = +1/2. 
1.5 Mass spectroscopy 
At electron beam energy of about 9 to 15 electron volts, depending on the molecule 
involved, a molecular ion is formed by interaction with the beam electrons. Recognition 
of the parent ion (actually a radical ion) is of great importance because it gives the 
molecular weight of the sample [177]. At this point, the molecular weight is an exact 
numerical molecular weight not the approximation obtained by the all other molecular 
weight procedures. Mass spectra is usually obtained at an electron beam energy of 70 
electron volts and under these conditions numerous fragment ions (including the parent 
ions) versus their relative concentrations constitutes the mass spectrum of the samples. 
The fragmentations occur on the basis of mass/charge (m/z). The largest peak in the 
spectrum is called base peak and assigned a value of 100%. The other peaks are reported 
as percentage of the base peak. 
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1.6 Conductance measurements 
The conductivity measurement is one of the simplest and easily available techniques used 
to study the nature of the complexes. It gives direct information regarding whether a 
given compound is ionic or covalent. For this purpose, the measurement of molar 
conductance (Am), which is related to the conductance value in the following manner is 
made. 
cell constant x conductance 
Am = 
concentration of solute expressed in mol cm''' 
Conventionally, solutions of 1x10" M strength are used for the conductance 
measurements. Molar conductance values of different types of electrolytes in a few 
solvents are given as, 1:1 electrolyte has a value of 80-115 ohm"' cm"^  mol"' in MeOH, 
65-90 ohm"' cm^ mol"' in DMF, 78-80, 50-70 ohm"' cm^ mol"' DMSO and 35-45 ohm"' 
cm mol" in EtOH [178- 179]. Similarly a solution of 2:1 electrolyte has a value of 160-
220 ohm"' cm^ mol"' in MeOH, 130-170 ohm"' cm^ mol"' in DMF and 70-90 ohm"' cm^ 
mol"' in EtOH. 
1.7 Magnetic moment 
When a substance is placed in an inhomogeneous magnetic field it is either attracted 
towards the strong part of the field or repelled towards the weaker part. If it is attracted 
by the field, it is said to be paramagnetic, if repelled it is said to be diamagnetic. The 
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force F with which a diamagnetic substance is repelled when placed in a field of strength 
H and gradient dH/dx is determined by 
dH 
F = VH 
where x 's called magnetic susceptibility 
V is the volume of the substance 
The magnetic susceptibility is a measure of the change in the magnetic moment ' |i ' of the 
atoms caused by applied field. It is determined by the Langevin's equation. 
Noe-
6 mc^ 
where No is Avogadro's number, 
r is the average radius of the orbits of the electrons 
Paramagnetic susceptibility is inversely proportional to the absolute temperature 
5C p 
T 
where C is the Curie constant and is characteristic of the material. 
The relationship between li^trand magnetic susceptibility is given below 
Heft- = 2 . 3 4 ( X A / T ) " ' 
where T is the absolute temperature 
51 
XA is the molar susceptibility corrected for diamagnetic effects 
H€ff is the magnetic moment of the compounds in units of Bohr magnetons. 
Magnetic susceptibility measurements are mostly made with Gouy method [180]. 
1.8 Polarimetry 
Optical isomerism manifests itself by the rotation that certain molecules impart to the 
plane of polarized light when in gaseous, liquid or molten state or in solution (Figure 39). 
This rotation is observed and measured by a rather simple instrument, known as 
polarimeter. The specific rotation [a] of a dissolved substance is given by the expression 
a 
[a] = 
1 X c 
where a is the observed rotation in degrees 
1 is the path length of the sample in decimeters 
c is the concentration in grams per milliliter 
The dependence on wavelength and temperature is indicated by subscripts and 
superscripts respectively. Thus [a]D^^  means the specific rotation at 25° C measured at 
the wavelength of the sodium D line. 
Optical rotation is generally measured using light from a sodium-vapour lamp, which 
gives essentially monochromatic radiation (the yellow sodium D line is a doublet at 5890 
and 5896 A ). A beam of light is polarized by passage through nicol prism (the polarizer), 
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Figure 39. Rotation of plane of polarized light by optically active compounds 
which consists of two calcite prisms cemented together so that only one of the two rays 
formed by double refraction is transmitted. The beam of polarized light passes through 
the solution and then through a second nicol prism. When no optically active material is 
placed between the prisms (O" rotation), the prisms are positioned at right angles so that 
no light is transmitted. When an optically active material is placed between the prisms, 
the analyzer must be turned in order to maintain the darkness in the field of view. The 
optical rotation is the angle by which the analyzer is turned in order to reach darkness. It 
is very difficult to determine by eye the setting for complete darkness, because positions 
near the completely dark position are very dark. Therefore, many instruments are 
constructed such that the field of view is divided into two equal parts, and the analyzer is 
adjusted so as to equalize the light intensity in each half of the field. 
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2. DNA binding studies 
CT DNA was procured from Sigma Chemical Company and tris base was obtained from 
E. Merck. Ail tlie experiments involving interaction of the complexes with CT DNA were 
conducted in buffer containing tris (0.01 M) adjusted to pH 7.2 with hydrochloric acid. 
The CT DNA was dissolved in tris-HCl buffer and was dialyzed against the same buffer 
overnight. Solutions of CT DNA gave ratios of UV absorbance at 260 and 280 nm above 
1.8, indicating that the DNA was sufficiently free of protein [181]. DNA concentration 
per nucleotide was determined by absorption spectroscopy using the molar absorption 
coefficient 6600 dm^mol' cm'' at 260 nm [182]. The stock solution was stored at 4°C. 
2.1 Cyclic voltaminetry 
Cyclic voltammetry involves the measurement of current-voltage curves under diffusion 
controlled, mass transfer conditions at a stationary electrode, utilizing symmetrical 
triangular scan rates ranging from a few millivolts per second to hundred volts per 
second. The triangle returns at the same speed and permits the display of a complete 
polarogram with cathodic (reduction) and anodic (oxidation) waveforms one above the 
other. Two seconds or less is required to record a complete polarogram [183]. 
Consider the reaction 
O + ne • R (i) 
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Assuming semi-infinite linear diffusion and a solution containing initially only species O. 
With the electron held at a potential Ei where no electrode reaction occurs. The potential 
is swept linearly at v v/sec so that the potential at any time is 
E(t) = E|-vt 
or Epeak = E°-0.0285 
The rate of electron transfer is so rapid at the electrode surface that species O and R 
immediately adjust to the ratio according to the Nernst equation, which is as follows., 
Co(0,t) - Co* - [nFA(7rDo)"']-' | I(Tt)(t-T)-'^  dx (ii) 
I = nFACo*(TtDoa)"^ X (a t) (iii) 
Redox (electron-transfer) reactions of metal complexes can be investigated by cyclic 
voltammetry. An electrode is immersed in a solution of the complex and voltage is swept 
while current flow is monitored. No current flows until oxidation or reduction occurs. 
After the voltage is swept over a set range in one direction, the direction is reversed and 
swept back to the original potential. The cycle may be repeated as often as desired. 
Figure 40 b shows the cyclic voltammograms (CV) for a reversible one-electron redox 
reaction such as, 
CpFe(CO)LMe • CpFe(CO)LMe^ + e" 
Sweeping the potential in an increasing direction oxidize the complex as the anodic 
current la flows; reversible reduction of CpFe(CO)LMe"^ generates cathodic current Ic on 
Asad L)6f 
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the reverse sweep. The magnitude of the current is proportional to the concentration of 
the species being oxidized or reduced. 
The measured parameters of interest on these cyclic voltammograms are Ipa/Ipc the ratio 
of peak currents, Epa - Epc the separation of peak potentials and the formal electrode 
potential E°. For a Nernstian wave with stable product, the ratio Ipa/Ipc = 1 regardless of 
scan rate, E*' and diffusion coefficient, when Ipa is measured from the decaying current as 
a base line. The difference between Epa and Epc (AEp) is a useful diagnostic test of a 
Nernstian reaction. Although AEp is slightly a function of E", it is always close to 2.3RT/ 
nF. 
Figure 40. (a) Cyclic potential sweep (b) Resulting cyclic voltammogram 
The technique yields information about reaction reversibilities and also offers a rapid 
means of analysis for suitable systems. The method is particularly valuable to study 
interaction of metal ions to DNA as it provides a useful compliment to other methods of 
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investigation, such as UV/vis spectroscopy. Cyclic voltammetric studies were 
accomplished on a CH Instrument Electrochemical analyzer using a three-electrode 
configuration comprised of a Pt wire as the auxiliary electrode, a platinum micro-cylinder 
as the working electrode and Ag/AgCl as the reference electrode. Supporting electrolyte 
for the experiments was 0.4 KNO3. Electrochemical measurements were made under 
nitrogen atmosphere. All electrochemical data were collected at 298 K and are 
uncorrected for junction potentials. 
2.2 Absorption spectral studies 
In a closed constant volume system, the rate of a chemical reaction is defined as the rate 
of change of the concentration of any of the reactants and products with time. The 
concentration can be expressed in any units of quantity per unit volume e.g. moles per 
liter, moles per cubic centimeter. The rate will be defined as positive quantity regardless 
of the component whose concentration change is measured. 
The rate of a chemical reaction is not measured directly instead the concentration of one 
of the reactants or products is determined as a function of time. A common procedure for 
determining the reaction order is to compare the experimental results with integrated rate 
equations for reactions of different orders. For a first order rate equation, integrating by 
separate variables using integration limits such that at t = 0, c = CQ and at t = t, c = c. 
[184]. 
-dc/dt = kc 
57 
or In (CQ/C) = kt 
The intrinsic binding constant Kb of the complex to CT DNA was determined from Eqn. 
(1), through a plot of [DNA]/ea-8f vs. [DNA], where [DNA] represents the concentration 
of DNA, and Ea, Sf, and eb the apparent extinction coefficient (Aobs/[M]), the extinction 
coefficient for free metal complex (M), and the extinction coefficient for the free metal 
complex (M) in the fully bound form, respectively. In plots of [DNA]/8a-SfVS. [DNA], 
Kb is given by the ratio of slope to intercept [185]. These absorption spectral studies were 
performed on USB 2000 Ocean Optics spectrometer. 
[DNA] = [DNA] , _ ! (1) 
Sa-Sf 8b-£r Kb(eb-Sf) 
2.3 Fluorescence spectral studies 
When molecules that have absorbed light are in a higher electronic state, they must lose 
their excess energy to return back to the ground state. If the excited molecule returns to 
the ground state by emitting light, it exhibits fluorescence and spectrum thus obtained is 
called emission spectrum. This phenomenon is generally seen at moderate temperature in 
liquid solution. The emission spectrum is obtained by setting the excitation 
monochromator at the maximum excitation wavelength and scanning with emission 
monochromator. Often an excitation spectrum is first made in order to confirm the 
identity of the substance and to select the optimum excitation wavelength. Further 
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experiments were carried out to gain support for the mode of binding of complexes with 
CT DNA. Non fluorescent or weakly fluorescent compounds can often be reacted with 
strong fluorophores enabling them to be determined quantitatively. On this basis 
molecular fluorophore EthBr was used which emits fluorescence in presence of CT DNA 
due to its strong intercalation. Quenching of the fluorescence of EthBr bound to DNA 
were measured with increasing amount of metal complexes as a second molecule and 
Stern-Volmer quenching constant K was obtained from the following Eqn. [186] 
lo/I =1+Kr (2) 
where r is the ratio of total concentration of complex to that of DNA and lo and I are the 
fluorescence intensities of EthBr in the absence and presence of complex. Emission 
intensity measurements were carried out using Hitachi F-2500 spectrofluorometer at 
room temperature. 
2.4 Circular dichroism spectral studies 
Circularly polarized light represents a wave in which the electrical component spirals 
around the direction of propagation of the ray, either clockwise or counterclockwise. 
Within the absorption band the molar absorptivity for right and left handed circularly 
polarized light is different, that is (Sd-Si) i^ 0. This effect changes linearly polarized light 
into elliptically polarized light and is known as circular dichroism. 
When a substance near an absorption band absorbs left circularly polarized light, the 1 
component, more strongly than the right circularly polarized light, the d component, i.e. 
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8i > Ed then the amplitude of d component will be greater than the 1 furthermore, if £d > si 
then the d component will be retarded more than the 1 component (Figure 41). 
d component 
/ component 
Plane of 
incident beam -*l 
I 
Figure 41. Elliptically polarized light produced when tjd>t]i and Ei>Ed 
The ellipticity, that is the angle whose tangent is ratio of minor axis of the ellipse OB to 
the major axis OA, is denoted by 9. The molecular ellipticity [6] can be shown by the 
relationship [187]. 
[9] = 3305 (s, - Sd) 
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Circular dichroism graphs are plots of [9] against wavelength. Circular dichroic spectra 
were obtained on JASCO J-715/J-710 CD spectropolarimeter at 25^ C. 
2.5 Viscoinetry studies 
The hydrodynamic changes are the consequence of the change in length of the molecule, 
the diminished bending between layers and the diminished length-specific mass. 
Viscosity measurements were carried out using Ostwald's viscometer at 29±0.01 C. Flow 
time was measured with a digital stopwatch. Each sample was measured three times and 
an average flow time was calculated. Data were presented as (rj/rio) versus binding ratio 
([M]/[DNA]), [188-189] where t] is a viscosity of DNA in the presence of complex and 
r|o is the viscosity of DNA alone. Viscosity values were calculated from the 
observed flow time of DNA containing solution (t >100s) corrected for the flow time of 
buffer alone (to), r| = t- to. 
3. In vitro antitumour studies 
Cell Culture 
SH-SY5Y human neuroblastoma cell line 
SH-SY5Y cells were obtained from the American Type Culture, collection was 
maintained in DMEM supplemented with 10% FBS, antibiotic-antimycotic (Iml/lOOml), 
non-essential amino acid (Iml/lOOml) and glutamine (2.5ml/100ml). Incubation was 
performed at 37°C in a humidified atmosphere, with 5% CO2 in the air. 
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Neuro2A (N2A) mice cell line 
N2A cells were maintained in DMEM supplemented with 10% fetal calf serum, and 
antibiotic-antimycotic (Iml/lOOml). Incubation was performed at 37" C in a humidified 
atmosphere, with 5% CO2 in the air. 
PC-12 rat pheochromocytoma cell line 
PC-12 cells were maintained in DMEM supplemented with 10% horse serum, 5% fetal 
calf serum, and antibiotic-atimycotic (Iml/lOOml). Incubation was performed at 37"C in 
a humidified atmosphere, with 5% CO2 in the air. 
3.1 Cell counting 
The cells were plated in a 24 well plate at a density of 2.5 x 10^  cells per well. 
Approximately 800|.il of medium was added to each well and the plate was kept in the 
incubator. After about 24 hours the cells were serum starved for 12 hours and various 
concentrations of complex were added in duplicates to the plate. After 24 hours of 
incubation the cells were counted with haemocytometer. A graph of the number of live 
cells vs. compound concentration was plotted [190]. 
3.2 MTT assay for cell viability 
The internal environment of proliferating cells is more reduced than that of non-
proliferating cells. This reduced state can be measured using tetrazolium salts. Most 
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frequently used salt is MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium), 
which is a water soluble tetrazoiium salt and has been used in models for screening 
cytocidal chemical agents. MTT is converted to an insoluble purple formazan by 
cleavage of the tetrazoiium ring by the dehydrogenase enzymes (Figure 42). 
o-<;:r NADH 
CH, 
CH, 
MTT 
-NAD 
Formazan 
Figure 42. Molecular structures of MTT and its reaction product Formazan 
This water insoluble formazan can be solubilized with DMSO or HCl/ isopropanol and 
the dissolved material is measured spectrophotometrically yielding absorbance as a 
function of concentration of converted dye. The cleavage and conversion of the soluble 
yellow dye to the insoluble purple formazan is used as an assay for the measurement of 
cell proliferation. Active mitochondrial dehydrogenases of the living cells will cause this 
conversion. Dead cells do not cause this change [191]. 
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3.3 Hoechst DNA staining 
DNA staining with Hoechst was performed as reported earlier [192]. Cells were treated 
with complex for a definite time interval, then fixed with 3.7% paraformaldehyde at room 
temperature and stained with Hoechst stain dissolved in PBS. Cells were then washed 
with PBS and the stained nuclei were visualized under a fluorescence microscope. 
Apoptotic cells were morphologically defined as cells showing aberrant Hoechst stained 
nuclei and chromosomal fragmentation. 
3.4 DNA laddering 
The DNA laddering experiment was carried out to find out whether the cells were 
undergoing apoptosis. Apoptosis is an organized self destruction of redundant and 
damaged living cells and is different from the usual or necrotic cell death. While cells 
undergoing necrosis undergo swelling, and leakage of cellular contents, cells 
programmed for apoptosis show membrane blebbing, nuclear condensation and a 
characteristic DNA fragmentation ultimately leading to packing of the cellular contents, 
including DNA into membrane vesicles known as apoptosis bodies. 
Cells undergoing apoptosis can be studied experimentally by light microscopy and/or by 
biochemical methods. In our experiments we have used the biochemical methods in 
which cells including apoptotic bodies are collected and processed to extract genomic 
DNA which is then resolved in 2% ethidium bromide agarose gel. Characteristic DNA 
64 
ladder formation of the genomic DNA on the agarose gel is considered as a key feature of 
apoptosis [193]. 
3.5 Flow cytometry 
Growth and proliferation in eukaryotic cells is characterized with distinct phases of 
development known as the cell cycle (Figure. 43). The sequence of cell cycle events can 
be identified as, initiating from a quiescent or resting state Phase Go, cell growth and 
preparation of chromosomes for replication takes place in Phase Gi. The cycle continues 
with synthesis of DNA in S Phase and is followed by preparations for cell division in 
Phase G2. The cycle completes with mitosis i.e. M Phase and is perpetuated with the 
newly divided cells (Figure. 44). 
G,PHASE 
S PHASE 
(ONA replication) 
Figure 43. The cell cycle 
Gi and 
someS 
Figure 44. Formation of daughter haploid cells from the parent diploid cell 
M and G2 
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Flow cytometry offers a rapid method for measuring the DNA content of cells and 
provides a convenient research tool to monitor cell cycle status and regulation [194]. An 
exponentially growing population of cells will have a DNA content distribution 
containing an initial peak of Go/Gi cells, a valley of S Phase cells, and a second peak 
containing G2/M cells. Cells in the G2/M Phase have twice the DNA content as cells in 
the Go/Gi Phase. DNA content measurements can be performed with the Fluorescence 
Activated Cell Sorting (FACS) Analysis which is based on the ability of nuclear dyes, 
such as DAPI and PI, to bind selectively to DNA under appropriate staining conditions 
(Figure. 45). Cells stained with such dyes emit fluorescence in direct proportion to their 
DNA content [195]. 
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Figure 45. Fluorescence Activated Cell Sorting (FACS) Analysis 
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Preparation of whole cell lysates and mitochondrial fraction 
Preparation of total cell lysates and mitochondrial fractionation of cells into membrane 
and cytosolic fractions used for detection of cyto c were performed according to the 
methods described earlier [173, 196]. 
Protein estimation 
Quantitative determination of the protein content in each well was estimated by Pierce 
BCA protein assay, which is a highly sensitive method of determination of total protein 
content in dilute aqueous solutions. In this method, the lysates diluted with corresponding 
lysis buffer were treated with 50)0.1 of Reagent A and 1|4,1 of Reagent B for 30 minutes. 
Then the optical density at 570 nm was monitored, which is proportional to the total 
protein content and the number of cells in each well. This reagent system utilizes BCA as 
a detection reagent for Cu'*', which is formed when Cu^ "^  is reduced by protein in alkaline 
environment. The purple coloured reaction product is formed by chelation of two 
molecules of BCA with one cuprous ion. This water soluble complex exhibits strong 
absorbance at 570 nm that is linear with increasing protein concentrations. 
Protein + Cu^"*" • Tetradentate-Cu* complex 
Cu"" complex + BCA • BCA-Cu^ complex 
(Purple colour) 
67 
3.6 Western blot analysis 
The method of transferring or blotting a pattern of separated proteins from the gel onto a 
sheet of PVDF membrane is called western blotting. Transfer of proteins from the gel to 
PVDF can be achieved either by capillary blotting or by electroblotting [197]. The 
transferred proteins are bound to the surface of the membrane, providing access for 
reaction with immunodetection reagents. This involves probing the blot, usually using an 
antibody to detect the specific protein. For this an indirect detection method is used in 
which the blot is first incubated with a primary antibody added first to bind to the 
antigen, will block all remaining hydrophobic binding sites on the PDVF membrane. The 
blot is then incubated in a dilution of a labeled secondary antibody that is directed against 
the primary antibody (Figure. 46). 
Sytatrate Oeteclfilile 
Profiuci 
Eiuyne 
Detectable 
Product 
^d^lKfrne 
Figure 46. A. In the direct detection method, labeled primary antibody binds to antigen 
on the membrane and reacts with substrate creating a detectable signal. B. In the indirect 
detection method, unlabeled primary antibody binds to the antigen. Thus a labeled 
secondary antibody binds to the primary antibody and reacts with the substrate 
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This IGg molecule will bind to the blot if it detects the antigen, thus identifying the 
protein of interest. The primary antibody is conjugated with the enzyme horseradish 
peroxidase, which uses H2O2 as its substrate. The detection of horseradish peroxidase 
oxidizes the luminol with concomitant production of light, the intensity of which is 
increased 1000 fold by the presence of a chemical enhancer. The light emission can be 
detected by exposing the blot to a photographic film. 
3.7 Caspase-3 colorimetric assay 
Activation of caspases initiates apoptosis in mammalian cells [198]. The assay is based 
on spectrophotometric detection of the chromophore p-nitroanilide (pNA) after cleavage 
from the labeled substrate DEVD-pNA. ThepNA light emission can be quantified using 
a microtiter plate reader at 405 nm. Comparison of the absorbance of pNA from an 
apoptotic sample with an uninduced control allows determination of the increase in 
CPP32 activity. 
CHAPTER III 
Synthesis, Characterization, Solution Stability Studies, 
Electrochemistry and DNA Binding Behaviour of 
Cu(ll)Complexes of D-Gluconic Acid 
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CHAPTER III 
Experimental 
All reagents were of the best commercial grade and were used as received. 2-hydroxy 
ethylamine, ethane-1,2-diamine, CUCI2.2H2O and NiCl2.6H20 were procured from E. 
Merck. D-gluconic acid was obtained from s. d. Fine-Chem Ltd. The compounds were 
highly hygroscopic and hence special precautions were necessary while handling. 
Carbon, hydrogen and nitrogen contents were analyzed on a Carlo Erba Analyzer Model 
1108. Molar conductance was measured at room temperature on a Digisun Electronic 
Conductivity Bridge. Fourier-transform IR (FTIR) spectra were recorded on an Interspec 
2020 FTIR spectrometer, as KBr pellets. The UV/vis absorption studies were carried on a 
Systronics 119 spectrophotometer (ESP-300). The solid state EPR spectra of the copper 
complexes were acquired on a Varian E 112 spectrometer using X-band frequency 
(9.1GHz) at liquid nitrogen temperature. The NMR spectra were obtained on a Bruker 
DRX-300 spectrometer. Specific rotations of the complexes were obtained on a Rudolf 
Autopole polarimeter at 20 °C at the sodium D line in a 1-dm tube containing the 
complex dissolved in water. Experiments involving the interaction of complexes with CT 
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DNA were carried out by measuring absorbance changes at 260 nm (kmax of CT DNA) 
under varying concentration of CT DNA (4 - 6.4 x 10"^  M). Pseudo-first order rate 
constants, kobs, were obtained by the linear least regression method. 
Synthesis of (Cu(en)2]Cl2, [Ni(en)2]Cl2and [Cu(ea)2]Cl2 
All the complexes have been synthesized by the procedure reported earlier [I99J. 
Synthesis of [Cu(D-GlcC en*)2 (H20)2]Cl2 [C,6H36Cl2CuN40,2] 
To a methanolic solution of [Cu(en)2]Cl2 (0.25 g, 1 mmol) was added D-gluconic acid 
(0.31 ml, 2 mmol). Immediately, a deep blue product precipitated which was collected, 
washed with hexane, and dried in vacuo. 
Synthesis of [Ni(D-GlcC en*)2lCl2 [C,6H32Cl2N4NiOio] 
To a solution of [Ni(en)2 ]Cl2 (0.24 g, 1 mmol) in dry methanol was added D-gluconic 
acid (0.31 ml, 2 mmol). On mixing, a green coloured product precipitated out, which was 
isolated, washed with hexane, and dried in vacuo. 
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Synthesis of [Cu(D-GlcC ea*) (H20)2]Cl2 [CoHzeChCuNzOo] 
Complex [Cu(ea)2]Cl2 (0.51 g, 2 mmol) was dissolved in MeOH (50 ml). To this solution 
was added D-gluconic acid (0.31 ml, 2 mmol) dropwise with constant stirring. A deep 
green amorphous product was obtained which was separated, washed with hexane and 
dried in vacuo. 
Synthesis of [Ni(D-GlcC ea*) (H20)2lCl2 [C,oH26Cl2N2Ni09l 
A mixture of 2-hydroxy ethylamine (0.12 ml, 2 mmol) and NiCl2.6H20 (0.23 g, 1 mmol) 
dissolved in 50 ml of MeOH gave a bluish green solution. The colour of solution turned 
to light green when D-gluconic acid (0.15 ml, I mmol) was added. A light green 
amorphous product precipitated out within 5 minutes by setting the solution aside. The 
precipitate was isolated, washed with hexane and dried in vacuo. 
Results and discussion 
The corresponding chiral Schiff base complexes were synthesized via the condensation 
reaction of compounds, [Cu(en)2 ]Cl2, [Ni(en)2 JCb and [Cu(ea)2 JCb with D-gluconic 
acid as depicted in Scheme 1. Complexes [Cu(D-GlcC en*)2 (H20)2]Cl2, [Ni(D-GlcC 
en*)2]Cl2, [Cu(D-GlcC ea*) (H20)2]Cl2 and [Ni(D-GlcC ea*) (H20)2]Cl2 were found to 
be soluble only in water and were insoluble in common organic solvents. However, 
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[Ni(D-GlcC ea*) (H20)2]Cl2 is soluble in slight acidic aqueous solution. All the 
complexes exhibited aqueous molar conductivity, which is in good agreement with the 
proposed complex formulae and also correlate their 1:2 electrolyte behaviour. Complexes 
[Cu(D-GlcC en*)2 (H20)2]Cl2 and [Ni(D-GlcC en*)2]Cl2 are hygroscopic, while 
complexes [Cu(D-GlcC ea*) (H20)2]Cl2 and [Ni(D-GlcC ea*) (H20)2]Cl2 are not 
moisture sensitive and are acquired in good yields (Table 1). All the complexes have 
been characterized extensively both in solid and in solution states. Furthermore, all the 
aqueous solution spectral analyses were carried out using freshly prepared solutions. 
Crystallization of the complexes was not easy, probably because of the structural 
flexibility of the metal-sugar complexes and in the absence of crystal structure, a definite 
conclusion regarding the three-dimensional structure could not be obtained. Regardless of 
this fact, all the complexes were exhaustively characterized by IR, UV/vis, CD, EPR, 'H, 
'^ C and 2D COSY NMR spectroscopies. The optical rotation + 29, + 13, - 59 and - 40 
for [Cu(D-GlcC en*)2 (H20)2]Cl2, [Ni(D-GlcC en*)2]Cl2, [Cu(D-GlcC ea*) (H20)2]Cl2 
and [Ni(D-GlcC ea*) (H20)2]Cl2, respectively, indicate that complexes are optically 
active. Kinetic experiments were performed using copper complexes [Cu(D-GlcC en*)2 
(H20)2]Cl2 and [Cu(D-GlcC ea*) (H20)2]Cl2, and analogous nickel complexes were 
synthesized only for NMR studies. 
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FTIR studies 
The FTIR spectra of all the sugar complexes were recorded as KBr pellets and exhibited 
merged and broadened bands with the loss of fme structures. Complexes [Cu(D-GlcC 
en*)2 (H20)2]Cl2, [Ni(D-GlcC en*)2]Cl2, [Cu(D-GlcC ea*) (H20)2]Cl2 and [Ni(D-GlcC 
ea*) (H20)2]Cl2 showed the presence of sharp u(C=N) [73] stretching vibrations at 1600, 
1602, 1608 and 1610 cm"', respectively, supporting the formation of the imino center. In 
addition, the bands at ca. 3180 cm'' and 1358-1379 cm' are ascribed to t)(N-H) and 
\)(C-N) groups, respectively. Free gluconic acid shows a u(O-H) band in the region of 
3500-3280 cm"' [200]. However, the complexes exhibited a broad envelope around ca. 
3400 cm"', which is further complicated due to overlapping of \)(0-H) of water 
molecules present as moisture in these hygroscopic compounds. The FTIR spectra of 
[Cu(D-GlcC en*)2 (H20)2]Cl2, [Ni(D-GlcC en*)2]Cl2, [Cu(D-GlcC ea*) (H20)2]Cl2 and 
[Ni(D-GlcC ea*) (H20)2]Cl2 showed the occurrence of broad bands for all the vibrational 
modes which rendered the individual assignments difficult, however, the ranges of 
different frequencies could be identified (Table 2, 3). The skeletal vibrations centered 
around 1465 cm"' [5(0CH, CH2, CCH)], 1080 cm"' [u(CO, CC)], 760 cm"' [6(CCH,CH)] 
and 800 cm" [\)(CC.CO)] depict the presence of D-gluconic acid in the metal complexes. 
All the metal complexes exhibited broadening of band around 535-600 cm"', which 
makes the assignment of \)(M-0) and t)(M-N) very difficult. 
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Solution absorption studies 
Absorption spectra of freshly prepared aqueous solutions of [Cu(D-GlcC en*)2 
(H20)2]Cl2, [Ni(D-GlcC en*)2]Cl2, [Cu(D-GlcC ea*) (H20)2]Cl2 and [Ni(D-GlcC ea*) 
(H20)2]Cl2 were recorded in the region of 200-800 nm as shown in Figure 47. The bands 
observed in the range 232 nm to 253 nm are ascribed to possible ligand transitions 
influenced by the presence of metal ions. The electronic spectrum of [Ni(D-GicC 
en*)2]Cl2 showed ligand —» metal charge transfer band in the region 280 to 306 nm and a 
prominent broad band in the region 561-599 nm attributed to an 'Aig —»• 'A2g transition 
indicative of square planar geometry of the complex [201]. However, the solution spectra 
of [Ni(D-GlcC ea*) (H20)2]Cl2 exhibits three principal bands around 293 nm, 390 nm 
and 690 nm assigned to the three spin- allowed ^A2g(F) -^ ^T2g(F), ^A2g(F) -* ^T,g(F) and 
^A2g(F) —> ^Tig(P) transitions, respectively, for an octahedral Ni(ll) complex [61]. Crystal 
field theory provides a simple interpretation of the spectra of Ni(II) in the fields of Oh 
symmetry [202]. The ratio 1)2/1)1 of the frequencies of the first and second band maxima 
lie in most octahedral Ni(ll) complexes between 1.5 and 1.7. The value (1.7) obtained for 
[Ni(D-GlcC ea*) (H20)2]Cl2 falls within this range, which supports the octahedral 
geometry around the Ni(Il) ion in [Ni(D-GlcC ea*) (H20)2]Cl2. In the UV/vis spectra of 
[Cu(D-GlcC en*)2 (H20)2]Cl2 and [Cu(D-GlcC ea*) (H20)2]Cl2 recorded in water, bands 
are observed at ca. 650 nm and ca. 712 nm corresponding to d-d bands, followed by a 
high-intensity band at 295 nm and 300 nm, respectively. The d-d bands are assigned to 
the Eg -* T2g transition [203], and the high intensity bands are attributed to 
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ligand -> metal charge transfer transitions indicating the presence of a typical octahedral 
geometry around the Cu(Il) ion. 
too aoo 
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Figure 47. Absorption spectra of [Cu(D-GlcC en*)2 (H20)2jCh (curve a), [Ni(D-GlcC 
en*)2jCh (curve b). [Cu(D-GlcC ea*) (H20)2]Cl2 (curve c) and [Ni(D-GlcC ea*) 
(H20)2]Cl2 (curve d) in water 
EPR studies 
The X-band EPR spectra of [Cu(D-GlcC en*)2 (H20)2]Cl2 and [Cu(D-GlcC ea*) 
(H20)2]Cl2 have been recorded at liquid nitrogen temperature (LNT) in the solid state 
using TCNE (g = 2.00277) as a field marker. A typical EPR spectrum of complex [Cu(D-
GlcC en*)2 (H20)2]Cl2 is depicted in Figure 48. The spectra are isotropic and exhibited a 
band at g = 2, which is characteristic for octahedral copper complexes [204]. 
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Similar spectra having 'g' isotropic values were reported by C.P. Rao and co-workers 
[81, 205] for metal-saccharide complexes comprised of different transition metal ions. 
2500 3S00 
Figure 48. X-Band EPR spectrum at 77K of solid sample of [Cu(D-GlcC en*)2 
(H20)2]Ch 
NMR studies 
The 'H NMR spectrum of [Ni(D-G!cC en*)2]Cl2 in D2O is not very informative due to 
the presence of broad signals. These broad signals with a bunch of fine structures in the 
region of 3.2-4.8 ppm are the result of a strongly coupled system of the hydroxyl protons 
of D -gluconic acid, which makes the assignment of individual resonances very difficult. 
Free gluconic acid shows hydroxyl protons in the region of 3.2-4.8 ppm. The retention of 
these signals in 'H NMR spectrum of complex [Ni(D-GlcC en*)2]Cl2 indicate that 
hydroxyl groups are not involved in the complex formation through deprotonation. 
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However, the absence of a broad carboxylic group proton resonances of free gluconic 
acid at 8.5 ppm [206] indicates the deprotonation of COOH group leading to formation of 
gluconic acid derived metal complexes. Furthermore, the signal at 6.5 ppm in the 2D 
COSY 'H N M R spectrum of [Ni(D-GlcC en*)2]Cl2 (Figure 49) is assigned to the N-H 
proton [207], which confirms the condensation of gluconic acid with appropriate complex 
[Ni(en)2 ]Cl2. 
lu I Figure 49. 'H-H2D COSY spectrum of [Ni(D-GlcC en*)2jCh in D2O solution 
The '^ C NMR spectrum of [Ni(D-GlcC en*)2]Cl2 (Figure 50) is highly informative in 
comparison to 'H NMR spectrum. The '^ C NMR spectrum of complex exhibits two 
signals at 41.6 and 39.2 ppm at higher field ascribed to two carbon atoms of ethane-1,2-
diamine, while six signals at lower field were attributed to six carbon atoms of 
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Figure 50. "C NMR spectrum of [Ni(D-GlcC en*j2jCl2 in D2O solution 
gluconic acid (Table 4). The peak at 177.9 ppm is ascribed to C|=N indicating the 
formation of a Schiff base type complex. Furthermore, peaks of skeletal carbon atoms 
from C2 to C(> appeared at 75.5, 74.5, 73.6, 72.9 and 65.2 ppm, respectively, in the '^ C 
NMR spectrum of the complex [Ni(D-GlcC en*)2]Cl2, which is evident of the presence of 
D-gluconic acid in the complex [208]. Thus, the structure of complex [Ni(D-GlcC 
en*)2]Cl2 is in good agreement with the observed 'H and '^ C NMR data. However, 
complex [Ni(D-GlcC ea*) (H20)2]Cl2 acquires octahedral geometry, as the Ni(II) ion has 
two unpaired electrons. Due to the paramagnetic nature of this complex, the 'H and '^ C 
NMR signals are featureless [209]. 
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Electrochemical studies 
Cyclic voltammetric studies were carried out in 0.4 M aqueous KNO3 as supporting 
electrolyte with 10"'' M concentration of complexes, in the potential range 0.10 to -1.0 V. 
The complexes [Cu(D-GlcC en*)2 (H20)2]Cl2 and [Cu(D-GlcC ea*) (H20)2]Cl2 exhibited 
an irreversible cathodic reduction peak for Cu" —• Cu' at scan rate 0,1 V s" . Strong 
cathodic reduction peaks are observed at -0.40 V and -0.63 V for complexes [Cu(D-
GlcC en*)2 (H20)2]Cl2 and [Cu(D-GlcC ea*) (H20)2]Cl2 with Ipc values of 6.41 A and 
2.54 A, respectively. At different scan rates, the voltammograms do not show any major 
change. On addition of CT DNA the reduction potentials (Epc) are found to be shifted to 
the more negative side (-0.67 V) for complex [Cu(D-GlcC ea*) (H20)2]Cl2, while to the 
less negative side (-0.37 V) for [Cu(D-GlcC en*)2 (H20)2]Cl2. These shifts in Epc values 
suggest that both Cu(II) and Cu(I) forms of the complexes [Cu(D-GlcC en*)2 (H20)2]Cl2 
and [Cu(D-GlcC ea*) (H20)2]Cl2 bind to DNA but with different affinity. The 
voltammogram profiles of free complexes ([Cu(D-GlcC en*)2 (H20)2]Cl2 and [Cu(D-
GlcC ea*) (H20)2]Cl2) and DNA bound complexes are depicted in Figure 51 a and 51 b, 
respectively. In addition to the change in Epc values, the cathodic peak currents (Ipc) 
increases to 8.19 A and 3.62 A after the addition of CT DNA for complex [Cu(D-GlcC 
en*)2 (H20)2]Cl2 and [Cu(D-GlcC ea*) (H20)2]Cl2, respectively, indicating that the 
adsorption of the Cu(I) product tends to be suppressed in the presence of DNA [210]. The 
shifts in Epc and Ipc values suggest that [Cu(D-GlcC en*)2 (H20)2]Cl2 and [Cu(D-GlcC 
ea*) (H20)2]Cl2 bind strongly to CT DNA. 
(a) 
(b) 
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Figure 51. Cyclic voltammograms at the scan rate of 0.1 V s'' (a) [Cu(D-GlcC en*)2 
(H20)2]Cl2 alone (curve i), [Cu(D-GlcC en*)2 (H20)2j.Ch in presence ofCTDNA (curve 
ii) (b) [Cu(D-GlcC ea*) (H20)2]Cl2 alone '(curve i), [Cu(D-GlcC ea*) (H20)2]Cl2 in 
presence ofCTDNA in aqueous solution (curve ii) 
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Solution stability studies 
The cyclic voltammetric studies were performed with [Cu(D-GlcC en*)2 (H20)2]Cl2 and 
[Cu(D-GlcC ea*) (H20)2]Cl2 at various pH values (4-12) in aqueous solution. Both 
complexes show a single irreversible cathodic reduction Cu" -^ Cu' peak at all pH values. 
The Epc values of both the complexes are very sensitive to changes in pH. In the pH range 
of 4-12, the voltammetric behaviour of the complexes ([Cu(D-GlcC en*)2 (H20)2]Cl2 and 
[Cu(D-GlcC ea*) (H20)2]Cl2) was found to be reproducible, and the data for these 
complexes are listed in Table 5. The reduction potentials shift to less negative values with 
increase in pH in aqueous solution. This suggests that H2O molecules are directly 
involved in the coordination sphere of the complexes. Figure 52 show the 
voltammograms of complex [Cu(D-GlcC en*)2 (H20)2]Cl2 at various pH values. In both 
the complexes there is a linear relationship between the cathodic potential Epc and the 
various pH values as depicted in Figure 53, indicating that complexes do not undergo any 
structural rearrangement [211], The slopes of the lines (in mV/unit of pH) for complexes 
([Cu(D-GlcC en*)2 (H20)2]Cl2 and [Cu(D-GlcC ea*) (H20)2]Cl2 are 10 and 11, 
respectively, which further authenticate the sensitivity of the overall structure of 
complexes towards the pH of environment [212]. Non-precipitation and hydrolytic 
stability of the complexes at extreme pH conditions suggest the robust nature of these 
complexes in aqueous solution over a wide range of pH [213]. 
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Figure 52. Cyclic voltammograms of [Cii(D-GlcC en*)2 (H20)i]Cl2 at various pH (a) 4 
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Figure 53. Plot of the Cu" -^ Cu reduction potential (Epc) as a function of pH for 
fCu(D-GlcC en*)2 (H20)2]Cl2 (A) and[Cu(D-GlcC ea*) (H20)2]Cl2 (•) complexes 
Absorption spectral features of DNA binding 
The DNA binding properties of complexes [Cu(D-GIcC en*)2 (H20)2]Cl2 and [Cu(D-
GlcC ea*) (H20)2]Cl2 were established by monitoring the changes in absorbance at 260 
nm (>.max of CT DNA) under pseudo-first order conditions, i.e. [DNA] » [complex] 
(Figure 54 a and b). Different sets of kinetic measurements were carried out at fixed 
concentration of complex [Cu(D-GlcC en*)2 (H20)2]Cl2 and [Cu(D-GlcC ea*) (H20)2] 
CI2 (0.4 X 10"' M) with varying concentrations uf CT DNA (4-6.4 x 10"^  M). 
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(a) 
300 400 
Wavelength (nm) 
(b) 
460 
Wavelertgth (nrtj) 
Figure 54. UV absorption spectra of CT DNA (a) in presence of complex [Cu(D-GlcC 
en*)2 (H20)2]Cl2 (b) in presence of [Cu(D-GlcC ea*) (H20)2j CI2. Arrows show the 
absorbance changes upon increasing DNA concentration. Inset: plots of kinetics 
measurements of different CT DNA concentration with respect to time L, u, • 
experimental data points, full lines linear fitting of the data 
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The spectral changes were monitored as a function of time. During the interaction of the 
complex with CT DNA, the absorption band of calf thymus DNA is affected, exhibiting 
hyperchromism. This resulting hyperchromism upon interaction with DNA implies the 
binding of the complexes with DNA. Similar hyperchromism results were cited in the 
literature for a Cu (II) complex with a ligand bearing -NH- and -OH groups [171]. 
Changes in absorption spectral behaviour are possibly due to the substitution of H2O 
molecule by the DNA base nitrogen atom and then coordination of these nitrogen bases 
to the cupric ion in the complex [214]. 
The observed pseudo-first order reaction rate constants (kobs) were calculated from the 
slopes of the straight lines obtained by plotting logarithmic peak growth vs. time for 
bands obtained upon interaction of complexes with CT DNA. The slopes of these straight 
lines are different for [Cu(D-GlcC en*)2 (H20)2]Cl2 and [Cu(D-GlcC ea*) (H20)2] CI. 
which may be ascribed to the structural difference in the two complexes i.e. complex 
[Cu(D-GlcC en*)2 (H20)2]Cl2 bearing more -NH and -OH groups in comparison to 
complex [Cu(D-GlcC ea*) (H20)2] CI2 is more reactive towards DNA. Hence, these are 
used to compare the relative binding of the two complexes with DNA. The following rate 
law has been derived [215] 
kobs ^ ki k, [DNA]/(k.,+k2) (1) 
where ki, k2 and k.| are respective rate constants. The subscript describes the direction in 
which the rate constant is acting. The rate determining step for DNA-complex formation 
is k2. The rate law (1) holds good only if the plot of kobs versus [DNA] is linear and the 
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suggested mechanism derived from tlic kinetic data for binding of complexes [Cu(D-
GlcC en*)2 (H20)2]Cl2 and [Cu(D-GlcC ea*) (H20)2]Cl2 with CT DNA is correct as 
shown in Scheme 2. Furthermore, the plots of kobs values versus different CT DNA 
concentrations are found to exhibit excellent linear behaviour, (Figure 55) which provides 
a supportive evidence for the proposed mechanism. 
IZ) 
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Figure 55. Plots of kobs versus concentration of CT DNA. Complex [Cii(D-GlcC en*)^ 
(H20)2]Cl2 (A) and complex [Cu(D-GlcC ea*) (H20)2] CI 2 (•) 
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S = Solvent 
+ k-i 
k2 + DNA 
Scheme 2 
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Circular dichroism studies 
The stereochemical contribution to the CD spectra probably arises due to the presence of 
the asymmetric groups in the ligands. The CD spectra of complexes [Cu(D-GlcC en*)2 
(H20)2]Cl2 and [Cu(D-GlcC ea*) (H20)2]Cl2 were recorded in aqueous solution in the 
range of 200-400 nm (Figure 56 a and b). Complex [Cu(D-GlcC en*)2 (H20)2]Cl2 
exhibits a positive rise at 230 nm and a negative Cotton effect at 226 nm. The strong 
negative Cotton effect in complex [Cu(D-GlcC ea*) (H20)2]Cl2 indicates a large 
dissymmetry around the Cu(II) ion. This is due to the inversion of the absolute 
configuration around the metal center and is attributed to the differences observed in the 
orientation of hydroxyl groups of D-gluconic acid [216J. These findings are also 
consistent with the polarimetric data. Thus, the CD response of complexes [Cu(D-GlcC 
en*)2 (H20)2]Cl2 and [Cu(D-GlcC ea*) (H20)2] CI2 indicate that Cu(Il) was ligated by an 
optically active D-gluconic acid moiety. 
Circular dichroism (CD) was an effective method to examine the structural modification 
of DNA caused by an interaction with complex [Cu(D-GlcC en*)2 (H20)2]Cl2 and [Cu(D-
GlcC ea*) (H20)2]Cl2. The UV circular dichroic spectrum of CT DNA exhibits a positive 
band at 282 nm due to base stacking and a negative band 242 nm (Figure 57 curve a) due 
to helicity of DNA [217]. It is observed that addition of complexes [Cu(D-GlcC en*)2 
(H20)2]Cl2 and [Cu(D-GlcC ea*) (H20)2]Cl2 causes significant and distinct spectral 
perturbation in the CD spectrum of CT DNA. The induced CD spectra of CT DNA in 
presence of complexes [Cu(D-GlcC en*)2 (H20)2]Cl2 and [Cu(D-GlcC ea*) (H20)2]Cl2, 
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(a) 
CD 
200 Wavelength [nm] 400 
(b) 
CD 
-120 
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Figure 56. Circular dichroism spectra o/(a) [Cu(D-GlcC en*)2 (H20)2]Cl2 {h)[Cu(D-
GlcC ea*) (H20)2]Cl2 in water 
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respectively exhibit increase in positive ellipticity, while the intensity of negative 
ellipticity band decreases (Figure 57 curve b,c) with the latter being affected slightly 
more than the other. These results suggest that both the complexes [Cu(D-G!cC en*)2 
(H20)2]Cl2 and [Cu(D-GicC ea*) (H20)2]C]2 interact with CT DNA and the binding of 
these complexes with CT DNA induces certain conformational changes within the DNA 
molecule [218]. 
-90 L 
200 Wavelength I nm) 400 
Figure 57. Circular dichroism spectra ofCTDNA alone (curve a), CT DNA in presence 
of [Cu(D-GlcC en*)2 (H20)2]Cl2 (curve b) and CT DNA in presence of [Cu(D-GlcC ea*) 
(H20)2]Cl2 [DNA] = 3 X lO'^M (curve c) 
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Viscosity studies 
Spectroscopic data obtained for the binding nature of [Cu(D-GlcC en*)2 (H20)2]Cl2 and 
[Cu(D-GlcC ea*) (H20)2]Cl2 with DNA are not sufficient to support the binding mode of 
the complexes. In order to further authenticate the interaction of complexes with DNA 
and to clarify the mode of binding of complexes, hydrodynamic measurements such as 
viscosity studies were performed. These measurements are sensitive to length change and 
are considered to be as least ambiguous and most critical tests of binding in solution 
[219]. A classical intercalation model is expected to increase the length of the DNA helix, 
as base pairs are pushed apart to accommodate bound ligand. On the other hand, partial 
or non-classical intercalators reduce the effective DNA length as they produce kinks in 
the DNA helix, which results a decrease in viscosity [220]. 
0.10 0.20 
l/R(=[Cu]/[pNA]) 
0.30 
Figure 58. Effects of increasing amounts of complex [Cu(D-GlcC en*) 2 (H20)2]Cl2 (•) 
and complex [Cu(D-GlcC ea*) (H20)2]Cl2 (•) on the specific relative viscosity of CT 
DNA at 29 ± 0.01 °C 
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The relative specific viscosity of DNA decreases with increment in the concentration of 
complexes [Cu(D-GlcC en*)2 (H20)2]Cl2 and [Cu(D-GlcC ea*) (H20)2]Cl2 as shown in 
Figure 58. The experimental results suggest that complexes [Cu(D-GlcC en*)2 
(H20)2]Cl2 and [Cu(D-GlcC ea*) (H20)2]Cl2 bind covalently to DNA to effect this 
change in viscosity. 
Conclusions 
The present work offers a new attempt towards the synthesis of transition metal-
saccharide complexes and their interaction with calf thymus DNA. Although extensive 
work is going on in this field, metal-carbohydrate DNA interaction is largely unexplored. 
As the crystal structures are scarce for transition metal-carbohydrate complexes, herein 
exhaustive analytical and spectroscopic investigations are carried out to ascertain the 
structure of the complexes. The UV/vis and EPR spectroscopy indicate the octahedral 
geometry around the metal ions in complexes [Cu(D-GlcC en*)2 (H20)2]Cl2, [Cu(D-GlcC 
ea*) (H20)2]Cl2, and [Ni(D-GlcC ea*) (H20)2]Cl2 and square planar geometry of 
complex [Ni(D-GlcC en*)2]Cl2. Solution stability studies of complexes [Cu(D-GlcC 
en*)2 (H20)2]Cl2 and [Cu(D-GlcC ea*) (H20)2]Cl2 exhibit a linear relationship between 
pH and cathodic peak potentials suggesting the hydrolytic stability and the robust nature 
of these complexes in aqueous solution over a wide range of pH. Moreover, considering 
the biocompatibility of saccharides and bioessentiality of the copper ion, interest arose to 
study DNA binding behaviour of these complexes. Spectroscopic and electrochemical 
94 
studies together with viscosity measurements support that complexes [Cu(D-GlcC en*)2 
(H20)2]Ci2 and [Cu(D-GicC ea*) (H20)2]Ci2 bind covalentiy to calf thymus DNA. Thus, 
natural occurrence, biocompatibility, low toxicity, high solubility and DNA interaction 
studies support that these complexes may prove to be useful as DNA inhibitors. 
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CHAPTER IV 
Synthesis and Characterization of a New iVIacrocyciic 
Copper (II) Complex with an N-Glycosidic Pendant Arm: 
in vitro Cytotoxicity and Binding Studies with 
Calf-Thymus DNA 
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CHAPTER IV 
Experimental 
Reagent grade chemicals were used without further purification for all synthesis. 
D-Glucosamine hydrochloride (Lancaster), l,8-diamino-3,6-diazaoctane (Fluka), ethane-
1,2-diamine, CuCl2-2H20, NiCl2-6H20, and formaldehyde (E. Merck) were used as 
received. All solvents were obtained from Merck, and dried immediately before use. 
Molar conductances were determined at room temperature with a Digisun electronic 
conductivity bridge. Magnetic measurements were performed at room temperature 
according to Gouy's method using mercury (II) tetrathiocyanatocobaltate (II) for 
calibration. Specific rotations of the complexes were obtained on a Rudolf Autopole 
polarimeter at 20 °C at the sodium D line in a 1-dm tube containing the complexes 
dissolved in water. IR (FTIR) spectra were recorded on an Interspec 2020 FTIR 
spectrometer, as KBr pellets. 'H and '''C NMR spectra were obtained on a Bruker DRX-
300 spectrometer at 100/300 MHz, respectively in ppm. The solid-state EPR spectrum 
was acquired on a Varian E 112 spectrometer at the X-band frequency (9.1 GHz) and at 
room temperature. Microanalysis was performed on Carlo Erba 1108 analyzer. 
Antitumour Activity 
Antitumour activities (in vitro) were evaluated with the MTT assay [221]. Stock solution 
of [MacCu (D-GlcN-en)*]Cl2 (1 mg/ml) was freshly prepared in H2O and diluted to the 
required concentration with culture before use. PC-12 Tumour cells were grown in 
DMEM medium supplemented with 10% freshly inactivated fetal bovine serum (FBS), 
5% fetal horse serum (FHS) and antibiotics while SY5Y cells were grown in DMEM 
medium supplemented with 10% FBS, \% antibiotic-antimycotic, 1% non-essential 
amino acid and 2.5% glutamine. Cells harvested from exponential phase (2 x 10^  
cells/ml) were seeded into a 96-well plate. Then, complex [MacCu (D-GlcN-en)*]Cl2 
was added in a concentration gradient and the final concentrations were adjusted to 
0.25 - 1.00 fJ.M. Untreated cells were used as negative control before each experiment. 
The plate was maintained at 37 °C in a humidified atmosphere with 5% CO2 and 
incubated for 24 hours. MTT solution (5 mg/ml) was then added to each well and the 
wells were incubated for 3 hours at 37 °C. Then, i-PrOH containing 40 mM HCl (100 )il) 
was added to all wells, which were mixed thoroughly to dissolve the dark blue formazan 
crystals. The UV/vis absorbances of the solutions related to the number of alive cells, 
were recorded with a Bio-Rad 680 microplate reader at 570 nm and 655 nm [222]. The 
results were expressed as the percentage of alive cells vs. concentration of [MacCu (D-
GlcN-en)*]Cl2, as calculated from MTT reduction, assuming that the absorbance of the 
negative controls is 100%. 
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Synthesis of 2-Amino-2-deoxy-N-[2-(l,3,5,8,ll-pentaazacyclotridecan-3-yl)ethyl]-p-
D-glucopyranosylamine copper(II) dichloride [MacCu(D-GlcN-en)*]Cl2 
[C,6H37N704CuCl2l 
A solution of ethane-l,2-diamine (0.33 ml, 4.97 mmol) and D-GlcN (1.07 g, 4.97 mmol) 
in MeOH (50 ml) was heated at 60 °C for 70 minutes. The resulting pale yellow solution 
was cooled to room temperature. Then, CuCl2-2 H2O (0.85 g, 4.97 mmol), 1,8-diamino-
3,6-diazaoctane (0.74 ml, 4.97 mmol) and CH2O (0.28 ml, 9.81 mmol) in MeOH (50 ml) 
were added and the mixture was heated at reflux for 4 hours, which resulted in a clear, 
deep-green solution. The solvent was evaporated in vacuo, the resulting green-coloured 
solid was dissolved in H2O, re-precipitated by addition of MeOH, washed with 
diethlyether and dried in vacuo. 
Synthesis of 2-Aniino-2-deoxy-N-[2-(l,3,5,8,ll-pentaazacyclotridecan-3-yl)ethyl]-P-
D-glucopyranosylamine nickel(II) dichloride [MacNi(D-GlcN-en)*]Cl2 
[Cl6H37N704Ni CI2] 
Ethane-1,2-diamine (0.33 ml, 4.97 mmol) and D-GlcN (1.07g, 4.97 mmol) were mixed in 
equimolar ratio (1:1) in 50 ml MeOH and the mixture was heated at 60 °C for 70 minutes. 
The resulting pale yellow solution was cooled to room temperature. To this solution was 
added solution of NiCl2-6H20 (1.18 g, 4.97 mmol), l,8-diamino-3,6-diazaoctane (0.74 
ml, 4.97 mmol) and CH2O (0.28 ml, 9.81 mmol) in MeOH. The reaction mixture was 
allowed to reflux for 4 hours, which resulted in a clear orange solution. This solution was 
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evaporated by rotary evaporator and orange colour solid was obtained, which was 
purified by dissolving in H2O and reprecipitating the same with MeOH. The complex 
[MacNi (D-GlcN-en)*]Cl2 thus obtained was washed with ether and dried in vacuo. 
Results and discussion 
The two novel macrocyclic complexes [MacCu (D-GlcN-en)*]Cl2 and [MacNi (D-GlcN-
en)*]Cl2 were prepared by a three-component one pot metal-template condensation 
between the N-glycoside, l,8-diamino-3,6-diazaoctane and formaldehyde, as shown in 
the Scheme 3 a, b. Since both complexes were found to be water soluble and hygroscopic 
(but insoluble in many organic solvents), they require special handling. The molar-
conductance values of [MacCu (D-GlcN-en)*]Cl2 and [MacNi (D-GlcN-en)*]Cl2 in H2O 
— I 9 —1 
were in the range of 150 - 200 Q cm mol , which indicates that these compounds are 
1:2 electrolytes. Both complexes were optically active, with [a]u~^ values of-33 and - 40, 
respectively, in H2O (Table 6). Further, [MacCu (D-GlcN-en)*]Cl2 and [MacNi (D-
GlcN-en)*]Cl2 complexes exhibited a high degree of hydrolytic stability. When left 
overnight in aqueous solution, neither precipitation nor any changes in spectroscopic 
pattern were observed. 
Infrared Spectra 
The IR spectra of [MacCu (D-GlcN-en)*]Cl2 and [MacNi (D-GlcN-en)*]Cl2 exhibited 
merged and broadened bands compared to the sharp bands of uncomplexed D-GlcN 
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(Table 7). Where as the \)(0-H) bands of free D-GlcN were observed at 3200 - 3500 
cm" , on complexation, a broad band at ca. 3400 cm"' was found. The strong, 
characteristic IR bands at 1447, 1088 and 800 cm"' were assigned to 5(OCH,CH2,CCH), 
D(CO,CC) and 8(CCH,CH), as well as u(CC,CO)] vibrations, respectively [205]. 
OH 
HO' ^ ""NH, 
OH 
D-Glucosamine ethane-1,2-diamine 
MeOH,A •H.O 
,0H 
H, 
L^O.^^NH 
HO''' N ^ '" 'NHT 
OH 
D-GlcN-en 
Scheme 3a 
105 
NH, 
,0H 
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MO' ^-^ " N i l . 
OH 
D-GlcN-en 
+ MCl2(hydrated) + 2HCH0 + 
-HN NH-
' NH-, H.N-
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MeOH,A -2H,0 
,0H 
O^  
H 
H 
H H 
N' "^ N— 
.CI. 
^ N / 
HO V ^ "NH2 
OH 
M = Cu(II),Ni(Il) 
Scheme 3b 
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A moderate peak at ca. 1600 cm~' was assigned to a 8(N-H) vibration of the glycosidic 
ligand [66]. Additionally, a single band at ca. 3251 cm"' was observed in the IR spectra 
of [MacCii (D-GlcN-en)*]Cl2 and [MacNi (D-GlcN-en)*]Cl2 which was attributed to 
t)(N-H) of the coordinated secondary amino groups of the macrocycle [223] and the 
signals at 1398 and 1284 cm"' were ascribed to t)(C-N) and T(C-H) vibrations. The 
far-IR spectra of the complexes exhibited a further absorption at ca. 412 cm" due to 
u(M-N) vibrations (M = Cu, Ni). These IR spectra, thus revealed the presence of both the 
amino-sugar ligand and the macrocyclic moiety, in accord with the proposed structure. 
UV/vis Spectra 
In the electronic spectra of [MacCu (D-GlcN-en)*]Cl2 and [MacNi (D-GlcN-en)*]Cl2 in 
H2O, two main transitions were observed in the UV region, an intense band at 281 --285 
nm, attributed to a ligand-to-metal charge-transfer transition and a strong band at 
233 - 240 nm, which was ascribed to intraligand transitions. In the visible region, the 
spectrum of the complex [MacCu (D-GlcN-en)*]Cl2 exhibited a broad band at ca. 563 
nm, which was assigned to the ^Big _ "Eg transition, suggesting a square-planar geometry 
around the metal ion [224]. The diamagnetic Ni(II) complex [MacNi (D-GlcN-en)*]Cl2 
showed a similar band at 526 nm, which was assigned to the 'Aig(F) —>• 'Big(G), in 
agreement with a square-planar geometry [215]. 
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Magnetic Moment and EPR Spectrum 
The e^ff value of [MacCii (D-GlcN-en)*]Cl2 was found to be 1.74 Bohr magnetons, 
which shows that the complex is paramagnetic in nature [225]. This value indicates a d 
electronic configuration of the Cu(Il) atom characteristic for monomeric species. The 
geometry of [MacCu (D-GlcN-en)*]Cl2 was investigated by recording the X-band 
electron paramagnetic resonance spectrum at room temperature in the solid state, using 
TCNE (g = 2.00277) as a field marker. The spectrum exhibited an isotropic signal 
centered at g = 2.06, confirming a square planar Cu(ll) ion [226-227]. 
NMR Spectra 
The complex [MacNi (D-GlcN-en)*]Cl2 was characterized by 'H and '^ C NMR 
spectroscopy in D2O (Table 8, 9). The 'H NMR spectrum revealed characteristic signals 
for the CH2 and NH groups of the macrocycle at 5(H) 2.4 - 2.8 and 6.4 ppm, respectively 
[228-229]. The signals at 5(H) 3.2 - 4.2 were attributed to the skeletal H-atoms of the 
D-GlcN-en pendant arm. Due to the saccharide typical strongly coupled system, the 
individual sugar resonances could not be assigned. 
The '^ C NMR spectrum of [MacNi (D-GlcN-en)*]Cl2 showed signals at 5(C) 46.6 and 
39.0 ppm, attributed to the two linking C-atoms of the ethane-1,2-diamine (en)-based 
linker [230], together with five distinct sugar resonances at 57.4, 76.9, 71.6, 78.8 and 
62.7 ppm due to C2 - C6 carbon atoms, respectively [64]. A literature survey revealed that 
the '^ C NMR signals due to C-atoms adjacent to secondary NH groups commonly appear 
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at lower field than those adjacent to primary NH2 groups [231]. Hence, the observed 
signal at 8(C) 81.1 ppm presumably corresponds to the anomeric C(l) (adjacent to the 
glycosidic Nil group of the en linker). Further, the '^ C NMR spectrum of 
[MacNi (D-GlcN-en)*]Cl2 exhibited an intense signal at 6(C) 51.5 ppm due to the 
N(CH2)2N groups oTthe macrocyclic moiety [232J. 
Stability in Aqueous Solution 
The stability of [MacCu (D-GlcN-en)*]Cl2 complex in aqueous solution was tested by 
means of UV/vis spectroscopy, cyclic voltammetry, conductance measurement, and also 
by monitoring the change in solution pH. The UV/vis spectra of [MacCu (D-GlcN-
en)*]Cl2 were recorded as a function of time (Figure 59) and also at different pH values 
(Figure 60). As can be seen from Figure 59, there was basically no change in the position 
of the intraligand and MLCT bands over a period of 50 hours, with only minor changes in 
intensity. Further, the complex was reasonably stable over a broad pH range (pH 4 - 12), 
as evident from the corresponding spectra (Figure 60). 
The change in pH of an aqueous solution of [MacCu (D-GlcN-en)*]Cl2 was measured as 
a function of time (Figure 61). The hydrolysis of a complex is directly related to the 
change in H^ concentration, which, in turn, alters the solution pH. The complex [MacCu 
(D-GlcN-en)*]Cl2 gave rise to only a negligible increase in solution pH (0.2 - 0.5 units) 
over a time period of 50 hour, which indicates that the complex does hardly undergo 
spontaneous hydrolysis. Also, no precipitation was observed. Finally, the pH of a freshly 
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Wavelength [nm] 
500 
Figure 59. UV/vis Absorption spectra of the fMacCu(D-GlcN-en)*JCl2 as a function of 
time. Conditions: H2O. pH 6.0. 25 "C, Cone, of [MacCu(D-GlcN-en)*]Cl2 = / x 10'^ M. 
The curves (from top to bottom) correspond to 0, 10, 20, 30, 40, and 50 h, respectively 
300 liOO 
Wavelength [nm] 
500 
Figure 60. UV/vis Absorption spectra of [MacCu(D-GlcN-en)*]Ch as a function of pH. 
Conditions: H2O, 25 "C, Cone, of the [MacCu(D-GlcN-en)*JCl2 = Jx 10'^ M. The curves 
(from top to bottom) correspond to pH 12, 10, 8, 6, and 4, respectively 
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ex 
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Figure 61. Changes in the pH of a solution of [MacCu(D-GlcN-en)*]Cl2as a function of 
time. Conditions: H2O, 25 "C, Cone, of [MacCu(D-GlcN-en)*]Cl2 = Ix 10'^M 
prepared aqueous solution of [MacCu (D-GlcN-en)*]Cl2 was found to be 6.0, as 
compared to 5.3 for CuCl2-2 H2O, indicating that binding of Cu(ll) does not take place by 
deprotonation of the OH groups of the amino sugar pendant arm. 
Conductance measurements with a freshly prepared solution of [MacCu (D-GlcN-
en)*]Cl2 showed that this compound is a 1:2 electrolyte. After 50 hours, no change was 
observed in the conductivity data, suggesting that the dissociation of the complex had not 
taken place. 
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Figure 62. CV (scan rate 0.1 Vs', H.O, 25" C) of [MacCu (D-GlcN-en)*]Ch at various 
pH (a) 4 (b) 6 (c) 8 (d) 10 (c) 12 
PH 
Figure 63. Plot of the formal electrode potential (Fp) of [MacCii (D-GlcN-en)*]Ch vs. 
pH 
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The solution stability of [MacCu (D-GlcN-en)*]Cl2 was further studied by cyclic 
voltammetry in the pH range 4 - 1 2 (Figure 62) [81]. The complex exhibited, at all pH 
values, quasi-reversible voltammograms typical for a one electron transfer process 
corresponding to the Cu'VCu' redox couple. Thereby, a linear correlation was observed 
between the formal potential -E° vs. solution pH (Figure 63), further corroborating the 
hydrolytic stability [200] of [MacCu (D-GlcN-en)*]Cl2. This stability can be mostly 
attributed to the chelate type macrocyclic moiety. 
DNA binding studies 
Many studies have revealed that DNA is the primary intracellular target of antitumour 
drugs. Small molecules that interact with DNA can induce DNA damage, which leads to 
blockage of cell division and eventually to cell death (apoptosis). The interaction of the 
target complex [MacCu (D-GlcN-en)*]Cl2 with DNA was analyzed by a number of 
techniques such as absorption titration, cyclic voltammetry, circular dichroism and 
viscosity measurements. 
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Cyclic Voltaninictry Studies 
In the absence of CT DNA, complex [MacCu (D-GlcN-en)*]Cl2 exhibited a quasi-
reversible redox wave for a one electron transfer process corresponding to the Cu /Cu 
redox couple [233], with an anodic peak potential Epa of-0.33 V, and a cathodic peak 
potential EpcOf-0.26 V, respectively (Figure 64 curve a). The formal potential E , taken 
as the average of the experimental Epc and Epa values, is -0.29 V, and AEp is -0.06 V. 
Thus, the AEp value for [MacCu (D-GlcN-en)*]Ci: is slightly larger than the Nernstian 
value observed for a one electron transfer couple. 
At different scan rates, the voltammogram did not show any major change. The ratio of 
the anodic to cathodic peak current (Ipa/lpc) was 0.13 for free [MacCu (D-GlcN-en)*]Cl2, 
but increased to a value of 0.22 upon addition of CT DNA, which indicated DNA 
binding. When keeping all the parameters constant (T = 25 °C, scan rate 0.1 V s"', 
potential range 0.0 to -0.8 V), [MacCu (D-GlcN-en)*]Cl2 experienced a large shift in 
cathodic peak potential upon addition of CT DNA (Figure 64 curve b). The shift in E° 
(-0.37) and AEp (-0.10) values with increasing Ip/Ipc values are indicative of strong 
binding of the complex to the CT DNA [234]. 
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The E° value for the Cu'VCii' couple can be expressed as E = E^  + 0.059 log K', with K' = 
K(Cu')/K (Cu"). The ratio K' ol' the stability constants K (Cu") vs. K (Cu') was 
determined as 2.01 x 10"^  (in H2O) using an E value of-0.10 V (vs. normal H2 electrode) 
and an E° value of -0.29 V. This indicates that complex [MacCu (D-GlcN-en)*]Cl2 is 
fairly stable [235]. 
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Figure 64. Cyclic voltammogram of [MacCu (D-GlcN-en)*JCh alone (curve a) and of 
[MacCu (D-Glch^-enjyCh in the presence ofCTDNA (curve h). Conditions: H.O (pH 
7.2). 25 C, cone, of [MacCu (D-GlcN-en)*JCh = 1 x W^ M. fCT DNAJ = 6x lO'^ M, at 
a scan rate of 0.1 V s ' 
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UV Titration studies 
A fixed amount of complex [MacCu (D-GlcN-en)*]Cl2 (2.5 x 10"'' M) was titrated with 
increasing amounts (2.5 - 3.5 x lO""* M) of CT DNA. The corresponding UV titration 
curves are shown in Figure 65. In the presence of CT DNA, both hyperchromism and red 
shift (bathochromism) of 3 nm were observed for the intraligand and ligand to metal 
charge-transfer bands. Hypochromisrn results from the contraction of double-helical 
DNA with respect to the helix axis and hyperchromism results from structural damages 
[236]. Therefore, the observed hyperchromic changes in the UV spectra of the complex 
[MacCu (D-GlcN-en)*]Cl2 suggest strong binding to CT DNA, probably due to H-bond 
interactions [237], as supported by related studies [238-239]. DNA possesses several 
accessible H-bond-acceptor sites, both in the minor and major grooves, and [MacCu (D-
GlcN-en)*]Cl2 contains four NH-type H-bond donors on the macrocycle, with additional 
NH and OH groups on the pendant arm all these functions should be capable of forming 
favourable H-bonds with DNA base pairs [240]. Our results are consistent with a number 
of earlier reports on DNA interaction [16-171]. 
The DNA-binding constant Kb for [MacCu (D-GlcN-en)*]Cl2 was determined as 2.4 x 
10 M~ , which is three orders of magnitude lower than the corresponding values for 
classical intercalators, that mainly bind through TC- % stacking interactions. Therefore, we 
assume that mostly H-bonding interaction are responsible for the DNA-binding properties 
of [MacCu (D-GlcN-en)*]Cl2. 
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Figure 65. Change in UV/vis absorbance of [MacCu (D-GlcN-en) *JCl2 upon addition of 
CTDNA. Conditions: in 10 x W^M Tris'HCl buffer (pH 7.2). Insert: Plot of[DNA]/(£a -
e^ vs. [DNAJ for the titration of CT DNA with [MacCu (D-GlcN-en)*JCl2, and linear 
fitting of the data. Cone of [MacCu (D-GlcN-en)*]Ch. = 0.25x lO'^M (const.), [DNA] = 
0.25 - 0.35 xlO'^M 
Circular Dichroism Studies 
As shown in Figure 66, tiie CD spectrum of [MacCu (D-GlcN-en)*]Cl2 proper in aqueous 
solution exhibited positive bands at 230 nm, 255 nm and 270 nm due to the chiral N-
glycosidic pendant arm. The corresponding spectrum of CT DNA is shown in (Figure 67 
curve a) where a typical positive CD band at 280 nm (base stacking) and a negative one 
Figure 66. CD spectrum of [MacCu (D-GlcN-enjyCh (1 x 10'^ M, HjO, 25 "C, pH6.0) 
IfO 210 
WoviltngU lam) 
300 320 
Figure 67. CD spectra of (a) CT DNA alone (1 x 10"' M, H2O, 25 "C, pH 7.2) (b) CT 
DMA in presence of 1 x 10"^ M complex [MacCu (D-GlcN-en)*]Cl2 
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at 245 nm (intrinsic helicity) are observed [217]. Upon addition of complex [MacCu (D-
GlcN-en)*]Cl2, the 270 nm band of CT DNA was shifted to longer wavelength by 3 nm, 
with an intensity decrease in the positive and negative ellipticities, but no shift in the 245-
nm band (Figure 67 curve b) [210]. These results support that the complex [MacCu (D-
GlcN-en)*JCl: interacts with CT DNA and that the binding event induces certain 
conformational changes in DNA [241]. 
Viscosity Measurements 
Another useful technique for exploring the binding mode of [MacCu (D-GlcN-en)*JCl2 
with CT DNA are viscometric studies. We, thus, measured the flow rate of a CT DNA 
solution through a capillary viscometer as a function of the concentration of the added 
complex. The effect of [MacCu (D-GlcN-en)*]Cl2 on the viscosity of CT DNA is shown 
in Figure 68. The plot shows that the relative solution viscosity of the DNA decreases 
with increasing concentration of complex [MacCu (D-GlcN-en)*]Cl2. Liu et al. [234] 
have reported a similar decrease in the relative viscosity of DNA on addition of a 
macrocyclic Cu(II) complex and proposed that the complex is bound by partial 
intercalation, resulting in DNA aggregation. DNA aggregation upon complex binding 
would reduce the number of independently moving DNA molecules in solution and 
hence, lead to a decrease in viscosity. Our studies are consistent with the observed 
UV/vis hyperchromic effect and red shift of [MacCu (D-GlcN-en)*]Cl2 bound to CT 
DNA. 
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Figure 68. Change in relative specific viscosity (rj/rjo) of a solution of CT DNA as a 
function of the binding ratio (fCu]/[DNA]). Conditions: [DNA] = 8x 10'\ H2O (pH 7.2), 
'T = 29±0.1"C 
Antitumour Activity 
The in vitro inliibitory effect of complex [MacCu (D-GlcN-en)*]Cl2 against two tumour 
cell lines, were derived by classical MTT cell growth inhibition assay. The results of 
these experiments are collected in Figure 69. As can be seen, the complex [MacCu (D-
GlcN-en)*]Cl2 exhibited significant cytotoxicity towards both the PC-12 and SY5Y cell 
lines. Note that the relative number of alive SY5Y cells was lower than for the PC-12 cell 
line. Such differences in cell viability illustrate that [MacCu (D-GlcN-en)*]Cl2 is 
selective towards different cell types, which suggests that distinct mechanistic pathways 
are followed [242]. The estimated IC50 value (50% inhibitory concentration) for 
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[MacCu (D-GlcN-en)*]Cl2 towards the SY5Y cell line was extrapolated to lie in the 
micromolar range, similar to that of the positive control 5-fluorouracil. 
I PC-12 
ISY5Y 
5.Fu 0.25 0.5 0.75 1.0 
Cone IMacCu (D-GIcN-en)*lCb(jiM) 
Figure 69. Dose-dependent antitumour activity of the new complex [MacCu (D-GlcN-
en)*]Cl2 towards SY5Y and PC-12 cells. The MTT-based data are compared to those of 
5-fluorouracil (5-Fu) as positive control 
Conclusion 
The synthesis of a novel type of macrocyclic Cu(Il) complex containing an N-glycosidic 
pendant arm has been described. The resulting complex [MacCu (D-GlcN-en)*]Cl2 was 
found to exhibit a high degree of hydrolytic stability, which is a significant feature of a 
robust chemotherapeutic drug. The interaction of [MacCu (D-GlcN-en)*]Cl2 with CT 
DMA in aqueous solution was examined by various techniques and the results suggest 
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that the complex binds to DNA mainly through H-bond interactions. An in vitro assay 
with [MacCu (D-GlcN-en)*]Cl2 showed a remarkable antitumour activity (ICso value in 
the micromolar range) towards the PC-12 and SY5Y cell lines. Fine-tuning of 
[MacCu (D-GlcN-en)*]Cl2 by introducing substituents with different steric, electronic 
and/or H-bonding properties to modulate this new potential drug candidate are still in 
progress. 
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CHAPTER V 
DNA Binding Behaviour of Novel N-glycoside Sn (IV) 
Complexes: Induction of Apoptosis in Mammalian Cells 
by 1-{(2-ethoxy) amino}-2-amino-1, 2-dideoxy-D-glucose 
Triphenyl Tin (IV) Complex 
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CHAPTER V 
Experimental 
Reagents grade chemicals were used without further purification for all syntheses. 
2-amino-2-deoxy-D-glucose was obtained from Lancaster, 2-hydroxy ethylamine, 
triphenyltin chloride, were procured from E. Merck and SnCU " SHiO was obtained from 
Loba Chemie. Solvents obtained from E. Merck, were dried immediately before use. 
Carbon, hydrogen and nitrogen contents were analyzed on a Carlo Erba Analyzer Model 
1108. Molar conductances were measured at room temperature on a Digisun Electronic 
Conductivity Bridge. Fourier-transform IR (FTIR) spectra were recorded on an Interspec 
2020 FTIR spectrometer, in nujol mull. The 'H and '^ C NMR spectra were obtained on a 
Bruker DRX-300 spectrometer and "^Sn NMR spectra were recorded on a VXR-300 
Varian spectrometer operating at room temperature. Specific rotations of the complexes 
were obtained on a Rudolf Autopole polarimeter at 20°C at the sodium D-line in a 1-dm 
tube. 
Evaluation of in vitro antitumor activity 
Stock solution of GATPT (Img/ml) was prepared in DMSO, stored at room temperature 
and diluted suitably with corresponding medium to required concentrations for all the 
experiments. 
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Cell Culture 
SH-SY5Y cells were obtained from the American Type Culture, collection was 
maintained in DMEM medium with high glucose, supplemented with 10% freshly 
inactivated FBS, 1% antibiotic-antimycotics, 1% non-essential amino acid, and 2.5% 
L-glutamine (all from Life Technologies, Inc.). PC-12 cells were cultured in DMEM with 
high glucose, supplemented with 10% FHS, 5% PCS and 1% antibiotic-antimycotic 
while N2A cells were maintained in DMEM supplemented with \0% PCS, and 1% 
antibiotic-antimycotic. All the cell cultures were grown in a humidified incubator at 37 C 
with 5% CO2. The medium was replaced after 3 days and cells were split before they 
reached confluence. Cells were discarded after ca. 15 passages. 
Cell counting 
The cells (SY5Y, PC-12, N2A) were plated in a 24 well plate at a density of 2.5 x 10^  
cells per well in ca. 800)^ 1 of medium and was kept in the incubator for 24 hours. The 
cells were then serum starved for ca. 12 hours and treated with various doses (0.5)j,l, 1^ 1, 
LSfxl, 2^1 and 3^1) of GATPT in duplicates. Untreated cells were used as negative 
control, since GATPT is DMSO-soluble so the cells treated with DMSO without GATPT 
were used as controls. After 12 hours of treatment, the media was removed and the cells 
were washed with PBS (400|al). In order to detach cells, the wells were trypsinised with 
501x1 of trypsin in case of SY5Y cells. The cell mortality was evaluated by counting the 
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cells using a haemocytometer. The data were represented by plotting a graph between 
percentage of live cells and compound concentration. 
MTT assay 
The cytotoxicity exerted by GATPT was assessed by the MTT assay. Briefly, 7 x 1 0 
tumour cells (SY5Y and PC-12) were plated in a 96 well flat bottom microtiter plates, in 
ISOfil of corresponding medium. Cells were incubated for 24 hours to adhere properly. 
The cells were treated with GATPT in different concentrations, and incubated for 12 
hours. Untreated cells were used as negative control before each experiment. MTT (15^1) 
was added to each well to a final concentration of 5mg/ml and incubated additionally for 
3 hours at 37 C. The reaction was terminated by removing the medium, the formazan 
dye was dissolved by adding 50^1 of 0.1 N HCI in isopropanol. The plates were read at 
570 and 655 nm on Bio-Rad 680-microplate reader. The assay was performed in triplicate 
and the arithmetic means were determined by using Excel Software. The results were 
expressed as the percentage of alive cells vs. [GATPT] as calculated from MTT 
reduction, assuming that the absorbance of the negative controls was 100%. 
Hoechst DNA staining 
SY5Y and PC-12 cells were treated with GATPT at concentrations l|.d, 1.5).il and 
1.5nl/ml for 12 hours, washed with PBS, fixed with 3.7% Paraformaldehyde at room 
temperature, and stained with Hoechst 33342 dissolved in Ix PBS at a final concentration 
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of lOixg/ml. Preparations were then washed 4 times with Ix PBS, and the stained nuclei 
were visuahzed under a fluorescence microscope. Apoptotic cells were morphologically 
defined as cells showing aberrant Hoechst 33342 stained and chromosomal 
fragmentation. 
DNA fragmentation assay 
PC-12 and SY5Y cells were grown in the six well tissue culture plates. After GATPT 
treatment, cells were harvested at different time points, washed once with ice cold PBS at 
2000g for 5 min at 4°C. Cells were resuspended in 20|.il of lysis buffer [lOmM EDTA; 
50mM Tris-HCl pH 8.0; 0.5% (w/v) sodium laurylsarkosinate] and 5[i\ of 20mg/ml 
RNase A and incubated at 37°C for 18 hours. Proteinase K (10^1 of 20mg/ml) was 
subsequently added and the samples were incubated for further 1.5 hours at 50°C. The 
whole samples containing extracted genomic DNA fragments were fractionated by 2% 
agarose gel and were visualized by ethidium bromide staining and photographed under 
UV illumination. 
Fluorescence Activated Cell Sorting (FACS) Analysis 
DNA contents and cell cycle distribution for PC-12 cells were determined by flow 
cytometry. The cells were grown in 6-well plates at a density of 5 x 10'* cells/well. The 
PC-12 cells were treated with GATPT, and harvested after 2,6 and 12 hours. Harvested 
cells were washed with ice cold PBS and fixed with 70% ethanol for 2 - 4 hours at 4°C. 
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One hundred microliters of RNase (Img/ml) and 400^1 of PI (50ng/ml) were added to the 
cell pellet, which was resuspended and incubated at 37°C for 30 minutes. Analyses were 
performed on a FACScan flow cytometer using the Cell Quest program. 
Preparation of whole cell lysates 
To prepare the whole cell lysates, cells were first grown in 6 cm dishes, after treatment 
with GATPT, cells were harvested at different time points. Cells were washed with PBS, 
pH 7.2, lysed with 500^1 of lysis buffer (lOmM Tris, 150mM NaCl, 1% Triton X-100, 
5mM EDTA, 25mM glycerophosphate, ImM PMSF, 2mM, benzamidine, lOmg/ml 
aprotinin, lOmg/ml leupeptin, and ImM sodium orthovanadate) and incubated on ice for 
15 minutes. The lysed cells were transferred to 1.5 ml Eppendorf tubes, and were 
centrifuged at 16,000 rpm for 20 minutes at 4 C. Supernatant was collected, and Pierce 
BCA protein assay reagent was used to determine the protein concentration. The aliquots 
of cell lysates were boiled with SDS sample buffer, and analyzed by Western blot using 
the indicated antibodies. 
Preparation of mitochondrial lysates 
To prepare the mitochondrial lysates, cells were first grown in 6 cm dishes, after 
treatment with GATPT, cells were harvested at different time points. Cells were washed 
twice with ice cold sterile PBS (pH 7.2) and cell pellets were resuspended in RSB buffer 
(a hypotonic buffer) (lOmM NaCl, 1.5mM MgCb, lOmM Tris-HCl, pH 7.5) for 10 min 
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to allow cells to swell. Swollen cells were break opened by several strokes of pestle of 
DoLince homogenizer. 2.5 X MS buffer (an iso-osmotic buffer) (525mM mannitol, 
i75mM sucrose, l2.5mM Tris-liCl, pll 7.5, 2.5mM F.DTA, pli 7.5) was added 
immediately to it and mixed well by inverting the homogenizer a couple of times. The 
homogenate was transferred to a centrifuge tube for differential centrifugation then 
1 X MS buffer (210mM mannitol, 70mM sucrose, 5mM Tris-HCl, pH 7.5, ImM EDTA, 
pH 7.5) was added. The mitochondrial and cytosolic extracts for the detection of Bcl-2 
family proteins (Bad, Bak and Bax) and cyto c were fractionated onto 12% 
polyacrylamide gel. Proteins were visualized by ECL. 
Western blot analysis 
Cell lysates containing a total protein of 20-30|ig were loaded onto 12% SDS-
polyacrlamide gels. Resolved proteins were then electrophoretically transferred onto 
PVDF membrane. The blot was blocked with 5% skim milk, in 0.1%) Tween 20 TBS 
solution for 2 hours at room temperature, all antibody binding reactions were performed 
in the same buffer. The membrane was incubated at 4°C overnight with primary 
antibodies, after washing, the membrane was then incubated with activator protein-
conjugated secondary antibody for 1 hour at room temperature and washed again in 
TBS/Tween 20. The signal was detected by the ECL Western blot system (Pierce). 
Caspase activation and activity assay 
The caspase activity assay was based on spectrophotometric detection of the 
chromatophore pNA after cleavage from the labelled substrate DEVD-pNA by caspase-3 
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like proteases. Cultured PC-12 cells were treated with and without GATPT (1.5^1/ml) for 
0 to 18 hours at 37°C. Cells were lysed and assay was performed with the Caspase-
3/CPP32 colorimetric kit (BioVision) according to the manufacturer's protocol. 
Synthesis of l-{(2-ethoxy) imino}-2-amino-l, 2-dideoxy-D-glucose tin (IV) dichloride 
[GATDC] [CsHifiNzOsSnCli] 
A methanolic solution containing 2-hydroxy ethylamine (0.3 ml, 5 mmol) and 
2-amino-2-deoxy-D-glucose (1.07 g, 5 mmol) was heated at 60 °C for 80 minutes. The 
resultant pale yellow solution was cooled to room temperature, and a methanolic solution 
of SnCU • SHiO (1.75 g, 5 mmol) was added to this solution in 1:1 molar ratio. The 
reaction mixture was stirred overnight at room temperature, refluxed for ca. 25 hours and 
then filtered. The solvent was gradually removed by evaporation under vacuum until a 
solid brown product was obtained. The solid was isolated, washed thoroughly with 
methanol and dried in vacuo. 
Synthesis of l-{(2-ethoxy) amino}-2-amino-l, 2-dideoxy-D-glucose triphenyl tin (IV) 
[GATPT] [CzeHszNzOsSn] 
A mixture of 2-hydroxy ethylamine (0.3 ml, 5 mmol) and 2-amino-2-deoxy-D-glucose 
(1.07 g, 5 mmol) in methanol was heated at 60 C for 80 minutes. The resultant pale 
yellow solution was cooled to room temperature, and a methanolic solution of triphenyl 
tin chloride (1.92 g, 5 mmol) was added to this solution in 1:1 molar ratio. The reaction 
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mixture was refluxed for ca. 65 hours and then fiUered. The solvent was gradually 
removed by evaporation under vacuum until a solid brown product was obtained. The 
solid was isolated, washed thoroughly with methanol and dried in vacuo. 
Results and discussion 
Synthetic routes of Sn(IV) saccharide complexes GATDC and GATPT and N-glycoside 
ligand (D-Glc-N-ea), in the present report are depicted in Scheme 4 a, b. The elemental 
analysis results (Table. 10) are in agreement with the proposed formulae. Molar 
conductance values of GATDC and GATPT in DMSO (Ix 10"^ M) at 25 "C suggest their 
non-electrolyte nature. GATDC and GATPT are soluble in DMSO but insoluble in 
common organic solvents and water. Both the compounds are optically active, which is 
supported by their CD spectra. The composition of both the complexes along with colour, 
yield and FAB-mass spectral data (Figure 70 a) are given in Table 10. 
IR studies 
The IR spectra of GATDC and GATPT exhibited merged and broadened bands compared 
to the sharp bands of uncomplexed D-GlcN (Table 11). The \)(0-H) bands of free D-
GlcN were observed at 3200-3500 cm"', after complexation a broad band around 3400 
cm"' was found. The strong characteristic IR bands at ca. 1428, 1066, 730 and 691 cm"' 
were assigned to 5(0CH, CH2, CCH) D(CO, CC) , 5(CCH, CH) and \)(CC.CO) vibrations 
respectively [205]. The IR spectrum of GATPT exhibited a moderate peak at ca. 1635 
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cm"' assigned to a 5(N-H) vibration indicating the successful formation of the 
N-glycoside [66]. However, the absence of any band in this region in the IR spectrum of 
GATDC suggests the deprotonation of N-glycoside on complexation with tin 
tetrachloride. The far IR of the GATDC and GATPT revealed absorptions at ca. 452 cm'' 
due to i)(Sn-0) vibration. Furthermore, bands at 402 cm'' and 320 cm"' assigned to u(Sn-
N) and u(Sn-Cl), respectively were also present in the far IR spectrum of GATDC [243]. 
Electronic spectra 
The electronic spectra of GATDC and GATPT in DMSO were very similar to each other 
and showed in UV region two high-energy intra ligand bands at ca. 244 and 262 nm, 
respectively. The electronic spectra of both the complexes have also been investigated 
after 24 hours, neither precipitation nor any change in spectroscopic pattern was 
observed, which clearly suggest that the complexes are quite stable in solution. 
NMR studies 
GATDC and GATPT were also characterized by 'H and '^ C NMR spectroscopy in 
DMS0-d6 [Table 12]. The 'H NMR spectra of GATDC and GATPT revealed signals at 
2.5-3.5 ppm attributed to the skeletal protons of the D-GlcN-ea. Due to the saccharide 
typical strongly coupled system, the individual sugar resonances could not be assigned. 
Coupled with this observation, 'H NMR spectrum of GATPT exhibited singlet at 5.1 ppm 
and multiplet at 7.3-7.8 ppm assigned to N-H and aromatic protons, respectively [244]. 
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The '^ C NMR spectra of GATDC and GATPT showed signals at ca. 41.2 and 38.7 ppm, 
attributed to the two linking C-atoms of the 2-hydroxy ethylamine (ea) based linker [230] 
together with six distinct sugar resonances at 90.0 (C (1)), 56.2 (C (2)), 77.9 (C (3)), 70.3 
(C (4)), 79.5 (C (5)), 60.7 (C (6)) ppm, respectively [64]. In addition, '^ C NMR spectrum 
of GATPT exhibited signals at 123-132 ppm due to aromatic carbon atoms of triphenyl 
tin (Table 13) [245]. 
"^Sn NMR spectroscopy has been found to be useful technique for elucidation of the 
nature of coordination of tin atom in complexes. It is known that Sn chemical shift 
6 ("^Sn) is sensitive to the chemical environment of the tin atom. The "^Sn NMR 
spectrum of the GATPT displayed signal at - 92.05 ppm (Figure 70 b) suggesting the 
presence of tetra coordinated tin atom in the complex [246]. 
DNA binding studies 
Coordination compounds offer many binding modes to polynucleotides, including outer-
sphere non-covalent binding, metal coordination to nuleobases and phosphate backbone 
interactions. Organotin (IV) compounds are known to exert therapeutic effect on various 
tumour cells and anticancer activities of organotin (IV) complexes are 100 times higher 
than that of carboplatin and cisplatin used in clinical applications [247-248]. A literature 
survey reveals that Sn(IV) compounds interact with DNA through phosphate backbone. 
Therefore, in order to have an insight into the binding event, interaction mechanism of 
Sn(IV) saccharide complexes GATDC and GATPT with CT DNA was analyzed by a 
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number of techniques such as UV titrations, fluorescence studies, circular dichroism and 
viscosity measurements. 
Electronic absorption titration 
The electronic absorption spectroscopy is the most common way to investigate the 
interactions of complexes with DNA. A complex bound to DNA through intercalation 
usually results in hypochromism and red shift (bathochromism), due to the intercalation 
mode involving strong stacking interaction between aromatic chromophore and the base 
pairs of DNA [234, 249]. The extent of spectral change is related to the strength of 
binding and spectra for intercalators are more perturbed than those for groove binders. 
With increasing concentration of CT DNA, the absorption bands of the complexes are 
affected, resulting in the obvious tendency of hyperchromism or hypochromism 
accompanied by slight shift. Thus an electronic interaction between the Sn(IV) saccharide 
complexes and CT DNA can be accessed through the data of hyperchromism or 
hypochromism and shift in the absorbance maxima of the two complexes. The two Sn 
(IV) complexes can bind to the double-stranded DN\ in different binding modes on the 
basis of their structure and type of ligands. 
The absorption spectra of the two complexes in the absence and in the presence of CT 
DNA are depicted in Figure 71 a, b. In the UV region, both GATDC and GATPT exhibit 
two intense absorption bands around 244 nm and 262 nm which are attributed to n-^ii* 
and n->7i* transitions, respectively. Upon addition of an increasing amount of CT DNA 
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(0.12-0.24 X 10"-' M) to GATPT (2.3 x 10"^  M) the absorption bands at 246 and 262 nm 
exhibited hypochromism with a slight shift oTS nm (246 to 249 nm), which suggested an 
intimate association of GATPT with DNA likely by intercalation [237]. Structurally, 
GATPT contains aromatic moieties of triphenyi tin, which overlap, with the stacking base 
pairs of the DNA helix by intercalation [33, 250]. 
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Figure 71 a. Absorption spectral traces of GATPT upon addition of CT DNA. Inset: 
Plots of[DNA]/Sa-SfVs. [DNA] for the titration ofCTDNA with GATPT, m experimental 
data points; full lines, linear fitting of the data. [GATPT] 2.3 x lO"* M, [DNA] 0.12-0.24 x 
la' M 
14] 
While when a fixed amount of GATDC (2.3 x 10"^  M) was titrated with increasing 
amount of CT DNA (0.03-0.15 x 10"" M) a hyperchromism with no shift was observed 
which indicates weak interaction between GATDC and DNA (Figure 71 b). Since 
GATDC do not contain any aromatic ring to facilitate intercalation, such strong 
interaction would not be possible. The hyperchromism of GATDC caused by addition of 
CT DNA imply that the binding mode of GATDC with DNA is different from that 
exhibited by GATPT. 
w 
u 
c 
o 
u 
o 
10 
< 
300 400 
Wavelength I nm) 
Figure 71 b. Absorption spectral traces of GATDC upon addition of CT DNA. Inset: 
Plots of [DNA]/ Sa-Sfvs. [DNA] for the titration ofCTDNA with GATDC, u experimental 
data points: full lines, linear fitting of the data. [GATDC] (2.3 x Uf M. [DNA] 
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Similar hyperchromism was previously observed for transition metal complexes, which 
was attributed to hydrophobic interactions between the ligand and the minor groove of 
DNA [16, 169 217, 238|. DNA possesses several hydrogen bonding sites, which arc 
accessible, both in the minor and major grooves and GATDC contains -Nl I- and multi 
hydroxyl groups of the N-glycosides, which are capable of forming favourable hydrogen 
bonds with DNA base pairs [240]. Nevertheless electrostatic binding of the Sn(lV) atom 
to the phosphate backbone of the DNA double helix could not be ruled out [101, 109, 
215]. 
In order to compare quantitatively the DNA binding affinities of the two complexes the 
intrinsic binding constant Kb has been determined from the eq. 1. The binding constants 
obtained for GATDC and GATPT are 1.4 x 10^  and 3.6 x 10^  M"', respectively. These 
values indicate that GATPT binds more strongly to CT DNA than GATDC. However 
their Kb values are lower than those observed for typical classical intercalator (EB-DNA 
1.4 X 1 oSn 25 mM tris-HCl/ 40 mM NaCl buffer pH = 7.9, 3.0 x 1 OSn 5 mM Tris-HCl/ 
50 mM NaCl buffer, pH = 7.2). 
Emission spectral studies 
GATDC and GATPT are non-emissive at room temperature in DMSO or in presence of 
CT DNA. So the binding of these complexes has been evaluated using competitive 
binding studies involving ethidium bromide (EthBr), which is to emit strongly (X^ x, 480; 
Xem 598 nm) due to its intercalative interaction with DNA [251]. It was previously 
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reported that this enhanced fluorescence could be quenched, partly by the addition of a 
second molecule. The extent of fluorescence quenching of EthBr bound to DNA is 
utilized to determine the extent of binding between the second molecule and DNA [252]. 
The study involves addition of increasing concentration (0.33-1.6 x lO'^ M) of complexes 
with fixed concentration (1.6 x 10"^ M) of CT DNA pretreated with EthBr and then 
measurement of intensity of emission. 
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Figure 72 a. Emission spectra of EthBr bound to DNA in the presence ofGATPTin Tris-
HCl buffer [EthBr] = 2x W^M, [DNA] = 1.6 x W^M, [GATPTJ 0.33-1.6 x W^M, Xe,= 
480 nm, kem= 598 nm. Arrow .shows the intensity changes upon increasing concentration 
ofGATPT 
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The addition of GATPT to CT DNA pretreated witii EthBr causes appreciable reduction 
of the emission intensity, (Figure 72 a) suggesting that GATPT displace DNA-bound 
EthBr and binds to CT DNA strongly [253]. However, very small decrease in emission 
intensity is observed for GATDC (Figure 72 b) indicating weak binding affinity of 
GATDC with CT DNA. Moreover, GATPT contains aromatic ring, which may penetrate 
more freely into the base pairs in DNA, perturbing the DNA helix more than GATDC 
(which do not contain aromatic rings) to displace the bound EthBr more efficiently [254]. 
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Figure 72 b. Emission spectra of EthBr bound to DNA in the presence of GATDC in 
Tris-HCl buffer [EthBr] = 2x 10'^M, [DNA] = 1.6x Iff^M, [GATDC] 0.33-1.6x W^M. 
Xex= 480 nm, Xe,„= 598 nm. Arrow shows the intensity changes upon increasing 
concentration of GATDC 
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The fluorescence quenching curves of EthBr bound to CT DNA by GATDC and GATPT 
are shown in Figure 73. In the plot of IQ/I VS. [M]/[DNAJ, K is given by the ratio of the 
slope to the intercept. The K values for GATPT and GATDC estimated using Eqn. 2 are 
0.20 and 0.15, respectively and suggest that the interaction of GATPT with DNA is 
strong as compared to that with GATDC which is consistent with the absorption spectral 
results. 
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Figure 73 Fluorescence quenching curve of DNA bound EthBr by (a) GATDC and (b) 
T 5 ,-5} GATPT. [EthBr] = 2xlO''M, [DNA] = 1.6x W'M, [complexes] 0.33-1.6x W'M 
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Circular dichroic studies 
Circular dichroism studies are useful in diagnosing changes in the morphology of DNA 
during complex-DNA interactions [255]. The CD spectrum of GATDC exhibits positive 
Cotton effect at 226 nm and negative Cotton effect at 241 nm (Figure 74 curve a). 
Incubation of GATDC with CT DNA resulted in slight increase in the molecular 
ellipticity value of positive band and decrease in the negative band (Figure 74 curve b). 
These results suggest that DNA-binding of GATDC do not affect the conformational 
changes of DNA [237]. While strong CD signals appear for GATPT with a positive peak 
at 252 nm and negative peak at 240 and 273 nm, respectively (Figure 75 curve a). 
Wavelength (nm 
Figure 74. CD spectra of GATDC alone (1 x W' M. DMSO, 25 "C) (curve a) 
presence 1 xW^MofCT DNA (curve b) 
GATDC in 
MofCT  (curve b) 
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Addition of CT DNA causes significant changes in wavelength and ellipticity values of 
GATPT. In presence of CT DNA the peak, position shifts from 252 to 247nm and 240 to 
235 with no change in ellipticity while the intensity of negative ellipticity band at 273 nm 
decreases remarkably (Figure 75 curve b). This reduction of ellipticity has been related to 
the formation of short single stranded segments containing unpaired bases [190]. These 
spectral changes indicate strong interaction of GATPT with CT DNA. Thus, CD spectral 
changes in GATPT on addition of DNA are larger than that of GATDC. Such results 
suggest that the CD spectra closely correlates with DNA binding affinity. 
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Figure 75. CD spectra of GATPT alone (I x Uf M. DMSO. 25 "C) (curve a) GATPT in 
presence J xIO' MofCTDNA. (curve b) 
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Viscosity studies 
To explore further the interaction between the two saccharides Sn (IV) complexes and 
DNA, viscosity measurements were carried out on CT DNA (0.8 x lO'^  M) by varying 
the concentration of the complexes. The effects of the saccharide Sn (IV) complexes on 
the viscosity of CT DNA solution are given in Figure 76. The plot shows that GATDC 
and GATPT had a reverse effect on the relative viscosity of the CT DNA. With the 
addition of GATPT (0.16-0.64 x 10"' M) the relative viscosity of CT DNA significantly 
increase but is less than that for the potential intercalator viz. ethidium bromide, which is 
obviously due to the partial insertion of aromatic ring in between the DNA base pairs 
leading to increase in separation of base pairs at intercalation sites and hence an increase 
in overall DNA contour length [256]. 
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Figure 76. Effects of increasing amount of GATDC (A), GATPT (m) on the relative 
viscosity ofCTDNA at 29 ±0.1 T 
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However, for GATDC the relative viscosity of DNA decreases. The decrease in viscosity 
observed for GATDC suggest the hydrophobic interaction of the N-glycoside ligand with 
DNA surface, encouraged by the stronger hydrogen bonding interactions, leading to 
bending (kinking) of the DNA chain and thus reduces its effective length and 
concomitantly its viscosity [171]. These results are consistent with above spectral studies. 
In vitro antitumour studies 
Based on the results of DNA binding studies of GATPT and GATDC, GATPT in 
particular merits further investigation as potential metal-based antitumour drug. In an 
attempt, to develop novel metal-based drugs with a different therapeutic profile than 
cisplatin, J.J. Bonire and S.P. Fricker [257] observed that simple tin analogue of 
tetraplatin [SnCUCDACH)], where DACH is diaminocyclohexane has little potential 
antitumour activity than diorganotin DACH complexes towards human tumour cell lines. 
Moreover, during the systematic evaluation of antitumour activities of these compounds 
in vitro they have not only demonstrated that phenyltin analogues have greater 
antitumour activity but also established their differential chemosensitivity towards 
different cell lines. In the light of these findings the structural framework of GATPT 
provides a unique reactivity pattern at molecular level. 
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To investigate whether GATPT truly induces apoptosis, MTT assay, DNA fragmentation 
and Hoechst 33342 DNA staining experiments were performed. Furthermore, for the 
mechanistic insight into the GATPT induced apoptosis immunoblot analysis of whole 
cell lysates and mitochondrial extracts were carried out with Bcl-2 and p-53 family 
proteins. Additionally, caspase-3 colorimetric assay was also analyzed which authenticate 
that caspase-3 is indispensable from GATPT triggered apoptosis signaling pathway. 
Effects on cell proliferation 
The growth-inhibitory effect of GATPT was examined on PC-12, SY5Y and N2A cells 
using untreated cells as negative controls. In all the cases, drug treatment in the 
concentration range between 0.5-3|il resulted in a dose dependent inhibition of cell 
survival. The results of these experiments are collected in Figure 77. As can be seen, 
GATPT showed good antitumour activity towards all the cell lines. In PC-12, SY5Y and 
N2A cells, a progressive decrease of cell survival was observed after 12 hours for 
GATPT, when the drug concentration increased. In particular, GATPT showed IC50 value 
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Figure 77. Effect of GATPT on (a) PC-12 (b) SY5Y and (c) N2A proliferation after 12 
hours of treatment. Since GA TPT is DMSO soluble, cells treated M'ith DMSO without 
GA TP T were used as controls 
(50% inhibitory concentration) at 1.5 |il/ml. However, relative number alive cells at this 
concentration slightly vary in the three cell lines. Such differences in cell viabihty 
illustrate that GATPT is selective towards different cell types, which suggest that distinct 
mechanistic pathway is followed [242 -258]. 
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Cytotoxicity of GATPT 
The in vitro cytotoxicity effect of GATPT against PC-12 and SY5Y cell lines was 
analyzed by MTT assay, which serves as an index of cell viability by measuring the 
reduction of tetrazolium salt to a blue formazan product by mitochondrial enzyme 
activity of succinate dehydrogenase in living cells [259]. GATPT in the range of 0.5|al/ml 
to 2|il/ml caused dose dependent cytotoxicity with approximately 50% of the cells having 
lost viability after GATPT treatment at a concentration of 1.5^1/ml as shown in Figure 
78. However, DMSO alone did not inhibit the growth of cells. These results are in 
accordance with those of the counting experiments. 
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Figure 78. Dose-dependent cytotoxic effect of GATPTtowards (a) PC-12 (b) SY5Ycells. 
After 12 hours, cell viability was evaluated by MTT assay. The data expressed as a 
percentage of the control MTT reduction 
Morphological evaluation of GATPT induced apoptosis in SY5Y and PC-12 cells 
To analyze whether GATPT, is able to deliver an apoptotic signal to SY5Y and PC-12 
cells, cells stained with Hoechst 33342 were examined under a fluorescence microscope 
for characteristic morphological changes of apoptosis such as cell shrinkage, nuclear 
fragmentation and chromatin condensation. As shown in Figure 79, after treatment with 
GATPT for 12 hours, a majority of cells had underwent apoptosis and displayed typical 
apoptotic characteristics such as densely stained fragmented or compact nuclei, whereas 
the untreated controls showed intact and viable nuclei. 
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Figure 79. (A) PC-12 (B) 5757 ce//5 /reafef/ with GATPT exhibit nuclear changes 
characteristic of apoptosis. PC-12 (Ab and c) was treated with 1/ul and l.Sfil and SY5Y 
(Bb) were treated with l.Sfil of GATPT for 12 hours. Both treated and untreated cells 
were fixed in 3.7% paraformaldehyde and stained with Hoechst 33342. The 
morphological changes associated with apoptosis were photographed under fluorescence 
microscope. Arrows indicate apoptotic cells displaying fragmented or compacted nuclei 
(Ab and c) (Bb). Untreated cells showing viable and intact nuclei served as controls for 
GATPT treated cells (Aa and Ba) 
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Analysis of DNA fragmentation (DNA laddering) 
To further validate the apoptotic nature resulting from treatment by GATPT, DNA 
fragmentation analysis was performed. A hallmark of apoptosis is nucleosomal 
fragmentation of DNA [260]. A typical laddering pattern, which is believed to occur at 
the later stage in apoptosis, is easier to visualize in PC-12 cell line than in SY5Y cells 
(Figure 80). PC-12 cells were cultured for 24 hours in the presence of different doses 
(0.5-2.5^1) of GATPT, and the DNA was subsequently extracted and separated by 
agarose gel electrophoresis. Treatment of cells with GATPT produced a DNA pattern, 
which was divided into distinct fragments. The appearance of this DNA fragmentation 
''ladder'" is indicative of apoptosis (or programmed cell death) occurring in the cells in 
response to GATPT. 
0 0.5 1.0 1.5 2.0 2.5 Ml 
Figure 80. DNA laddering pattern of PC-12 cells treated with GATPT for 24 hours. DNA 
from Lane 1: control cells, Lane 2: 0.5nl, Lane 3: 1.0^1, Lane 4: 7.5/^ /, Lane 5: 2.0///, 
Lane 6: 2.5/id of GATPT 
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Cell cycle analysis 
To further examine that GATPT induces apoptosis in PC-12 cells, we studied the cell 
cycle profiles of GATPT-treated cells by fluorescence-activated cell sorting (FACS). 
Horizontal line represents DNA content (Gi/M phase cells contain the double amount of 
DNA than G| phase cells During S phase cells are actively replicating DNA so they fit 
between G| and G2/M phase). Vertical line represents number of cells [225]. FACS 
analysis of PC-12 cells exposed to the low concentration (l|j.g/ml) of GATPT showed a 
marked decrease in G2 peak after incubation for 12 hours (Figure 81), indicating a 
decrease in G2/M cells and an increase in GQ/GI phase cells in the cell population during 
the 12 hours treatment [110]. Besides, the apoptotic cells also appeared after 12 hours. 
These experimental results suggest that GATPT inhibits the growth of PC-12 cells by 
inducing ceil cycle arrest as well as apoptosis [261]. 
GATPT-induced apoptosis in PC-12 by intrinsic mitochondrial pathway 
The Bcl-2 family of proteins regulates apoptosis by controlling mitochondrial 
permeability and the release of cyto c. The anti-apoptosis proteins Bcl-2 and Bcl-xL 
reside in the outer mitochondrial wall and inhibit cyto c release. The pro-apoptotic Bcl-2 
proteins are Bad, Bax and Bak reside in the cytosol but translocate to mitochondria 
following death signaling, where they promote the release of cyto c [262]. 
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Figure 81. FACS analysis of GATPT induced apoptosis in PC-12 cells. Flow cytometric 
histogram of PC-12 cells after 12 hours on treatment with 1.5/.d of GATPT. Cells were 
treated with PI and subjected to flow cytometric analysis. The horizontal axis of 
histogram represents DNA content; the vertical axis denotes cell number 
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Reduced Bcl-2 protein level in response to GATPT treatment in PC-12 cells 
To investigate the role of anti-apoptotic members of the Bcl-2 family in the induction of 
apoptosis in PC-12 cells, we determined its expression in untreated and GATPT-treatcd 
cells by Western blot analysis of total cell extracts. As shown in Figure 82, GATPT 
provoked a lower level of expression of Bcl-2 in PC-12 cells as measured after 24 hours 
with different doses of GATPT (0.5-1.5^1). Decline in Bcl-2 level was dose dependent 
and was maximum for cells treated, with \.5\x\ of GATPT. These results support that 
GATPT induced apoptosis is associated with a reduced Bcl-2 protein level [263]. 
0^1 0.5 Ml 1.0 Ml 1.5 Ml 
Bcl-2 
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Figure 82. Protein levels of Bcl-2 determined through Western blotting using total cell 
lysates of PC-12 cells after 24 hours. Controls were used to ensure equal protein loading. 
Protein from Lane 1: untreated cells, Lane 2: 0.5^1 Lane 3: 7.0/J Lane 4: 1.5/^1 of 
GATPT 
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Bax and Bak expression in PC-12 cells after incubation with GATPT 
The most intuitive link between p53-mediated transactivation and apoptosis comes from 
the ability of p53 to control transcription of proapoptotic members of Bcl-2 family. To 
determine whether p53 is involved in GATPT-induced apoptosis, we examined the 
expression of its two direct downstream factors Bax and Bak. PC-12 cells were treated 
uith 1.5|.ig/ml GATPT, harvested at different time points and mitochondrial proteins 
were extracted which were then subjected to Western blot analysis with anti-Bak and 
anti-Bax antibodies as depicted in Figure 83. Expression level of the Bax and Bak in PC-
12 cells were shown to increase as the incubation time proceeded after the treatment of 
GATPT [264-266]. Since it is well known that proapoptotic proteins promotes cell death 
induced by a variety of stimuli, so up regulation of Bax and Bak is evidence of GATPT 
induced apoptosis. 
Bad regulation in apoptotic PC-12 cells 
The proapoptotic Bcl-2 family protein Bad resides in the cytosol but translocate to 
mitochondria following death signaling, where they promote the release of cyto c. Bad 
translocates to mitochondria and forms proapoptotic complex with Bcl-xL. This 
translocation is inhibited by survival factors that induce phosphorylation of Bad, leading 
to its cytosolic sequestration [267-269]. Phosphorylated Bad was seen only in control. No 
Bad was seen even at earliest time point of 15 minutes of GATPT treatment indicating 
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inhibition of piiosphorylation of Bad. No difference was seen in the total levels of Bad in 
mitochondria (Figure 83). 
0 15 45 60 180 min 
Bnk 
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Total bad 
Figure 83. The immunoblot analysis of Bak, Bax, phospho-bad and total bad in 
mitochondrial lysates ofPC-12 cells at indicated time treated with 1.5/ul ofGATPT 
Release of Cytochrome c from mitochondria into the cytosol after incubation with 
GATPT 
The mitochondrial matrix protein cyto c translocates to the cytosol in cells undergoing 
apoptosis and is known to be a direct participant in the activation of caspases [270-271]. 
To explore the role of mitochondria in the induction of apoptosis by GATPT, we 
determined the mitochondrial release of cyto c after GATPT treatment. Mitochondrial 
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and cytosolic extracts were isolated as described in experimental section and subjected to 
western blot analysis. Little cyto c expression was evident in the cytosolic fractions of 
control PC-12 cells (i.e. at 0 hours) with its greatest amount found in the mitochondrial 
fraction at this time (Figure 84). However, after 6 hours of treatment with GATPT 
(l.5^l/ml) cyto c was found in the cytosolic fraction of PC-12 cells and there was a 
concomitant decrease in the mitochondrial levels of this molecule. The release of cyto c 
into the cytosol plateaued after 24 hours of incubation with GATPT, which was well 
correlated with the loss in cyto c from mitochondrial fraction. Collectively the data show 
that PC-12 cells undergoing GATPT induced apoptosis exhibit cyto c release from 
mitochondria into the cytosol. 
cytoplasmic 
extract 
mitochondrial 
extract 
Oh 3h 6h 18h 24h 
*.£i:s?-$M 
control 
Figure 84. Effect of GATPT (1.5/JI) in cultured PC-12 cells on the cytochrome-c levels in 
cytosolic and mitochondrial fractions. Cytosolic and mitochondrial fractions of PC-12 
cells were separated and subjected to Western blotting 
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Role of p53 in the GATPT induced apoptosis 
The p53 tumour suppressor gene is the most frequently mutated gene in human cancer. 
Activation of p53 can lead to either cell cycle arrest and DNA repair or apoptosis [272]. 
p53 is phosphorylated at multiple sites in vivo and by several different protein kinases in 
vitro. DNA damage induces phosphorylation of p53 at Serl5 and Ser20 and leads to 
reduce interaction of p53 with its negative regulator, oncoprotein MDM2. MDM2 
inhibits the accumulation of p53 by targeting it for ubiquitination and proteasomal 
degradation [273]. 
15 45 60 180 min 
phospho-ser20 
p53 
Total p53 
Figure 85. Expression of p-53 proteins. Western blot analysis of nuclear cell extracts of 
PC-12 cells at different time points after treatment with l.Sfxl of GATPT 
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This section examines whether p53 protein is involved in GATPT-induced apoptosis. The 
p53 activity was studied by extracting nuclear protein from GATPT-treated cells and 
monitoring the p53 protein by immunoblot analysis (Figure 85). The p53 protein was 
detectable in the nuclear extract of the untreated cells (Figure 85, lane 1). After an 
exposure to GATPT, the phospho-Ser20 protein level was elevated in a time-dependent 
manner. A GATPT-induced increase in phospho-Ser20 was noticeable at 15, 45 and 60 
minutes (Figure 85, lanes 2, 3, 4) and this increase reached its peak at 180 minutes 
(Figure 85, laneS) during the period of GATPT treatment. However, there was no change 
in the total p-53 on treatment with GATPT. Collectively, these results demonstrate that 
p-53 was activated by GATPT because nuclear p-53 level was increased. 
GATPT induced cell death requires Caspase-3 activation 
Caspases have been reported to play vital roles in executing apoptosis [274-275]. To 
identify the role of caspase involved in the signaling of apoptosis induced by GATPT, we 
examined protein level of active caspase-3 (Figure 86). Short incubation of 2 hours with 
GATPT (1.5|il/ml) increased the protein level of caspase-3 to 966% of the control. 
Incubating PC-12 cells with GATPT for 6 hours resulted in an increase of caspase-3 to 
1933% of the control while a 18 hours incubation with GATPT increased the protein 
level many folds to that of control cells. 
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Figure 86. Caspase activity induced by GATPT (1.5^1) in PC-12 cells at 0 to 18 hours 
was expressed as a percentage of the 0-hour time value 
Conclusions 
The spectroscopic and analytical data presented in this chapter clearly indicate that the 
complexes, GATDC and GATPT are the results of the reaction of N-glycosides with 
tintetrachloride and triphenyltinchloride, respectively. DNA binding ability of the two Sn 
(IV) saccharide complexes were analyzed by absorption, circular dichroism and 
fluorescence spectroscopy along with the viscosity measurements. These techniques were 
successful in elucidating the relative binding affinities and binding modes of the two 
complexes. Corroborative results were obtained across the various techniques and 
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suggested an intercalative mode of DNA binding for GATPT containing phenyl rings and 
hydrogen bonding interactions for GATDC. However, both the complexes show that 
Sn(IV) cation binds preferably to the phosphate backbone of the DNA double helix. 
These results suggest that GATPT is more active than GATDC. 
In order to analyze the molecular level explanation for the effectiveness of GATPT, MTT 
assay, Hoechst 33342 DNA staining, cell cycle analysis, DNA fragmentation, Western 
blot analysis of whole cell lysates and mitochondrial fraction with Bcl-2 and p-53 family 
protein and caspase-3 colorimetric assay have been performed. These mechanistic studies 
have been extremely valuable in arriving at a pathway by which GATPT induces 
apoptosis. Considering cyto-c release from mitochondria, these studies demonstrated that 
GATPT is an inducer of cyto-c release as well as down regulation of Bcl-2, the up-
regulation of proapoptotic proteins (Bax and Bak), the activation of caspase-3, and the 
rupture of lysosomes. The importance of such work lies in the possibility of designing 
novel complexes like GATPT, which show potent antitumour activity against cancer cells 
in vitro and warrants further clinical investigations for their therapeutic use. 
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CHAPTER VI 
New Homodi- and Heterotrinuclear Metal Complexes 
of Schiff Base Compartmental Ligand: Interaction 
Studies of Copper Complexes with Calf-Thymus DNA 
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C H A P T E R VI 
Experimental 
All starting materials were commercially available and used as purchased. Benzaldehyde, 
Ethanolamine, Diethyloxalate, MnCl2.4H20, CoCb-eHsO, NiCb-eH.O and CuCl2-2H20 
were obtained from E. Merck. Phenylhydrazine was received from s. d. fine Chem. Ltd. 
SnCU was purchased from Lancaster. Microanalysis (CHN) was performed using a Carlo 
Erba Analyzer Model 1108. Molar conductances of the solutions (10'^ M) were measured 
at room temperature on a Digisun Electronic Conductivity Bridge. IR spectra were 
obtained on an Interspec 2020 FTIR spectrometer as nujol mull. Electronic spectra were 
recorded on a Systronics 119 spectrophotometer (ESP-300). Solid state EPR spectra of 
the copper complexes were recorded on a Varian E 112 X-band spectrometer at liquid 
nitrogen temperature. The NMR spectra were obtained on a Bruker DRX-300 
spectrometer in CD2CI2 and CDCI3. 
Synthesiserligand [LH2] [C32H32N6O2] 
The ligand LH2 was prepared by employing a three step synthetic method (Scheme 1) To 
a solution of benzaldehyde (5 01 ml, 50 mmol) in MeOH (25 ml) was added phenyl-
hydrazine (4.92 ml, 50 mmol) dropwise with constant stirring, which immediately 
precipitated to give a solid yellow Schiff base. The product was filtered, washed with 
hexane and dried in vacuo. To the solution of Schiff base (3.91 g, 20 mmol) in MeOH (50 
ml) was added diethyloxalate (1.32 ml, 10 mmol) in 2:1 molar ratio. This solution was 
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refluxed for ca. 1 hour and cooled at room temperature, then cone. HCl (5 ml) was added 
dropwise with constant stirring. The resulting mixture was refluxed for ca. 6 hour and 
later the volume of the solution was reduced to half on rotatory evaporator. This solution 
was kept aside for some time while green crystalline solid product appeared which was 
filtered and dried in vacuo. The product separated above (13.33 g, 2 mmol) was dissolved 
in MeOH (25 ml) and ethanolamine (0.32 ml, 4 mmol) was added in 1:2 molar ratio. The 
resultant mixture was set aside till orange solid product LH2 separated out on 
evaporation. It was thoroughly washed with MeOH and dried under vacuum. 
Synthesis of [LCu"2Cl2] [C32H30N6O2CU2CI2] 
To a solution of the ligand LH2 (0.53 g, 1 mmol) in dichloromethane (25 ml) was added 
CuCl2-2H20 (0.34 g, 2 mmol) in MeOH in 1:2 molar ratio. The coloured product was 
isolated by slow evaporation of the resultant mixture, filtered, washed with hexane and 
dried in vacuo. 
Synthesis of [LMn"2Cl2] IC32H3oN602Mn2Cl2] 
Ligand LH2 (0.53 g, 1 mmol) in dichloromethane (25 ml) and MnCl2.4H20 (0.32 g, 2 
mmol) in MeOH were added together. The resulting mixture was set aside for slow 
evaporation. A green solid product obtained, was filtered off, washed with hexane and 
dried in vacuo. 
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Synthesis of ILCo"2Cl2] [C32H30N6O2C02CI2] 
To a methanolic solution of CoCl2-6H20 (0.47 g, 2 minol) was added ligand LH2 (0.53 g, 
1 mmol) in dichloromethane (25 ml). The reaction mixture was left for sometime for 
slow evaporation, a brown solid product was collected, washed thoroughly with hexane 
and dried in vacuo. 
Synthesis of ILNi"2Cl2l [C32H3oN602Ni2Cl2] 
To a solution of the ligand LH? (0.53 g, 1 mmol) in dichloromethane (25 ml) was added 
NiCl2-6H20 (0.47 g, 2 mmol) in MeOH in 1:2 molar ratio. The reddish brown coloured 
product was isolated by slow evaporation of the resultant mixture, filtered, washed with 
hexane and dried in vacuo. 
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Synthesis of tLCu"2Sn'^ 'Cl6] [C32H3oN602Cu2SnCl6] 
To a solution of complex LCu"2Cl2 (0.72 g, 1 mmol) in dichlorometliane (25 ml) was 
added SnCl4 solution (0.11 ml, I mmol) in CCI4 (5 ml). The resulting solution was kept 
aside for 4 hour until dark purple solid was separated. The product was isolated, washed 
thoroughly with hexane and dried in vacuo. 
Synthesis of the complex [LNi"2Sn'^ Cl6] [C32H3oN602Ni2SnCl6] 
LNi'SCb (0.71 g, 1 mmol) complex was dissolved in dichloromethane was allowed to 
react with SnCU (0.11 ml, 1 mmol) in CCI4 (5 ml). On slow evaporation dark brown solid 
was obtained. The product was isolated, washed thoroughly with hexane and dried in 
vacuo. 
R R 
/Ph 
I^Ph ' 
R R 
LM^fcb LIv^IsLb. 
M=Cu(lI),Ni(II) 
Scheme 6b 
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Results and discussion 
Schiff base compartmental ligand abbreviated LH2 was synthesized by a three step 
synthetic route represented in Scheme 5, which contains two donor set N? and N2O2. The 
dinuclear complexes LCu"2Cl2, LMn'^Cb, LCo'^Cb, LNi'^Cb and trinuclear complexes 
l.Cu"2Sn'^ CI(„ LNi"2Sn''^ Ci6 were synthesized and characterized by various physico-
chemical methods. Their proposed structures are shown in Scheme 6 a,b. In the ligand 
LH2, diazine N-N nitrogen atoms do not participate in bond formation due to the 
formation of a three membered ring, which will be unstable. Thus, only terminal nitrogen 
atoms of diazine participate in complexation with two chloride ions in inner sphere 
showing a square planar environment around the metal ion. This is also authenticated by 
elemental analysis and conductance data, which show that the complex is covalent in 
nature. However, in N2O2 cavity of ligand LH2, two Schiff base nitrogens and oxygen 
atoms are involved in coordination with the second metal ion by substitution of 2Cr as 
2HC1. The second metal ion in the N2O2 environment exhibit rhombic geometry. 
Furthermore, homodinuclear complexes were further metallated with SnCU to achieve 
new hetero trinuclear complexes of the type [LM'^Sn'^Cle] where M= Cu(ll) and Ni(II). 
Both the complexes are air stable, soluble in CH2CI2, DMF and DMSO (Table 14). 
IR spectra 
The IR spectrum of the ligand LH2 reveals two characteristic bands at ca. 1651 cm'' and 
1688 cm'' attributed to azomethine o(C=N) groups [276]. In the complexes LCu"2Cl2, 
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LMn"2Cl2, LCo"2Cl2 and LNi"2Cl2 the peak at 1651 cm'' remains unaltered indicating 
that the two azomethine groups of N—N diazine linkage are not involved in complex 
formation. However, the band at 1688 cm'' was shifted to lower frequency (70-80 cm" ) 
exhibiting the coordination of azomethine nitrogen atom of N2O2 cavity to the metal ions. 
Coupled with this observation, the free ligand (LH2) also shows peaks at 1025 cm'' and 
1509 cm'' assigned to u(N—N) and i)(C—N) groups, respectively [277]. The shift in 
u(N—N) and u(C—N) bands to lower frequency by ca. 18-27 cm'' support the 
involvement of two nitrogen atoms of diazine linkage in complexation. The x)(0—H) band 
at 3305 cm' in the free ligand [278] is absent in the spectra of complexes suggesting 
deprotonation of alcoholic group in coordination. This is further confirmed by the 
appearance of u(M—N), u(M—CI) and D(M—O) absorptions at 530-537 cm"', 360-365 
cm"' and 475-482 cm'', respectively in the far IR region (Table 15). In addition, 
complexes LCu"2Sn'^ Cl6 and LNi"2Sn'^ Cl6 show one distinct u(Sn—0) band at 465-470 
cm'' confirming the formation of trinuclear complexes [279]. 
Electronic spectra 
The absorption spectrum of the ligand LH2 recorded at room temperature in 
dichloromethane exhibits one sharp band at 380 nm assigned to n-> n* transition 
associated with the azomethine chromophore. The absorption spectrum of complex 
LCu"2Cl2 shows a broad band at 532 nm attributed to ^Bjg -* ^Aig transition, [280] which 
is well within the range of 500-555 nm expected for square planar and rhombic Cu(II) 
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complexes. Both square planar and rhombic geometries exhibit d-d absorption bands in 
same region, therefore it is difficult to distinguish these absorption bands [281]. The 
tetrahedral complexes also exhibit a narrow band below 100 nm. However, no such bands 
are observed in the present complexes, thus ruling out tetrahedral or pseudo tetrahedral 
geometry. The complex LNi"2Cl2 has diamagnetic behaviour and its electronic spectrum 
shows a shoulder at 497 nm ascribed to 'Aig -^ 'Big transition supporting the square 
planar geometry around Ni(II) ion [228]. The weak bands at 470 nm and 446 nm in 
complexes LMn"2Cl2 and LCo"2Cl2, respectively, also support the square planar 
geometry of the metal ions [201]. 
NMR studies 
'H and '^ C NMR spectra of the ligand (LH2), complexes LNi"2Cl2 and LNi"2Sn'^ Cl6 
recorded in CD2CI2 and CDCI3 exhibits characteristic signals observed at 6.8-7.2 ppm 
and 7.9-8.2 ppm [282] assigned to aromatic protons and azomethine groups, respectively, 
suggesting the nonparticipation of azomethine group present in the complex formation. 
Additionally, 'H NMR spectrum of the ligand LH2 reveals two signals at 3.5 ppm and 6.2 
ppm attributed to CH2O group [232] and OH group respectively. On complexation, the 
resonance of CH2O group shifted slightly downfield relative to the free ligand, supporting 
the coordination of CH2O group to the metal center in the N2O2 tetradentate Schiff base 
cavity. However, the signal observed at 6.2 ppm ascribed to OH group [283] completely 
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disappears which confirms the coordination of the metal to oxygen atom by the 
elimination of two HCl molecules (Table 16). 
The complex LNi"2Sn'^ Cl6 show well-resolved '^ C NMR spectrum characterized by 
chemical shifts significantly different from those observed in the free ligand and complex 
LNi"2Cl2. The peak at 125 ppm is attributed to C=N which is slightly high field in 
comparison to free ligand indicating the coordination of C=N group to metal center in 
complex LNi"2Cl2. The '^ C NMR spectrum of complex LNi"2Sn'^ Cl6 exhibits signals at 
77.0 ppm and 126 ppm ascribed to N-CH2- CH2-O and Ar-C group, respectively 
(Table 17). 
Cyclic voltammetry studies 
The electrochemical methods are complementary tools over the previously used methods 
of studying interaction of complexes towards CT DNA. The cyclic voltammograms (CV) 
of complexes LCu"2Cl2 and LCu"2Sn'^ Cl6 were obtained in H2O/DMSO (95:5) solution, 
at scan rate 0.2 Vs'' over a potential range from 1.6 to -1.2V. In the absence of CT DNA, 
the anodic peak potential (Epa) of complex LCu"2Cl2 appeared at -0.48 V and the 
cathodic (Epc) at -0.58 V (Figure 87 a). The CV of complex LCu"2Cl2 reveals a one 
electron quasireversible wave attributed to the redox couple Cu(ll)/Cu(l) with the formal 
electrode potential, E°= -0.53 V, the ratio of anodic peak current to cathodic peak current 
(Ipa/lpc) is 0.47 and AEp = + 0.10 V which is larger than the Nernstian value observed for 
the one electron transfer couple. On addition of CT DNA, the complex 
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Figure 87. Cyclic voltammogram (scan rate 0.2 Vs', DMSO, 25\ pH 7.5) of (a.) complex 
LCu"2Cl2 alone and (h) complex LCu"2Cl2 in presence ofCTDNA. [LCu"2Cl2] 1x1 ff^ M, 
[DNA]6xW^ M 
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LCu"2Cl2 shows a shift in Epc (-0.58 V), Epa(-0.47 V) and AEp (0.10 V) values indicating 
strong binding of dinuclear complex with CT DNA (Figure 87 b). The decrease in ratio of 
anodic to cathodic peak currents from 0.47 to 0.33 signify that adsorption of Cu(I) is 
enhanced in the presence of CT DNA [147]. Further, the shift in E° value and increase in 
peak height potentials suggest that both Cu(II) and Cu(I) form of complex LCu"2Cl2 bind 
to CT DNA [210]. The ratio of equilibrium constants K+yK2+for the binding of the Cu(II) 
and Cu(l) forms of complex LCu"2Cl2 to CT DNA have also been calculated using the 
following equation (Scheme 7) 
Eb°-Ef° = 0.059 log (K+/K2+) 
suggesting that both Cu(ll) and Cu(I) forms interact with DNA to the same extent [233]. 
Cu"+e' 
A 
K2+ 
Cu"-CTDNA+e" 
Cu' 
A 
KH 
Cu'-CTDNA 
Scheme 7 
The cyclic voltammogram of complex LCu 2Sn CU in absence of CT DNA shows AEp 
= 0.10 V (Figure 88 a.) In addition to changes in the formal potential, the voltammetric 
peak currents decrease upon addition of CT DNA to the complex (Figure 88 b). 
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Figure 88. Cyclic voltammogram (scan rate 0.2 Vs'. DMSO, 25", pH 7.5) of (a) complex 
LCu"2Sn'^Cl6 (b) complex LCu"2Sn'^Cl6 in presence of CT DMA at different time 
intervals. [LCu'.Sn'^Ck] i x 10'^ M, [DNA] 6x 10'^ M 
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The decrease in current may be due to the diffusion of an equilibrium mixture of free and 
DNA-bound metal complex to the electrode surface [284]. The cyclic voltammogram is 
not affected by tin atom, as tin atom is not readily accessible to the electrode surface in 
this range [285]. 
Absorption spectral features of DNA binding 
Electronic absorption spectroscopy is universally employed to determine the binding of 
complexes with DNA. Figure 89 shows the absorption spectra of complex LCu"2Cl2 and 
LCu"2Sn'^ Cl6 (1.6 X 10'^  M) in the presence of increasing amounts of CT DNA (1.6 - 6.4 
X 10'^  M). In the UV region, complex LCu"2Cl2 shows an intense absorption band at 256 
nm attributed to ligand to metal charge transfer (LMCT) band. The interaction of 
complex LCu"2Cl2 with CT DNA results small perturbation in LMCT band with red shift 
of 2 nm which is probably due to the binding of the complex LCu"2Cl2 to the DNA bases 
through covalent bond formation at the vacant position of the coordination sphere of the 
metal ion [214, 218]. On the other hand, complex LCu"2Sn'^ Cl6 displays two well 
resolved bands at 252 nm and 325 nm attributed to LMCT bands. Upon the addition of 
CT DNA, complex LCu"2Sn'^ Cl6 exhibits hyperchromism in both the absorption bands. 
There is also an appreciable blue shift of 5 nm in one of the LMCT bands, from 325-320 
nm. The increase in absorbance and blue shift of 5 nm in this region suggests that 
complex LCu"2Sn'^ Cl6 strongly binds to CT DNA. Such findings in the light of previous 
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Figure 89. Absorption spectral traces of (a) complex LCu"2Cl2 (b) complex LCii'2Sn'^Cl6 
in Tris HCl buffer (0.01 M, pH 7.5) upon addition ofCTDNA. Inset: Plots of [DNA]/Sa-
SfVS. [DNA] for the titration of CT DNA with complexes; m: experimental data points, 
full lines: linear fitting of the data. [Complex] 1.6x10'^ M, [DNA] 1.6-6.4 x 10'^ M 
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reports [215, 240, 286] support the view that complex LCu"2Sn'^ Cl6 possess three metal 
centers, two Cu(II) and one Sn(IV) atom having different specificity at the molecular 
level. Complex LCu"2Sn''^ Cl6 has better prospectus as an antitumour agent than complex 
LCu"2Cl2 as it contains one Sn(IV) atom, a hard Lewis acid which additionally binds 
electrostatically to the phosphate backbone of the DNA helix [110] while the Cu(II) 
center may preferentially coordinate with the N? position of guanine, thus perturb the 
hydrogen bonding between the base pairs and results in destabilization of DNA [287]. In 
fact, Sn(IV) phosphate binding has been detected both in solution and solid state [99, 
288]. 
Quantitative parameter binding constant Kb has also been calculated to compare the 
binding affinity of complexes LCu"2Cl2 and LCu"2Sn'^ Cl6 towards CT DNA. The Kb 
values for complexes LCu"2Cl2 and LCu"2Sn'^ Cl6 are 3.2 x 10^  M"' and 9.6 x 10^  M"', 
respectively. The Kb value of complex LCu '2Sn'^ Cl6 is higher than that of complex 
LCu"2Cl2 but is lower than those observed for classical intercalators (EB-DNA 1.4 x 10^  
in 25 mM tris-HCl/ 40 mM NaCI buffer pH = 7.9, 3.0 x lOSn 5 mM Tris-HCl/ 50 mM 
NaCl buffer, pH = 7.2). This is an indicative of the binding of the complexes with CT 
DNA but with an affinity less than the classical intercalators. 
Fluorescence studies 
No luminescence was observed for the complexes LCu"2Cl2 and LCu"2Sn'^ Cl6 upon 
excitation at the n—>7i* band either in DMSO or in the presence of CT DNA. 
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Figure 90. Emission spectra of EthBr bound to DNA in the presence of (a) complex 
LCu"2Cl2 (b) complex LCu"2Sn'^Cl6 in Tris-HCl buffer [EthBr] =2x 10'^ M. [DNA] = 1 
X 10'*M, [complex] = 0-8 x 10'^ M, Xex= 510nm, Xem= 610nm 
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Hence competitive binding studies using EthBr bound to DNA was carried out for these 
complexes. The quenching extent of fluorescence of EthBr bound to DNA is utilized to 
determine the extent of binding of complexes and DNA [289]. Binding of the complex 
results in the displacement of bound EthBr molecule with the reduction of emission 
intensity due to fluorescence quenching of free EthBr by water [290]. 
The emission spectra of EthBr bound to DNA in presence and absence of complex 
LCu"2Cl2 and LCu"2Sn'^ Cl6 are given in Figure 90. The addition of the complex 
LCu"2Sn'^ Cl6 to CT DNA pretreated with EthBr causes appreciable reduction in the 
emission intensity, indicating that the displacement of the EthBr fluorophore by the 
complex LCu"2Sn'^ Cl6 results in a decrease of the binding of the ethidium to the DNA 
[171, 291]. However, slight decrease in emission intensity is observed for the complex 
LCu"2Cl2 indicating low binding affinity of complex LCu"2Cl2 with CT DNA in 
comparison to complex LCu"2Sn''^ Cl6. 
The fluorescence-quenching curves of EthBr bound to DNA by the complex LCu"2Cl2 
and LCu"2Sn'Xl6 are shown in Figure 91. The Stern-Volmer quenching constant K 
values for complexes LCu"2Sn'^ Cl6 and LCu"2Cl2 are 0.45 and 0.10, respectively, [290] 
suggesting that complex LCu"2Sn'^ Cl6 interacts with CT DNA more strongly in 
comparison to complex LCu"2Cl2 which is consistent with the absorption studies results. 
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Figure 91. Fluorescence quenching curve of DNA bound Eth Br by complex LCu 2CI2 (•) 
complex LCu"2Sn'^Cl6 (•) [EthBr] = 2 x W^M, [DNA] = 1 x W'M, [complex] = 0-8 x 
10'^ M. 
Viscosity studies 
To further clarify the binding modes of the complex LCu"2Cl2 and LCu"2Sn'^ Cl6 with 
DNA, viscosity measurements were carried out. There is a marked effect of complexes 
LCu"2Cl2 and LCu"2Sn'^ Cl6 on the viscosity of CT DNA as depicted in Figure 92. With 
an increasing amount of complex LCu"2Sn'^ Cl6, the relative viscosity of DNA decreases 
while the increasing amount of complex LCu"2Cl2 further reduces the effective length of 
DNA which supports that both the complex LCu"2Cl2 and LCu"2Sn'^ Cl6 bind through 
partial non classical intercalation mode but with different affinity. However, complex 
LCu 2Sn' Cl6 shows strong binding in comparison to complex LCu"2Cl2 presumably due 
to electrostatic interaction with DNA [237]. 
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Figure 92. Effects of increasing amount of complex LCu 2CI2 (•), and complex 
LCu"2Sn'^Cl6 (•) on the relative viscosity ofCTDNA at 29 ± 0.l"C. [DNA] = 5x10'^M, 
pH7.5 
Conclusions 
The new homodinuclear complexes LCu"2Cl2, LMn"2Cl2, LCo"2Cl2, LNi"2Cl2 and 
heterotrinuc lear complexes LCu"2Sn'^ Cl6, LNi"2Sn'^ Cl6 were synthesized from 
compartmental Schiff base ligand containing N2 and N2O2 donor sets in different 
environments. The interaction studies of complex LCu"2Cl2 and LCu"2Sn'^ Cl6 with CT 
DNA were carried out employing absorption studies, cyclic voltammetry, fluorescence 
studies and viscosity measurements. Analysis of the results suggests that heterotrinuclear 
complex LCu"2Sn'^ Cl6 binds to CT DNA mainly by electrostatic interaction that is 
different from the binding mode of homodinuclear complex LCu'^Cb. The Kb values of 
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complex LCu"2Cl2 and LCu"2Sn'^ Cl6 is 3.2 x 10^  M''and 9.6 x 10^  M"', respectively 
which indicate that the complex LCu"2Sn'^ Cl6 binds more avidly to CT DNA than 
complex LCu"2Cl2 which is quite evident as complex LCu"2Sn'^ Cl6 possess three metal 
centers. The two 'copper' centers may be associated covalently or by non- covalent 
interactions, however the 'tin' metal ion, a hard Lewis acid binds electrostatically to 
neutralize the dinegative charge of phosphate sugar and brings structural and 
conformational changes in DNA helix. These studies suggest that complex LCu"2Sn'^ Cl6 
having tin modulation has a better prospectus as an antitumour agent than the complex 
LCu"2Cl2 which may have activity only due to copper metal ions. 
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CHAPTER VII 
Template Synthesis of Novel Carboxamide Dinuclear 
Copper (II) Complex: Spectral Characterization and 
Reactivity towards Calf-Thymus DNA 
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CHAPTER VII 
Experimental 
All reagents were of the best commercial grade and were used without further 
purification. Phthalic anhydride, CUCI2.2H2O, NiCl2.6H20 were procured from E. Merck 
and l,8-diamino-3,6-diazaoctane from Fluka. Microanalyses were performed using Carlo 
Erba Analyzer Model 1108. Copper and nickel contents were determined on GBC 932 
Pius atomic absorption spectrophotometer. Molar conductances were measured at room 
temperature on a Digisun Electronic conductivity Bridge. Fourier-transform IR (FTIR) 
soectra were recorded on an Interspec 2020 FTIR spectrometer, as KBr pellets. UV/vis 
spectra were recorded on a USB 2000 Ocean Optics spectrometer and the data were 
reported as Xmax/nm. The solid state EPR spectrum of the copper complex was acquired 
on a Varian E 112 spectrometer using X-band frequency (9.1GHz) at LNT. ESI-MS 
spectra were recorded on Micromass Quattro II triple quadrupole mass spectrometer. The 
NMR spectra were obtained on a Bruker DRX-300 spectrometer. 
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Synthesis of Bis [aqua l,8-(l,2-dicarboxamido benzene)-3,6-diazaoctane copper (II)] 
tetrachloride [MacCu2(BC)]Cl4 [C28H44N8O6CU2CI4] 
l,8-diamino-3,6-diazaoctane (2.98 ml, 20 mmol) was added dropwise to the ethanolic 
solution of CUCI2.2H2O (3.40 g, 20 mmol) in a 1:1 molar ratio. The resulting deep blue 
solution, was stirred at 25 °C for 30 minute and subsequently phthalic anhydride (2.90 g, 
20 mmol) dissolved in 25 ml ethanol was added to it. The reaction mixture was refluxed 
for ca. 1 hour and a light blue solid product was obtained. The product was filtered, 
washed with ethanol and dried in vacuo. 
Synthesis of Bis [aqua l,8-(l,2-dicarboxamido benzene)-3,6-diazaoctane nickel (II)] 
tetrachloride [MacNi2(BC)]Cl4 [C28H44N806Ni2Cl4] 
To the ethanolic solution of NiCl2.6H20 (4.74 g, 20 mmol) was added dropwise 1,8-
diamino-3,6-diazaoctane (2.98 ml, 20 mmol) in a 1:1 molar ratio. The resulting purple 
solution, was stirred at 25 C for 20 minutes and subsequently phthalic anhydride (2.90 g, 
20 mmol) dissolved in 20 ml ethanol was added to it. The reaction mixture turned green, 
which was refluxed for ca. 4 hours and a light green solid product was obtained. The 
product was filtered, washed with ethanol and dried in vacuo. 
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-N U ,H ? 
+ 2M CI2 (hydrated) + 2 
-NH2 HjN 1 
/ 
1,8-Diamino-3,6diazaoctane Phthalic anhydride 
•2H2O EtOH 
-1 ^ / h P , 
H20-M JTM^OH^ 
I oAh/ \ I — 
CL 
M = Cu(ll),Ni(ll) 
Scheme 8 
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Results and discussion 
The synthetic procedure for the complexes is illustrated in Scheme 8. CHN analysis and 
spectral data (UV/vis, IR, EPR, 'H , '^C N M R , and atomic absorption) were consistent 
with the proposed formulation of the dinuclear complexes. The new complexes 
[MacCu2(BC)]Cl4 and [MacNiiCBQJCU are air and moisture stable solids with solubility 
in water and DMSO, respectively but they are insoluble in methanol and diethyl ether. 
The molar conductance value of [MacCu2(BC)]Cl4 and [MacNi2(BC)]Cl4 in water and 
DMSO, respectively indicates that these complexes are 1: 4 electrolytes (Table 18). 
Analytical data revealed that the complexes contain two metal centers and a water 
molecule in the coordination sphere. These indications were further supported by atomic 
absorption data and IR spectral bands. DNA binding studies were performed with the 
Cu(II) complex and analogous Ni(II) complex was synthesized only for NMR studies. 
IR Spectral studies 
The IR spectra of the complexes [MacCu2(BC)]Cl4 and [MacNi2(BC)]Cl4 showed 
characteristic bands in the region 3150-3268 cm"' ascribed to \)(N-H) of carboxamide 
moiety [292]. A medium intensity sharp band was observed in the region 1704-1713 cm"' 
assigned to u(C=0) of carboxamide linkage [293]. Previous reports on carboxamide 
ligands also support these assignments [294-295] and confirm the non-involvement of 
>C=0 group in coordination with the metal ion. Additionally, signals at -1394, -2877 
and -2933 cm"' were attributed to u(C-N), •u(CH2) and aromatic v(CH) 
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vibrations, respectively. A broad band in the range 3300-3500 cm"', assigned to D(O-H) 
of the water molecule present in the lattice or coordinated to metal ion was observed in 
the complexes [215]. The far IR spectra of the complexes [MacCu2(BC)]Cl4 and 
[MacNi2(BC)]Cl4 exhibited absorptions at 416 and 433 cm'', ascribed to u(Cu-N) and 
u(Ni-N), respectively (Table 19). 
Absorption spectral studies 
The absorption spectra of the complexes [MacCu2(BC)]Cl4 and [MacNi2(BC)]Cl4 
(1x10"^  M) were recorded at 25°C in H2O and DMSO, respectively in 200-800 nm as 
depicted in Figure 93. The solution spectra of the complexes were observed as three 
distinct bands. Complex [MacCu2(BC)]C!4 displayed a weak broad band around 619 nm 
due to d-d transition of the cupric ion. This band was assigned to dxz, dyz -^ d-^-y^ 
transition characteristic of square pyramidal geometry of Cu(II) complexes [296]. The 
diamagnetic Ni(II) complex [MacNi2(BC)]Cl4 showed a d-d band at 576 nm, assigned to 
^B|(F) -^ ^E(F) transition. The Xmax value was consistent with a pentacoordinate 
environment around the Ni(II) ion [297]. In addition, complex [MacCu2(BC)]Cl4 and 
[MacNi2(BC)]Cl4 displayed two strong bands in the UV region one at 245 nm attributed 
to intraligand charge transfer transitions and another at 268 nm assigned to ligand to 
metal charge transfer transition. 
200 
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Wovelengthtnm) 
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Figure 93. Absorption spectra of [MacCujfBCJJCl^ (1x10'^ M) in HjO (curve a) 
[MacNi2(BC)]Cl^ (IxW^ M) in DMSO (curve b) in the spectral range 220-800 nm 
NMR spectral studies 
The complex [MacNi2(BC)]Cl4 was characterized by ' H and '^ C NMR spectroscopy in 
DMS0-d6 (Figure 94). The ' H NMR spectrum of the complex [MacNi2(BC)]Cl4 showed 
signals for aliphatic and aromatic protons with chemical shift values in accordance with 
the proposed structure. The 'H NMR spectrum revealed characteristic signal at 8.1 ppm 
of the amide -NH proton [298]. Multiplets in the range of 7.8-7.4 ppm arise due to 
aromatic protons. Signals due to CH2 protons (adjacent to amide -NH proton) were 
observed from 4.2-3.1 ppm [299]. Furthermore, resonances at 3.0 and 2.9-2.6 ppm were 
assigned to (NCH2) and NCH2CH2 protons of presence of l,8-diamino-3,6-diazaoctane 
[228]. 
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ppm i2 10 
Figure 94. 'HNMR spectrum of complex [MacNi2(BC)]CU in DMSO-do 
The '^C NMR spectrum of complex [MacNi2(BC)]Cl4 exhibited a characteristic signal at 
167.8 ppm due to >C=0 functional group of amide linkage (Figure 95) [300]. 
Additionally multiplets in the region 122-134 ppm were ascribed to aromatic carbons. 
Signals in the range 35.3-40.3 ppm were assigned to N-C-C-N carbon atoms [148]. Thus 
' H and'^C NMR data are in well agreement with the proposed structure (Table 20). 
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175 150 125 100 75 ' SO 23 ppa 
13 Figure 95. C NMR spectrum of complex [MacNi2(BC)]Cl4 in DMSO-de 
EPR spectral studies 
The X-band electron paramagnetic resonance spectrum of complex [MacCu2(BC)]Cl4 
was recorded at frequency of 9.1GHz under the magnetic field strength 3000 ± 1000 
gauss using TCNE as field marker at LNT. Generally, the spectral parameters reflect the 
usual increase of the equatorial ligand field in four coordinate complexes vs. the five 
coordinate counterparts. The complex [MacCu2(BC)]Cl4 showed an anisotropic spectrum 
with different g|| and g± values. The EPR spectrum of complex [MacCu2(BC)]Cl4 
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exhibited gn = 2.20, gi = 2.04 values and gav. = 2.09 computed from the formula 
gav'^  = g||^+2gi^/3. The values gy and g± were in good agreement with an essentially dx -y 
copper (II) ground state and were anticipated for square pyramidal geometry [301]. The 
order gy >gi> ge (2.0023) further confirm that the ground state of copper (II) is 
predominantly dx% .^ The g values are also related to the axial symmetry parameter, G, 
by the expression G = (g||-2)/(gi-2). The G value measures the extent of the exchange 
interaction between two copper centers in the polycrystalline solids. If G<4, considerable 
exchange interaction occurs, whereas if G>4 exchange interaction is negligible. In the 
present case G = 4.56 which confirm that the two Cu(II) centers are too far apart to 
interact with each other [302]. 
DNA binding studies 
Metal complexes generally bind to DNA both through covalent as well as non covalent 
modes. When the present dinuclear Cu(II) complex interacts with DNA, the two labile 
water molecules in the complex are replaced by a nucleophiles on DNA, usually a 
nitrogenous base such as guanine N?, leading to a strong covalent binding of the complex 
with DNA [303]. In addition, incorporation of more than one Cu(Il) center in a single 
complex produces enhanced electrostatic interactions to the anionic DNA phosphate 
backbone and facilitates its binding to DNA [304]. The mode and propensity of binding 
of the complex [MacCu2(BC)]Cl4 to calf thymus DNA has been detected by absorption 
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titration, fluorescence spectroscopy, circular dichroism studies, cyclic voltammetry and 
viscosity measurement. 
Absorption studies 
Electronic absorption spectroscopy is universally employed to determine the binding of 
complexes with the DNA helix. Any interaction between the complex and DNA is 
expected to perturb the ligand centered spectral transitions of the complex [33]. The 
absorption spectrum of complex [MacCu2(BC)]Cl4, exhibited bands around 245, 268 and 
619 nm. On the incremental addition of CT DNA (0.8 - 4.1 x lO""* M) to the complex 
[MacCu2(BC)]Cl4 (1.6 x 10'^  M), a considerable increase in molar absorptivity (Figure 
96) 
a 
0.83 1.6 2.5 3.3 4.1 
[DNA]/[Cu] 
Figure 96, Hyperchromism of complex [MacCu2(BC)]Cl4 upon addition of CT DNA at 
245 nm 
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accompanied by a red shift of 7 and 12 nm, respectively of the 7t —» TC absorption bands 
was observed. The hyperchromic and hypochromic effects are the spectral features of 
DNA binding concerning its double helix structure [236]. Therefore, the observed 
hyperchromic changes in the UV spectrum of the complex [MacCu2(BC)]Cl4 suggest 
strong binding of CT DNA, probably due to covalent bonding (Figure 97). 
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Figure 97. UV spectral traces of complex [MacCuiiBQJCU, in Tris-HCl buffer (0.01 M, 
pH 7.2) upon addition ofCTDNA. Inset: Plots of [DNA]/ Sa-S/vs. [DNA] for the titration 
ofCTDNA with complex [MacCu2(BC)]Cl4, and linear fitting of the data. Concentration 
of[MacCu2(BC)]Cl4 = 1.6x 10'^ M. [DNA] = 0.8-4.1 x 10'^ M 
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Structurally, complex [MacCu2(BC)]Cl4 provides two water molecules directly attached 
to the metal ion, which can be replaced by a nucleophile in DNA, usually a nitrogenous 
base such as guanine (N?) leading to a strong binding of the complex [MacCu2(BC)]Cl4 
[31, 250, 305]. The present ligand system lack extended 7i-systems thus ruling out the 
possibility of any intercalative interactions but have the potential to bind to DNA 
covalently. Furthermore, appreciable changes are observed also in the ligand field (LF) 
band of the complex [MacCu2(BC)]Cl4. Intensity of the LF band at 619 nm was found to 
decrease (hypochromism) with the addition of CT DNA as shown in Figure 98. 
400 500 600 
Wavelength (nm) 
700 800 
Figure 98. Absorption spectral traces of complex [MacCu2(BC)JCl4, in Tris HCl buffer 
(0.01 M, pH 7.2) upon addition of CT DNA in the LF band. Concentration of 
[MacCu2(BC)]Cl4= 1.6x W" M. [DNA] ^ 0.8-4.1 x W" M 
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These results further support that the complex [MacCu2(BC)]Cl4 is coordinated 
presumably to a DNA base such as guanine N7 [161, 173]. Additionally, a strong 
hydrophobic interaction between the macrocyclic moiety and the hydrophobic DNA 
interior is plausible [171]. It is interesting that the complex [MacCu2(BC)]Cl4 may 
sterically clash with the DNA surface, and the coordinated -NH- and carbonyl oxygens 
of complex [MacCu2(BC)]Cl4 may involve in hydrogen bonding with the N7/O6 sites of 
the intrastrand guanine bases. Therefore, it is reasonable to asses that complex 
[MacCu2(BC)]Cl4 binds covalently to CT DNA. Nevertheless, hydrogen-bonding 
interactions cannot be ruled out. Our results are consistent with a number of earlier 
reports on DNA interaction [132, 237]. 
To enable quantitative estimation of DNA binding affinity of complex [MacCu2(BC)]Cl4, 
the intrinsic binding constant Kb was determined using eq (1) by concomitant recording 
of the UV traces with increasing concentration of DNA. The intrinsic binding constant Kb 
for complex [MacCu2(BC)]Cl4 was determined as Kj^  = 1.95 x 10^ M"' which is of lower 
magnitude than those of classical intercalator (EB-DNA 1.4 x 10^  M"l in 25 mM tris-
HCl/ 40 mM NaCl buffer pH = 7.9, 3.0 x 10^  M'! in 5 mM Tris-HCl/ 50 mM NaCl 
buffer, pH = 7.2). 
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Emission spectral studies 
As the complex [MacCu2(BC)]Cl4 is non-emissive both in the presence and absence of 
CT DNA, competitive ethidium bromide (EthBr) binding studies were undertaken to gain 
support for the mode of binding of the complex [MacCu2(BC)]Cl4 with DNA. The 
molecular fluorophore EthBr emits intense fluorescence in the presence of CT DNA due 
to its strong intercalation between the adjacent DNA base pairs and stabilization of its 
excited state [251]. The study involves addition of the complexes to DNA pretreated with 
EthBr and then measurement of emission intensities of DNA-bound EthBr. The extent of 
quenching of fluorescence of EthBr bound to DNA would reflect the extent of binding of 
complexes to DNA [289]. 
Two mechanisms have been proposed to account for the quenching of EthBr emission, 
the replacement of the molecular fluorophores (if complexes binds to DNA more strongly 
than EthBr) and/or by electron transfer. The non replacement-based quenching has been 
correlated with DNA-mediated electron transfer from the excited EthBr to an acceptor 
(e.g. cupric ion, Cu^ "^ ) [161]. The emission intensity of DNA-bound EthBr is quenched 
considerably on addition of complex [MacCu2(BC)]Cl4 (Figure 99). As complex 
[MacCu2(BC)]Cl4 binds to DNA via covalent bonding, it cannot displace the strongly 
DNA-bound EthBr. So the observed quenching is obviously due to the facile 
intramolecular photo induced electron transfer from the excited EthBr to complex 
[MacCu2(BC)]Cl4 bound to DNA {Em 140mV) [306]. Perhaps, it is possible that the low 
energy ligand based % orbitals in complex [MacCu2(BC)]Cl4 facilitate the photo induced 
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electron transfer. Besides, the more rigid and shorter A-like conformation of DNA, is 
likely stabilized by the complex [MacCu2(BC)]Cl4 through hydrophobic interaction in 
DNA grooves is also not suitable for intercalative interaction by EthBr leading to its 
destabilization of the excited state of bound EthBr [169]. 
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Figure 99. Emission spectra of EthBr bound to DNA in the presence of complex 
[MacCu2(BC)]Cl4 in Tris-HCl buffer. [EthBr] = 2 x 10'^ M, [DNA] = 0.3 x 10'^M, 
[complex] = 0 - 1.2 x 10' M. Arrow shows the intensity change upon increasing 
concentration of the complex [MacCu2(BC)]Cl4 
The fluorescence quenching curve of EthBr bound to DNA by the complex 
[MacCu2(BC)]Cl4 is shown in Figure 100. The quenching plot illustrate that the 
quenching of EthBr bound to DNA by the complex [MacCu2(BC)]Cl4 is in good 
210 
agreement with the linear Stern-Volmer equation. The value of quenching constant K for 
the complex [MacCuiCBQjCU estimated using eq. (2) is 0.16, suggesting the strong 
interaction of the complex [MacCu2(BC)]Cl4 with DNA, which is consistent with the 
above absorption spectral results. 
1 2 3 
[Cu]/tDNA] 
Figure 100. Fluorescence quenching curve of DNA bound EthBr by complex 
[MacCu2(BC)]Cl4. [EthBr] = 2 xlO'^M, [DNA] = 0.3 x 10"'M. [complex] = 0-1.2x W^ 
M 
Circular dichroic spectral studies 
The circular dichroic spectrum of calf thymus DNA exhibited a band at 278 nm due to 
base stacking and at 248 nm, due to right handed helicity (Figure 101, curve a). These 
bands are quite sensitive to the mode of DNA interaction with complexes [307]. On 
interaction with metal complexes, the changes in the CD spectrum of DNA may 
correspond to the changes in DNA structure [308]. Simple groove binders and 
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electrostatic interaction of complexes show less or no perturbation on the base-stacking 
and helicity bands, while intercalators enhance the intensities of both the bands 
stabilizing the right-handed B conformation of CT DNA as observed for classical 
intercalator [309]. 
220 240 260 280 300 
Wovelength (nm) 
320 
Figure 101. CD spectra ofCTDNA alone (curve a) (1 x 10"' M. Tris HCl buffer, 25"C, 
pH 7.2) CTDNA in presence of complex fMacCu2(BC)JCl^ (1 x J0"'M) (curve b) 
Upon addition of complex [MacCu2(BC)]Cl4, the CD spectrum of DNA undergoes 
changes in both the positive and negative bands (Figure 101, curve b) with slight shift in 
the band positions. In the presence of complex [MacCu2(BC)]Cl4, the positive band 
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showed remarkable decrease in molar ellipticity revealing significant Cu(ll) complex-CT 
DNA interaction [218]. The extended K systems reduce the helical twist angle of the 
DNA base pairs and increase the intensity of the base-stacking band [310-311]. Thus the 
decrease in the stacking band on addition of complex [MacCu2(BC)]Cl4 rules out the 
intercalation mode of binding. Furthermore, decrease in the intensity of DNA helicity 
band indicates the hydrophobic interaction of -NH- groups with DNA. Such spectral 
changes are characteristic of B to A conformational change [254]. These CD spectral 
results support that the complex [MacCu2(BC)]Cl4 interact with CT DNA, and that the 
binding event induces certain conformational changes in DNA. 
Viscometry studies 
To support the DNA binding mode, viscosity measurements complex [MacCu2(BC)]Cl4 
bound to DNA has been undertaken. The changes in the specific relative viscosity of 
DNA on addition of increasing concentrations of complex [MacCu2(BC)]Cl4 are shown 
in Figure 102. The decrease in relative viscosity of DNA observed for the complex 
[MacCu2(BC)]Cl4 suggest covalent binding of the complex [MacCu2(BC)]Cl4 with CT 
DNA, which produced bends or kinks in the DNA and thus reduced its effective length 
and concomitantly its viscosity [161]. These result suggests that complex 
[MacCu2(BC)]Cl4 may bind to DNA covalently. 
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Figure 102, Effects of increasing amount of complex [MacCu2(BC)]Cl4 on the relative 
viscosity ofCTDNA at 29.00 ± 0.01 "C. [DNA] = 4x W^ M, pH 7.2 
Redox studies 
Cyclic voltammetry has been employed to study the interaction of the complex 
[MacCu2(BC)]Cl4 with CT DNA with a view to further explore the DNA binding modes 
assessed from the absorption, emission and viscometric studies. The cyclic 
voltammogram of the complex [MacCu2(BC)]Cl4 in the absence of CT DNA (Figure 103, 
curve a) reveal a non-Nernstian but a fairly reversible/quasi-reversible one electron redox 
process involving the Cu(Il)/Cu(I) couple, as judged from the peak potential separation 
(A£p) and formal potential (£1/2) of 1 lOmV (59mV for one electron transfer process) and 
230mV, respectively. At different scan rates, the cyclic voltammogram did not show any 
major changes. 
214 
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Figure 103. Cyclic voltammogram (scan rate 0.1 Vs'', H2O, 25"C, pH 7.2) of complex 
[MacCu2(BC)]Cl4 alone (curve a) and complex [MacCu2(BC)]Cl4 in presence of CT 
DNA. (curve b). Concentration of[MacCu2(BC)]Cl4 1x10'^ M. [DNA] 6x10'^ M 
Keeping ail the parameters constant (T= 25°C, scan rate O.i Vs'', potential range 0.60 to -
0.10 V), complex [MacCu2(BC)]Cl4 experienced a significant reduction in catliodic peak 
current on addition of DNA (Figure 103, curve b) wiiicii was due to the slow diffusion of 
an equilibrium mixture of the free and DNA-bound complex [MacCu2(BC)]Cl4 to the 
electrode surface [250]. Further, the observed shift (90 mV) in E\a value to more negative 
potential suggest that both Cu(Il) and Cu(I) forms of the complex [MacCu2(BC)]Cl4 bind 
to DNA but with Cu(ll) displaying higher DNA binding affinity than Cu(I) form [303]. 
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This is illustrated by the ratio of the equilibrium constants {K+/K2+) for the binding of 
Cu(I) and Cu(II) species to DNA. The value has been estimated from the net shift in E\/2 
on the addition of DNA assuming reversible electron transfer using the following 
equation: 
A - ^ f = 0.0591 \ogiKJK2+) 
where '^^ b and £P{ are the formal potentials of the Cu(II)/Cu(I) couple in the bound and 
free forms, respectively, and K+ and K2+ the corresponding binding constants for the 
binding of the 1+ and 2+ species to DNA, respectively (Scheme 9). The K+IK2+ value for 
complex [MacCu2(BC)]Cl4 is 0.03, which is less than unity suggesting preferential 
stabilization of Cu(II) form over Cu(I) form on binding to DNA [210, 233]. 
Cu"+e 
K-•2+ 
Cu"-CTDMA4e 
A 
Ki. 
^ Cii'-CTDNA 
Scheme 9 
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Conclusion 
The spectroscopic and analytical data presented above clearly indicate that the dinuclear 
Cu(Il)/Ni(ll) complexes resulting from the reaction between l,8-diamino-3,6-
diazaoctane, CuCl2.4H20/NiCl2.6H20 and phthalic anhydride contain two benzene-1,2 
dicarboxamide units closed by (CH2)2-NH-(CH2)2-NH-(CH2)2 links. The dinuclear 
Cu(ll) complex is highly water soluble and exhibit square pyramidal geometry with two 
water molecules coordinated to metal ion. The biological target of this complex is 
unknown, however, we have shown here that the complex [MacCu2(BC)]Cl4 is able to 
bind to CT DNA under physiological pH 7.2. Supported by the various DNA binding 
experiments, it is likely that complex [MacCu2(BC)]Cl4 interacts covalently with DNA, 
by replacement of the coordinated H2O molecules with DNA bases. In addition, the 
presence of coordinated -NH- groups facilitates hydrogen-bonding interactions with 
DNA. Therefore, the DNA binding studies of complex [MacCu2(BC)]Cl4 could provide 
information good enough for the rational design of new hydro soluble DNA binding 
agent. The final scope of this work is to better understand the interaction of water-soluble 
copper complex with DNA in view of its potential application in chemotherapy. 
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